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When I first entered the study of hormone action, some 25 
years ago, there was a widespread feeling among biologists 
that hormone action could not be studied meaningfully in the 
absence of organized cell structure.  
 
However, as I reflected on the history of biochemistry, it 
seemed to me there was a real possibility that hormones might 
act at the molecular level. 
 
— Earl W. Sutherland, Nobel Address, 1971 
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SUMMARY 
During the last two and a half decades a large body of research has accumulated indicating the presence 
of various natural and synthetic chemical compounds within the environment capable of inducing 
hormone-like responses in humans and animals.  Such compounds, termed endocrine disruptors, have 
been implicated in a variety of developmental, reproductive and physiological abnormalities which have 
been shown to converge on the endocrine system.  Given that endocrine disrupters are comprised of a 
diverse group of molecules with dissimilar chemical structures, general screening techniques are not 
feasible for effective environmental monitoring.  A primary method of action by which these exogenous 
molecules affect the homeostatic regulation of the endocrine system is believed to be via the modulation 
of gene transcription.  It is now well established that many endocrine disrupting compounds act upon a 
principal group of transcription factors, the nuclear receptors, by chance interaction with the ligand 
binding domains of these proteins. 
With a view to ultimately design a portable kit for the detection of endocrine disrupting compounds in 
water based on the bio-specific immobilisation of nuclear receptor ligand binding domains to a stationary 
membrane matrix, this study specifically describes: 
1. The effects on recombinant protein expression by the addition of small molecules to the 
cultivation media of bacteria. 
2. The optimisation of conditions for the lysis of bacterial cells to increase the solubility of 
heterologously expressed proteins. 
3. The purification of recombinant proteins from bacterial cell lysates by means of a two-step 
chromatographic methodology. 
4. The cloning of the genes for the human androgen and estrogen receptors’ ligand binding domains 
into baculovirus transfer plasmids. 
5. Transfer of genetic material from the created baculovirus transfer plasmids to a linearised 
baculovirus genome for the generation of recombinant viruses. 
6. The cultivation, and baculoviral infection, of Spodoptera frugiperda and Trichoplusia ni cell 
lines. 
7. Expression and purification of N-terminal hexahistidine-tagged human nuclear receptor LBDs 
from insect cell lysates by means of immobilised metal affinity chromatography. 
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OPSOMMING 
Die teenwoordigheid van natuurlike en sintetiese chemiese middels wat oor die vermoë beskik om die 
aksies van hormone in die mens en dier na te boots het toenemend aftrek gekry in navorsing gedurende 
die laaste twee en ’n halwe dekades.  'n Verskeidenheid van ontwikkelings-, reproduktiewe- en 
fisiologiese abnormaliteite ontstaan as gevolg van die aksies van hierdie molekule, genaamd endokriene-
ontwrigters, op die natuurlike funksionering van die endokriene-sisteem.  Gegewe dat die groep chemiese 
middels waaruit endokriene-ontwrigters bestaan van diverse oorsprong afkomstig is lei dit daartoe dat 
algemene analitiese tegnieke nie in alle gevalle geskik is vir effektiewe omgewingsmonitering is nie.  Die 
modulasie van geentranskripsie is een van die metodes wat voorgestel word as ’n metode waarop hierdie 
eksogene molekule die homeostatiese regulering deur die endokriene-sisteem omverwerp.  ’n Algemene 
metode waarop vele endokrien-ontwrigtende stowwe geentranskripsie beïnvloed, is deur interaksie met 
die hormoon-bindende gedeeltes van ’n belangrike groep transkripsiefaktore, die nukluêre reseptore. 
Hierdie studie, met die uiteindelike ontwikkeling van ’n draagbare toetsstelsel vir die opsporing van 
endokrien-ontwrigtende-stowwe in water, gebasseer op die bio-spesifieke immobilisering van nukluêre 
reseptor ligand bindingsdomeins op ’n stasionêre membraanmatriks, het ten doel om die volgende te 
beskryf: 
1. Die effek wat die byvoeging van klein molekule tot die groeimedium van bakteriëe het op die 
uitdrukking van rekombinante proteïene. 
2. Die optimisering van bakteriese sel-lisering in terme van verhoging in die oplosbaarheid van 
heteroloë proteïene. 
3. Die suiwering van rekombinante proteïen vanuit bakteriese sellisate deur middel van ’n twee-stap 
chromatografiese sisteem. 
4. Die klonering van die gene vir die menslike androgeen en estrogeen reseptore se ligand 
bindingsdomeine in bakulovirus oordragplasmiede. 
5. Die oordrag van genetiese materiaal vanaf hierdie bakulovirus oordragplasmiede na ’n 
gelineariseerde bakulovirus genoom deur middel van homoloë rekombinasie vir die produksie 
van rekombinante virusse. 
6. Die groei en infeksie van Spodoptera frugiperda en Trichoplusia ni sellyne wat lei tot die 
uitdrukking van menssoortgelyke nukluêre reseptor ligandbindingsdomains. 
7. Suiwering van N-terminaal heksahistidien-etiket-gekoppelde menslike nukluêre reseptor 
ligandbindingsdomeins vanuit inseksellisate deur middel van geïmmobiliseerde metaal 
affiniteitschromatografie. 
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CHAPTER 1 
INTRODUCTION 
Numerous natural and synthetic chemical compounds, which are ubiquitous in the environment, have 
been discovered to bring about hormone-like responses.  Such compounds have been implicated in a 
variety of developmental, reproductive and physiological abnormalities which have been shown to 
converge on the endocrine system (1).  This large group of molecules, aptly termed endocrine disrupting 
chemicals (EDCs), consists of a heterogeneous mixture of pharmaceuticals, pesticides, industrial 
chemicals, fuels, heavy metals, plastics and plasticisers; with the particular identities of many still 
remaining unknown.  The environmental concentrations of these chemicals are generally very low.  
Nevertheless, some have been shown to be highly persistent in nature (2, 3) and since the effects of EDCs 
might be seen at very low concentrations, concerns have arisen about the effects of complex mixtures of 
chemicals occurring at such levels (4).  Moreover, since many of these molecules are of a hydrophobic 
nature it has been suggested that bio-accumulation may occur within trophic webs, leading to higher than 
environmental exposure to wildlife and humans (5).  Initial reports of EDC impact on wildlife and the 
subsequent studies on the aetiology of multiple human physiological states, including cancers of the 
breast and prostate, cryptorchidism, endometriosis and metabolic disorders have led to the scientific 
understanding that EDCs pose a prominent threat to human and animal health.  Consequently, several 
thousand articles have been written prior to, and subsequently to, the original coining of the term 
‘endocrine disruptor’ at the Wingspread Conference Centre in Racine, Wisconsin, in 1991 (6).  In its 
simplest form an endocrine disruptor is “an exogenous substance or mixture that alters function(s) of the 
endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or 
(sub)populations”; and a potential endocrine disruptor is “an exogenous substance or mixture that 
possesses properties that might be expected to lead to endocrine disruption in an intact organism, or its 
progeny, or (sub)populations” (7). 
The presence of EDCs is a global environmental issue.  Certain persistent organic pollutants (POPs), such 
as organochlorine (OC), various pharmaceuticals and personal care products (PPCP), polybrominated 
diphenyl ethers (PBDEs), dichlorodiphenyltrichloroethane (DDT) and hexachlorocyclohexane (HCH) 
have been reported as far as the Arctic and Antarctic regions (8–10).  Many of these compounds have 
also been identified in the Lake Tanganyika basin in Tanzania (11), while measurable concentrations of 
the EDCs nonylphenol (NP), bisphenol A (BPA) and phenolic steroids hormones such as estrone, 17α-
estradiol, 17β-estradiol and 17α-ethinylestradiol was found to be present at concentrations varying from 
20 pg/L to 135 ng/L in a study of drinking water, sewage treatment effluent and river systems in 
Germany (12).  Recently, high concentrations of the malarial vector controlling agent DDT, and its 
metabolites, have been identified within the blood and breast milk of nursing mothers in South Africa 
(13).  Subsequently, these compounds have also been detected at levels ranging between 0.8 ng/g to 
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123 ng/g of sediment at locations in southern Africa’s largest natural freshwater lake, Lake Sibaya, in 
northern KwaZulu-Natal (14).  These results are of critical concern, since studies suggest an association 
between pre- and post natal exposure to DDT and urogenital malformations in new-born boys (15).  
Furthermore, mounting evidence supports a link between non-occupational exposure to DDT and reduced 
semen quality in men (16), as well as altered retinoid and thyroid hormone profiles (17). 
A hallmark of these contaminants, and other EDCs, is the ability to elicit endocrine responses at 
extremely low concentrations (parts per billion to parts per trillion).  The modes of action by which EDCs 
affect molecular physiology involve divergent pathways.  These mechanisms include regulatory actions 
mediated by the nuclear receptors for estrogens, androgens, thyroid hormone, retinoids, and other 
hormones.  Moreover, steroidogenic enzymes, neurotransmitter receptors and many other pathways, 
which are highly conserved in wildlife and humans, are targets for disruption by exogenous molecules.  
Given that there are numerous EDCs that can negatively affect humans and wildlife, general screening 
techniques based on chemical structures are not feasible for effective environmental monitoring.  The 
impracticality of analysing samples for all possible known EDCs, even neglecting unknown EDCs, 
necessitates the production of a system that may selectively concentrate specific molecules by some 
property, such as analogous molecular responses.  At concentrated levels such molecules may be readily 
detected by standard colorimetric techniques.  Biologically based assays (BBAs) may provide major 
advantages by estimating the total effects of many EDCs in the environment (18).  These techniques may 
potentially be adapted for field portable biologically directed sampling and analyses. 
In light of the phenomenon of endocrine disruption via the nuclear receptors, and a requirement for the 
development of rapid, sensitive and economical means of EDC detection, the current study was initiated 
with the following aims in mind: 
1. to gain a thorough understanding of the structure and functions of nuclear receptors with regards 
to gene expression and the maintenance of cellular homeostasis from available literature;  
2. to identify and discuss the mechanisms by which homeostatic control over such processes may be 
disrupted by exogenous molecules; 
3. to review the most prominent existing approaches of heterologous protein production in various 
expression systems; 
4. the synthesis of the human androgen and estrogen receptor ligand binding domains, in soluble 
forms, using heterologous expression systems; 
5. the purification of the expressed recombinant proteins from complex cell lysates via affinity 
chromatography; 
6. and the validation of steroid binding activity of the purified proteins towards natural endogenous 
ligands. 
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The endocrine system is involved in various aspects of cellular regulation.  Hormones secreted by the 
endocrine glands, or which act as paracrine or autocrine signals, interact with multiple cellular pathways 
to exert control over diverse processes involved in growth, adaptation and proliferation.  Within the 
classical context of endocrinology small lipophilic molecules serve as chemical messengers that alter the 
expression of specific genes via cognate nuclear receptors.  In the current study, chapter two discusses the 
classification and organisation of the nuclear receptor superfamily, with specific reference to the family 
of steroid receptors.  The mechanisms involved in the activation of nuclear receptors, as well as more 
recent ideas on the hormonal management of cellular processes by endogenous ligands to the estrogen 
receptor are presented.  It is now well established that EDCs may interfere with homeostatic control by 
mixed mechanisms, including the activation of signalling cascades, the disruption of regulatory feedback 
loops and hormonal transport systems, and the alteration of gene expression via complementary 
interaction with nuclear receptors.  Consequently, there is a growing need for the detection of chemical 
pollutants within the environment, especially within aquatic systems.  Several of the methods commonly 
used for EDC detection are introduced, along with some of the inherent drawbacks associated with such 
techniques.  The construction of a rapid, on-site monitoring system, based on the interaction of EDCs 
with specific nuclear receptors, may serve as an auxiliary means to identify whether water sources are 
contaminated with specific classes of EDCs.  Consequently, the major recombinant expression systems 
used for the production of heterologous proteins are presented, with the intention of producing human-
like proteins for the design and fabrication of a novel EDC detection kit. 
Escherichia coli is the most widely used expression host for both structural analysis and screening of 
protein targets (19–21).  Consequently, the bacterial expression of the genes for the ligand binding 
domains of human androgen and estrogen receptors are discussed in the third chapter.  Within the cytosol 
of human cells the relatively hydrophobic nuclear receptor proteins are associated with stabilising protein 
complexes.  However, eukaryotic proteins expressed heterologously in prokaryotic cells are not afforded 
the added stability of these molecular chaperones.  Therefore, a challenging step in the expression of any 
protein or protein fragment is predicting whether such a construct can be produced in large, active 
quantities; considering many heterologous proteins express poorly or fold improperly in bacterial 
expression systems.  Thus, the efforts to increase the solubility of human-like proteins capable of binding 
natural steroid ligands and exogenous compounds, which have been expressed in E. coli, are conveyed.  
Furthermore, attempts to purify these proteins in functional forms are addressed by the use of 
immobilised metal affinity chromatography (IMAC) and immobilised ligand affinity chromatography. 
A contrasting system to prokaryotic heterologous protein production, the baculovirus expression vector 
system (BEVS), is presented in chapter four.  Baculoviruses form a big family of insect pathogens with 
large, double-stranded, circular genomes packaged in rod-shaped, enveloped nucleocapsids.  These 
viruses produce lethal infections in their hosts by appropriation of cellular transcriptional and 
translational machinery for viral replication, followed by cellular degeneration (22).  In the natural 
environment synthesised virions are protected after death of the insect host within crystalline matrices 
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known as occlusion bodies (OB).  BEVS relies on the infection of insects, or insect cells in culture, with 
an engineered vector capable of high level recombinant protein expression.  Within the confines of tissue 
culture experiments the formation of OB are not a prerequisite for viral replication or the production of 
infectious particles.  As a result, the viral genes encoding for the major proteins of OB, polyhedrin 
(nucleopolyhedroviruses) or granulin (granuloviruses), may be exchanged for heterologous genes.  The 
generation of recombinant baculoviruses expressing the human androgen and estrogen receptor ligand 
binding domains, in lieu of polyhedrin, is described in chapter four.  These recombinant proteins were 
subsequently purified by means of IMAC and subjected to radioligand binding assays to establish 
functionality.  A comparison between the two expression systems, BEVS and E. coli, is presented at the 
end of the chapter. 
In the final chapter the conclusions drawn from the results obtained in this study, and the implications for 
future work, are discussed.  The ability to detect EDCs within the environment is paramount in the 
development of strategies to reduce the effects these exogenous chemical compounds on human and 
animal health.  Therefore, a supplementary approach to the detection methods described in chapter two, 
based on the molecular conformation changes that occur upon receptor-ligand interaction, is also 
described. 
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CHAPTER 2 
OVERVIEW OF EXISTING LITERATURE PERTAINING TO THE 
ENDOCRINE SYSTEM, CHEMICAL DISRUPTION AND 
HETEROLOGOUS PROTEIN EXPRESSION 
The neuroendocrine system is an intricately connected web of control elements, signal transducers and 
effectors, of which diverging and converging pathways are in continual communication.  The specialised 
tissues and organs of multicellular organisms, such as human beings, require the essential integration of 
hormonal signals for the coordination of metabolic activities.  Receptors to various classes of lipophilic 
and hydrophilic ligands serve as binding sites for endocrine, paracrine and autocrine hormones.  Binding 
of peptides or small lipophilic molecules to cognate receptors initiate cascades of molecular events which 
direct the biological fate of the cells.  Tissue responsiveness to specific hormones are constrained and 
defined by the particular combination of membrane bound and cytosolic receptors available to cells.  
Moreover, hormonal action in different cells housing the same receptors may vary widely due to alternate 
intercellular targets.  Structural complementarity of a ligand to the three-dimensional arrangement of the 
receptor ligand binding pockets (LBP) results in high affinity coordinating binding between the two 
molecules.  As a result, hormones elicit cellular events at very low concentrations.  The molecular events 
that occur upon ligand binding are extremely selective, thus structurally similar hormones may elicit 
alternative responses within the same cell.  Accordingly, the receptors of the neuroendocrine system are 
choice targets for the development of pharmaceutical agents to address aetiologies relating to hormonally 
controlled bioprocesses. 
A current focus for endocrinologists is the potential of chemicals, discarded into human water treatment 
facilities or present in everyday life, to affect the molecular functioning of the endocrine system.  Several 
scientific reviews published by, for example, the Endocrine Society (1), the European Commission (23, 
24), the European Environment Agency (25) and the Endocrine Disrupters Expert Advisory Group (26) 
have discussed advances in the evaluation of potential EDCs, with specific focus on exposure risks, 
adverse effects on human and animal health, mechanisms of endocrine disruption and applied screening 
systems.  Since the first formal definition of endocrine disruption, the effects of these exogenous 
compounds have been linked to a multitude of disease states at different periods of the life cycle, 
including cancer, genetic modification, organ malfunction, metabolic syndromes and reproductive 
dysregulation.  It is now well established that EDCs may interfere with the maintenance of cellular 
homeostasis by mixed mechanisms, including the activation of signalling cascades, the disruption of 
regulatory feedback loops and hormonal transport systems, and the alteration of gene expression via 
complementary interaction with nuclear receptors. 
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2.1 DISRUPTERS OF THE ENDOCRINE SYSTEM 
Concern about the prevalence of hormones in drinking water (27), as well as the environmental effects of 
chlorinated hydrocarbons and other pesticides, have been raised as early as the 1960.  Spurred by Rachel 
Carson’s book, Silent Spring, a report by the President’s Science Advisory Committee that focused on 
pesticides and other substances, specifically including steroid hormones, proposed that “there must be an 
awareness of long-range and possibly synergistic effects of low-level amounts of toxic or physiologically 
active substances” (28).  However, already prior to that time, several studies indicated that exogenous 
compounds could interact and modulate the mechanisms governing the functions of the endocrine system 
by mimicry of endogenous ligands (29–32). 
Initial reports of the presence of several human hormones and pharmaceuticals in aquatic environments 
and water treatment facilities were published during the 1970s and 1980s (33, 34).  Apart from a few 
publications (35–38), these early reports did not attract significant investigation due to mere trace level 
detection, and a lack of knowledge of the possible toxicology of these substances (39, 40).  Nevertheless 
the small contributions have multiplied, and steadily a picture has emerged in which there may be 
astounding credence to the earliest statements that focused our attention on the phenomena of endocrine 
disruption (41).  It is now known that trace concentrations of EDCs can significantly alter the 
reproductive cycles and cellular homeostatic control mechanisms of animals by affecting the biological 
systems governing gene transcription, molecular transport and metabolism.  Numerous EDCs are present 
in the environment, the majority of which may exhibit only mediocre hormonal activity; yet certain 
molecules have been developed to specifically act upon the endocrine system.  Furthermore, EDCs that 
are present at low levels may elicit endocrine actions with physiological or reproductive relevance by 
non-monotonic dose responses (NMDR) (4). 
Recently, the effects of 17β-trenbolone [17β-17-hydroxyestra-4,9,11-trien-3-one; TREN] were shown to 
persist in the model organism Danio rerio, the zebrafish, following discontinuation of exposure to the 
potent androgen (2).  The zebrafish is sensitive to changes in its hormonal milieu and therefore it has 
routinely been employed as an indicator of reproductive endocrine disruption (42).  Known side-effects 
resulting from the abuse of potent synthetic androgens such as TREN, including neuropsychiatric 
disorders, sterility, gynaecomastia and testicular atrophy in males, and virilisation in females, are 
prevalent in athletes desiring increased muscle mass and strength (43, 44).  Yet in developed countries, 
the parent drug trenbolone acetate [17β-acetoxyestra-4,9,11-triene-3-one; TBA], is routinely used as a 
livestock growth promoter (45–47) to increase lean muscle mass with higher feed conversion efficiency.  
Consequently, the metabolites of TBA (TREN, 17α-trenbolone [17α-hydroxy-estra-4,9,11-trien-3-one] 
and trendione [estra-4,9,11-trien-3,17-dione]) have become environmental androgens due to urinary and 
faecal excretion with increased run-off to soil and surface water.  With relative binding affinity to the 
androgen receptor similar to DHT (48), the modulation of the AR by exogenous growth promoting 
agents, such as TREN, have been shown to induce endocrine, developmental, morphological, 
immunological, neurobiological, immunotoxic, genotoxic and carcinogenic effects in aquatic organisms 
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associated with concentrated animal feeding operation sites (45, 49–51) and epidemiological studies have 
provided evidence in support of a link between the amount of red meat and other animal-products 
consumed and the aetiology of certain forms of hormone-dependent cancers (52–54). 
There are, however, multiple ways of entry for steroid hormones and other EDCs to soil, aquatic systems 
and dietary sources.  The growing and aging global population has increased demand for intensive food 
production and has stimulated a need for escalated pharmaceutical utilisation.  It is estimated that several 
thousand tonnes of pharmacologically active substances are consumed and released into the environment 
every year due to pronounced use in animal husbandry and aquaculture, along with veterinary and 
medical practices (55, 56).  Many of these chemical compounds are distributed to land surfaces owing to 
the application of dry sewage biosolids for fertiliser or aqueous sewage effluent for irrigation (56).  A 
range of such pharmaceuticals have been shown to be persistent in the environment due to low 
biodegradability.  For example, the antidepressant fluoxetine (FX), the active ingredient in the most 
widely prescribed psychoactive drug, Prozac
®
, has an estimated dissipation half-life in receiving water of 
112 – 113 days (3).  FX is commonly detected downstream from point-sources of municipal waste 
effluent and, because of the ubiquitous use of the drug, such sampling areas are continually exposed to 
renewed insults of the drug.  Hazelton et al. (57) investigated the behaviour and physiology of the 
freshwater wavy-rayed lampmussel (Lampsilis fasciola) upon chronic exposure to FX and found 
significant alterations in the movement patterns and rates of lure display between treated and untreated 
mussels (57).  Furthermore, the presence of FX in aquatic and marine waters, at environmentally relevant 
concentrations, have been linked to detrimental effects in the Mediterranean mussel (Mytilus 
galloprovincialis) by affecting cAMP/PKA signalling and gene transcription regulation (58). 
Carter et al. (59) highlights the concern expressed over the detection of pharmaceuticals in soil as a 
number of studies have indicated the presence of human and veterinary medication, including 
antidepressants, anticonvulsants, nonsteroidal anti-inflammatory drugs and antibiotics in crops and plants.  
In a study on the fate and uptake of compounds covering a diverse range of physicochemical properties 
certain pharmaceuticals, notably the anticonvulsant carbamazepine (CBZ), FX, and propranolol, a 
sympatholytic nonselective beta blocker, were found to persist in soil unchanged for at least 40 days (59).  
Pharmaceuticals and chemical compounds that enter the municipal waste stream, including personal care 
products and other EDCs, and the subsequent application of treated water and biosolids to land as plant 
nutrients have also raised concern about intake by soil- or sediment-ingesting organisms or possible 
bioaccumulation in plants, with subsequent transferral to higher trophic levels (5).  For example, higher 
levels of two antimicrobial agents, triclocarban and triclosan, were detected in the soil and earthworms at 
a site treated with biosolids, as compared to a control site.  Moreover, the concentrations of these 
compounds were significantly higher in the eggs of European starlings (Sturnus vulgaris) nesting on 
biosolid-applied land while nesting success of another bird species, the American kestrel (Falco 
sparverius), was significantly lower compared to an untreated site (60); indicating that antimicrobial 
agents can be transferred from soil to secondary and tertiary consumers where it impacts not only on 
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reproduction, but also on behavioural success.  Yet with an estimated half-life of 18 days (59, 61), 
triclosan, and other pharmaceutical products, do not persist in soil or water to the extent exhibited by 
drugs such as FX and CBZ.  Nevertheless, their continual release to surface waters results in their 
classification as pseudo-persistent and some studies have indicated an apparent link between low-level 
chronic exposure and observed detrimental effects in aquatic and terrestrial organisms (62).  Moreover, 
these emerging pollutants are of concern not only because of the harmful effects that they inflict on the 
endocrine system, but also because of possible increases in the development of antibiotic resistance in 
bacteria due to their ubiquitous and constant presence (63).  Such concerns are sure to be intensified in 
light of a growing global human population; and emerging pollutants are likely to increase within the 
environment, thus supplementing the deleterious effects on human and animal endocrine health posed by 
traditional EDCs, including natural and synthetic hormones, phenol-derived compounds, phthalates and 
pesticides. 
Ultimately, the challenge is to elucidate the mechanism of actions of EDCs thus providing a basis of 
assessment of isolated, and possible synergistic, effects on human and animal well-being.  Rigorous 
clinical trials and regulatory bodies in the pharmaceutical industry enforce the assessment of medication 
influence on human physiology.  However, the ecological risk and impact of thousands of drugs, or drug 
metabolites, upon wildlife populations following excretion is not well researched.  A further challenge is 
the determination of causal links, rather than effects (64), between initial exposure to EDCs and 
subsequent adverse effects; which may occur years or decades later in mammalian life, or within the 
offspring of exposed individuals, as in the well-known case of diethylstilboestrol (65–70).  Historically, 
much of the focus has been on the developmental and reproductive effects of EDCs.  Accordingly, much 
more is known about the effects of compounds identified at the inception of the endocrine disruption 
research era which are known to inappropriately activate or antagonise the sex steroid receptors (71).  For 
example, owing to its omnipresence the estrogenic and antiandrogenic activities of bisphenol A and its 
analogues have been widely cited (72–77).  As a result, most of the initial research into the phenomena of 
endocrine disruption has been centred on the interruption or modulation of the processes governing gene 
transcription, with a specific focus on nuclear receptors; mostly with particular reference to the androgen, 
estrogen and thyroid hormone receptors.  From this early work the realisation sprouted that EDCs may 
“interfere with the synthesis, secretion, transport, binding, action, or elimination of natural hormones in 
the body that is responsible for the maintenance of homeostasis, reproduction, development, and/or 
behaviour” (78).  Consequently, many other proteins have also been implicated as targets for disruption.  
For instance, entrance of a molecule to the cell interior is dependent on its concentration within the 
extracellular environment.  In serum the concentration of androgens and estrogens are controlled by sex 
hormone binding globulins (SHBG).  Various EDCs capable of binding to the AR, ER or α-fetoprotein 
can also interact with the SHBG, thus inhibiting the binding of endogenous sex steroids to these transport 
proteins (79).  Consequently, sex steroid mediated gene transcription is interrupted, resulting in 
perturbation of negative feedback loops governing secretion of the key regulatory hormones of the 
hypothalamic-pituitary-gonadal axis (177).  Furthermore, localised within the cell membranes of certain 
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reproductive tissues are receptors to which SHBG can bind.  The interaction of the hormone conjugated 
SHBG is proposed to initiate cAMP mediated signalling cascades (81–84).  Binding of EDCs to SHBG 
may therefore activate signal transduction pathways, thus further modulating steroid hormone action. 
Moreover, transcriptional regulation is governed by a complex web of protein-protein interaction and 
post-translational modification of cofactors by second messenger mediated pathways.  Rapid non-
genomic responses to hormones include the activation of kinases, phosphatases, and phospholipases that 
govern calcium-dependent signalling and phosphorylation cascades.  Cytoplasmic cross-talk between 
classical nuclear receptor transcriptional pathways and membrane-associated signalling pathways can 
enhance the mechanisms involved in cell cycle control, cell survival and regulation of modifications to 
the epigenome (85).  Several studies have concluded that the recently identified GPER can bind to 
phytoestrogens and flavonoids (86, 87), synthetic estrogens (88), SERMs and selective estrogen receptor 
downregulators (SERDs) (89, 90), atrazine (91), bisphenol A (92), and the polychlorinated toxins 
methoxychlor, DTT and its metabolites (93), among other compounds.  Consequently, the G-protein 
coupled receptor has been implicated in the formation of various physiological malignancies, including 
cancers of the reproductive (88, 94, 95) and non-reproductive tissues (96–98).  However, the mechanisms 
of cross-talk and feedback involved in GPER regulated signalling pathways are not fully understood (99) 
and the possible means of GPER-mediated function-disruption by exogenous molecules, therefore, 
requires further investigation.  Of course, in light of the evidence presented by Chaudhri et al. (100), 
disruption of rapid estrogenic signalling may involve alternative pathways  requiring splice variants of 
the ER, for example ERα36. 
Risk assessment (101) of possible EDCs requires resolution on definitions of what constitutes an adverse 
effect and what constitutes a biological indicator.  The diversities of potential endocrine-active chemicals, 
coupled to the complexity of the regulatory system with which they interact, makes the evaluation of 
combined effects of EDCs a daunting task.  The 2013 WHO/UNEP state of science report on endocrine 
disruption (102), although criticised as biased in their approach to EDC data interpretation (64), 
especially with regards to NMDR, called for more research to improve global knowledge on the 
associations between the environmental impacts of EDCs and possible risks to humans and wildlife.  
Methods of identifying known and unknown EDCs are required to discover routes of exposure, while 
models of synergistic effects of such compounds necessitate clarification.  Improved data sharing 
between countries and research groups, with particular emphasis on developing countries and emerging 
economies, will help to close the gaps in knowledge on the underlying mechanisms of endocrine effects 
by exogenous chemicals. 
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2.1.1 Monitoring of endocrine disruptors 
The detection of chemicals, with the ability to modulate physiological processes, is important in the 
substantiation of cause and effect chains between the presence of EDCs within the environment, and their 
perceived detrimental effect on human and animal life.  Heterogeneity is a hallmark of EDCs, yet this 
chemically diverse group of molecules can elicit similar or related disruptive biological effects.  
Traditional methods of detection based solely on chemical structure are therefore not sufficient.  Several 
techniques have thus been developed for the detection of select or heterogeneous molecules within in vivo 
or in vitro contexts.  However, the extremely low concentrations at which most EDCs occur often 
severely hamper the assessment of such molecules within an environmental context.  Furthermore, the 
proposition that exogenous materials may effect physiologically relevant alterations to gene transcription 
and other regulatory mechanisms by NMDR places further impetus on the requirements for increasingly 
sensitive testing systems, capable of low-level EDC detection. 
Several classical in vivo systems have been designed for the prediction of estrogenicity or androgenicity 
of specific compounds.  These testing methods include uterotrophic and vitellogenin assays for 
measurements of estrogenic and anti-estrogenic effects, while the Herschberger assay assesses the 
maintenance of androgen dependent organs.  Several species of fish, such as the Japanese medaka 
(Oryzais latipes) and the zebrafish, along with certain amphibian creatures, including the South African 
clawed toad (Xenopus laevis), have been exploited as biomarkers for compounds with reproductive 
relevance (103–105).  These bioassays rely on the detection of serum proteins or the assessment of organ 
development and generally require the sacrifice of test animals.  Alternatives to adult animal utilisation, 
in line with the 3R principles (106), include the use of fish embryonic and early larval stages since most 
organs are functional at the end of embryogenesis.  Embryos express endocrine markers such as 
vitellogenin and aromatase, enabling strategies to evaluate cellular effects by monitoring of the 
transcriptome, with regards to the expression patterns of genes such as aromatase b, vitellogenin 1, 
11β-hydroxylase, 3β-hydroxysteroid-dehydrogenase and gonadotropin-releasing hormone receptor 2 
(107), amongst others (103, 104, 108). 
The incorporation of a multitude of biochemical processes within cellular and reproductive cycles, all 
with different temporal windows of sensitivities, poses significant challenges to environmental EDC 
assessment.  In vivo approaches towards confirmation of the endocrine activity of specific compounds are 
therefore invaluable.  However, low sensitivity, high costs, animal husbandry, the requirements for 
technical expertise and labour intensity of end-point measurements complicates the application of in vivo 
techniques for environmental monitoring.  As such, in vivo techniques often require additional in vitro 
methods for validation of environmentally relevant results.  These methodologies are performed under 
experimental conditions by the utilisation of unicellular organisms, immortalised cell lines in tissue 
culture or heterologous proteins.  Many EDCs affect cellular bioprocesses by direct interaction with 
endogenous hormone receptors.  Therefore, several in vitro techniques, such as competitive ligand 
binding assays and derivatives thereof (e.g. surface plasmon resonance sensors), enzyme linked receptor 
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assays (ELRA), enzyme linked immuno-sorbent assays (ELISA), cell proliferation screens (e.g. the E-
screen), as well as yeast based receptor/reporter assays and human chemical activated luciferase gene 
expression (CALUX), are based on receptor-ligand interactions (18).  There are, however, certain 
drawbacks to such in vitro techniques.  For example, competitive ligand binding assays offer an excellent 
means to assess the affinity of a test compound to a particular receptor under in vitro conditions.  
However, these assays cannot distinguish between agonist and antagonist activity, nor can they elucidate 
the effect of receptor binding on further biochemical events such as transactivation or repression of 
multiple genes, which relies on the presence of a large cohort of transcription cofactors and regulatory 
molecules.  Furthermore, these techniques are not indicative of the environmental milieu and, as a result, 
fail to take into account possible synergism between various molecules present at a specific location. 
Therefore, in view of the complexity of the endocrine system, several authors have indicated that a 
battery of complementary tests, comprised of in vivo, in vitro and chemical analysis by analytical 
methods such as GC/MS or LC/MS, may be beneficial in the prediction of developmental and 
reproductive toxicology of single compounds or heterogeneous mixtures found in the environment (109–
111).  Invariably these tests involve multiple pre-defined endpoints which collectively provide 
information about the system as a whole.  In addition, in silico methods, including quantitative structure-
activity relationships (QSAR) or parallel screening, which includes 3D- or 2D descriptors, are powerful 
approaches for the rapid qualification of suspected EDCs (112–114).  However, in light of environmental 
monitoring of molecules with endocrine disruptive capabilities, rapid, simple and economical assessment 
of specific locations require the development of in vitro biological or physicochemical detection systems.  
As a result, in vitro techniques still offer the simplest and most cost-effective mechanisms to assess 
whether environmental systems have been compromised by chemicals capable of acting as exogenous 
ligands to hormone receptors which act as signal transducing molecules or genetic transcription factors 
(115, 116). 
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2.2 NUCLEAR RECEPTORS 
The nuclear receptors form a large superfamily, encompassing proteins which bind small lipophilic 
molecules such as steroid and thyroid hormones, vitamin D and retinoids.  Nuclear receptors are involved 
in the regulation of cellular metabolism, growth and differentiation by acting as transcription factors, thus 
modulating the activation or repression of gene transcription.  As a result, these receptors are involved in 
a myriad of diverse physiological processes including, but not limited to, the regulation of the 
reproductive system, biosynthesis of cholesterol and bile and control over the pre- and postnatal 
developmental programs. 
The human genome contains genes encoding 48 nuclear receptors, thought to be evolutionarily derived 
from a common ancestor.  Within this large group, different orphan receptors, many of which are 
constitutively active transcription factors (117), are also included.  Ligands to this class of nuclear 
receptor have recently been identified as products of lipid metabolism, including prostaglandins, 
leukotrienes, fatty acids and cholesterol derivatives. The vast majority of ligands toward the orphan 
receptors remain unknown (118). 
Early classification grouped nuclear receptors into four categories based on ligands, DNA binding 
properties or other functional characterization (119).  More recent work, based on amino acid sequence 
alignment and phylogenetic tree construction, distributed these transcription factors into six subfamilies 
and resulted in the acceptance of systematic nomenclature based on designations similar to that of the 
P450 enzymes (Figure 2.1 and Table 2.1) (120). 
 
Figure 2.1 Neighbour joining tree of nuclear receptors phylogeny indicating the common evolutionary ancestry of the 
receptor superfamily (118). 
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Table 2.1 Nomenclature of mammalian nuclear receptors and selected ligands (121, 122).  The phylogeny groups the nuclear 
receptors into six subfamilies.  The three digit identifier after ‘NR’ designates respectively the subfamily, group 
and individual gene.  More information may be obtained from these references (123–125). 
Trivial name 
Common 
abbreviation 
Unified 
nomenclature 
Ligands 
Thyroid hormone receptor 
TRα NR1A1 Thyroid hormones 
TRβ NR1A2 Thyroid hormones 
Retinoic acid receptor 
RARα NR1B1 Retinoic acid 
RARβ NR1B2 Retinoic acid 
RARγ NR1B3 Retinoic acid 
Peroxisome proliferator-activated receptor 
PPARα NR1C1 Fatty acids, leukotriene B4, fibrates 
PPARβ NR1C2 Fatty acids 
PPARγ NR1C3 Fatty acids, prostaglandin J2 
Reverse erbA 
Rev-erbα NR1D1 Haem† 
Rev-erbβ NR1D1 Haem† 
RAR-related orphan receptor 
RORα NR1F1 Cholesterol, cholesteryl sulphate 
RORβ NR1F2 Retinoic acid, sterols† 
RORγ NR1F3 Retinoic acid, sterols† 
Liver X receptor 
LXRα NR1H3 Oxysterols 
LXRβ NR1H2 Oxysterols 
Farnesoid X receptor 
FXRα NR1H4 Bile acids, Fexaramine 
FXRβ‡ NR1H5 Lanosterol 
Vitamin D receptor VDR NR1I1 1α,25-dihydroxy vitamin D3, litocholic acid 
Pregnane X receptor PXR NR1I2 Xenobiotics, pregnenolone 16α-carbonitrile 
Constitutive androstane receptor CAR NR1I3 Xenobiotics, phenobarbital 
Hepatocyte nuclear factor 4 
HNF4α NR2A1 Fatty acids† 
HNF4γ NR2A2 Fatty acids† 
Retinoid X receptor 
RXRα NR2B1 9-cis retinoic acid and docosahexanoic acid 
RXRβ NR2B2 9-cis retinoic acid and docosahexanoic acid 
RXRγ NR2B3 9-cis retinoic acid and docosahexanoic acid 
Testicular orphan receptor 
TR2 NR2C1 Orphan 
TR4 NR2C2 Orphan 
Tailless homolog orphan receptor TLX NR2E1 Orphan 
Tailless TLL NR2E2 Orphan 
Photoreceptor-cell-specific nuclear receptor PNR NR2E3 Orphan 
Chicken ovalbumin upstream promoter-
transcription factor 
COUP-TFα NR2F1 Orphan 
COUP-TFβ NR2F2 Orphan 
 ErbA2-related gene-2 COUP-TFγ / EAR2 NR2F6 Orphan 
Estrogen receptor 
ERα NR3A1 17β-Estradiol, tamoxifen, raloxifene 
ERβ NR3A2 17β-Estradiol, various synthetic compounds 
Estrogen receptor-related receptor 
ERRα NR3B1 Orphan 
ERRβ NR3B2 DES, 4-OH tamoxifen 
ERRγ NR3B3 DES, 4-OH tamoxifen 
Glucocorticoid receptor GR NR3C1 Cortisol, dexamethasone, RU486 
Mineralocorticoid receptor MR NR3C2 Aldosterone, spirolactone 
Progesterone receptor PR NR3C3 
Progesterone, medroxyprogesterone acetate, 
RU486 
Androgen receptor AR NR3C4 Testosterone, flutamide 
Nerve growth factor-induced gene B NGFIB NR4A1 Orphan 
Nur-related factor 1 NURR1 NR4A2 Orphan 
Neuron-derived orphan receptor 1 NOR1 NR4A3 Orphan 
Steroidogenic factor 1 SF1 NR5A1 Orphan 
Liver receptor homologous protein 1 LRH1 NR5A2 Phospholipids† 
Germ cell nuclear factor GCNF NR6A1 Orphan 
Dosage-sensitive sex reversal-adrenal 
hypoplasia congenita critical region on the X 
chromosome, gene 1 
DAX-1 NR0B1 Orphan 
Short heterodimeric partner SHP NR0B2 Orphan 
† These ligands appear to be constitutively bound to receptors 
‡ FXRβ exists only as a pseudogene in humans 
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2.2.1 Canonical structural organisation of nuclear receptors 
Nuclear receptors, despite the vast and diverse regulatory roles which they govern, share remarkable 
structural and functional organisation.  In general, these molecules are modular in nature (126) and 
consist of a single polypeptide chain that may be delineated into four or five segregate domains (Figure 
2.2).  The centrally located DNA binding domain (DBD) recognises highly specific DNA sequences 
which, upon binding of the receptors, mediate activation or repression of gene transcription via an array 
of transcription factor recruitment.  Within the C-terminal half is located a ligand binding domain (LBD) 
which recognises particular hormonal and non-hormonal ligands that directs the specificity of the 
biological response.  These two domains are linked by a hinge domain of variable length while being 
flanked on either side by variable N-terminal and C-terminal domains. 
 
Figure 2.2 General modular structure of nuclear receptors. The N-terminal A/B domain, including the activation function 1 
(AF-1), is important for the constitutive transcription activity.  The central DNA binding domain (C) is followed 
by a hinge region (D) and the ligand binding domain (E) that includes the activation function 2 (AF-2) within the 
twelfth helix, crucial for the ligand-dependent cofactor interaction. A few nuclear receptors feature an additional 
F domain at the C-terminal of which the exact function is still poorly understood. 
2.2.1.1 N terminus (A/B) 
The domain towards the N-terminal domain (NTD) of the receptor is known as the modulator, 
hypervariable or A/B domain (118).  This acidic domain is constitutively functional and varies in length 
between different receptors or receptor subtypes.  The ligand independent transactivation activity 
exhibited by the A/B domain is facilitated by activation function 1 (AF-1) which contains a variety of 
kinase recognition sites.  Phosphorylation at these sites may modulate the activity of the receptor, 
possibly by affecting the interaction between transcription co-activators and AF-1 (127).  Furthermore, 
the many secondary start sites and alternative splicing loci contained within this domain may be a 
determining factor in the receptor-, cell type, and species-specific variations exhibited by different 
isoforms of receptors binding to the same ligand. 
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2.2.1.2 DNA-binding domain (C) 
The DNA binding domain (DBD) is the most highly conserved region among the various nuclear 
receptors and facilitates binding of the receptor to hormone response elements within the major groove of 
the DNA double helix (128).  In response to ligand binding two zinc finger motifs within the DBD, 
containing characteristic four-cysteine motifs which coordinate tetrahedrically with one zinc ion each 
(129), interact with specific sequences located in the promoter regions of target genes.  These hormone 
response elements, consisting of two half-sites, function as palindromic repeats of six base pairs 
separated by one to ten non-conserved nucleotides.  Each molecule of the receptor dimer interacts with 
one half-site; of which two variants exist, those recognised by steroid receptors, excluding the ER 
(5’-AGAACA), and others by the ER and other nuclear receptors (5’AGGTCA) (130).  Response 
elements may consist of direct repeats (DRx: e.g. AGGTCA-Nx-AGGTCA), everted repeats (ERx: e.g. 
ACTGGA-Nx-AGGTCA) or inverted repeats (IRx: e.g. AGGTCA-Nx-ACTGGA); N representing any 
nucleotide and x being a number between three and five (IR3: GR, PR, AR and ER / DR3: VDR / DR4: 
TR / and DR5: RAR) (121).  Some residues of the proximal zinc finger, between the last two cysteine 
residues (P-box), are located in the first helix of the DBD and are involved in discrimination of the core 
half site of the hormone response element.  The dimerization interface (D-box) of the nuclear receptor 
DBD is formed by residues of the second distal zinc finger located in the second α-helix of the DBD, 
perpendicular to the P-box.  The only exceptions to this method of receptor-DNA interaction within the 
entire family are dosage-specific sex reversal-adrenal hypoplasia congenital critical region on the X 
chromosome-1 (DAX-1) and short heterodimeric partner (SHP) (122).  These receptors lack DBDs, yet 
function as corepressors via interaction with other transcriptional factors, thus assisting in the regulation 
of their target genes (131, 132).  Depending on class of receptor, nuclear receptors bind DNA as either 
monomers (RVR, ROR, TLX, ERR, NGFI-B, FTZ-F1), homodimers (GR, PR, ER, AR and MR) or 
heterodimers (TR, RAR, VDR, PPAR and most orphan receptors) with the retinoid X receptor, 
recognising a variety of palindromic response elements.  The different three dimensional structures of 
heterodimers create different DNA binding affinities. 
2.2.1.3 Hinge domain (D) 
The hinge domain is located between the DBD and the LBD and is of an ill-defined function.  It seems as 
if the carboxy-terminal extension (CTE) of the DBD may recognise the extended 5’-end of the HRE; the 
A and T boxes, located within the CTE is critical to monomeric binding (133) of receptors to response 
elements via contacts with the DNA backbone.  Moreover, the hinge domain may contain nuclear 
localisation signals, mediate protein-protein interactions or allow for spatial arrangement between the 
DBD and LBD, thus allowing protein conformational change upon ligand binding (118, 134). 
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2.2.1.4 Ligand binding domain (E/F) 
Unlike the DBD, the LBD is slightly less conserved and substantial variation occurs between the domains 
of different nuclear receptors, such as to make ligand recognition distinct.  Four structurally discrete 
surfaces may commonly be observed: a dimerization interface facilitating interaction with partner LBDs, 
a helix towards the C-terminal involved in ligand dependent transactivation, termed activation function 2 
(AF-2), a surface that mediates coregulators interaction, which may modulate transcriptional activity in a 
positive or negative manner, and a hydrophobic ligand binding pocket of which specific residues 
mediates binding of the receptor with potential lipophilic ligands. 
To date, the LBDs of all the traditional nuclear receptors, along with the already adopted orphan 
receptors, have been resolved (135).  The molecular organisation of the majority of the orphan receptors, 
however, remains unknown.  Generally, the LBD of nuclear receptors consists of twelve highly structured 
α-helices arranged in a three layered anti-parallel sandwich (127), eleven of which are actively involved 
in the formation of a ligand binding pocket (LBP) at the narrower end of the domain.  Helix 12 (H12), 
comprising the activation domain of AF-2, extends away from the LBD.  Interaction of an agonistic 
ligand with the LBD results in a conformational change within the protein structure:  in the apo-state, 
H11 is in a position of near perpendicularity towards H10 (Figure 2.3, panel A).  In agonist mode H11 
shifts to a position in continuation with H10 (Figure 2.3, panel B). This repositioning allows H12 to 
translocate to a position underneath H4 and above the now formed hydrophobic LBP.  This repositioning 
creates the defined surface of AF-2, consisting of H3, H4, loop L3-4 and H12, thus forming a shallow 
surface accessible hydrophobic groove.  This arrangement allows for interaction with co-activator 
elements containing a helical nuclear receptor LxxLL motif called a nuclear box.  Agonists generally 
stabilise the LBD by tight-fitting interaction with the amino acid residues of the LBP.  Contrarily, 
antagonists cannot be accommodated within the LBP due to the presence of extended side chains from 
the molecule which exists between H3 and H11.  When an antagonist is present within the LBP, H11 
becomes slightly unwound while H12 is unable to translocate to the position underneath H4 and, instead, 
rotates approximately 120° in a clockwise direction towards the N-terminus of the LBD.  This 
conformational change results in the obstruction of the hydrophobic cleft to which the LxxLL nuclear box 
of a nuclear cofactor would bind, thus inhibiting activation of the receptor.  This molecular configuration 
is stabilised by a degenerated LxxLL motif within H12.  Consequently, the receptor itself inhibits the 
binding of co-activators to the activation domain (AD) of the LBD by competition for binding to the 
groove formed between H3, H4, L3-4 and H12. 
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Figure 2.3 Graphical representations of the retinoid X receptor LBD existing in three different conformational states.  The 
unliganded (apo) RXRLBD in panel A indicates destention of H1.  In panels B and C, which respectively 
represents the agonist (holo) and antagonist forms of the LBD, H12 is repositioned by between 120° and 270°.  
The various regions of the LBD have been coloured depeding on function.  The activation function, the 
coactivator/corepressor binding motif of the LBD is coloured orange.  Helix 12, which contains the core 
activation function activation domain, AF-2, is shown in red, while the LBD dimerisation interface is coloured 
green.  Other structural elements are shown in purple (127). 
2.2.2 Receptor classes and general transcriptional control 
Based on their respective DNA-binding and dimerization properties the nuclear receptor superfamily may 
be subdivided into four distinct classes (119).  Class I receptors bind DNA as ligand induced homodimers 
by recognising half-sites organised as inverted repeats.  This class includes all the receptors to the steroid 
hormones and, in the absence of ligand, are generally sequestered to the cytosol where the LBD is often 
associated with heat shock proteins (HSP) (136, 137).  In this state HSPs, notably HSP90, HSP70 and 
HSP56, interact directly with the LBD and, in some instances the CTE of the DBD (138), thus repressing 
receptor activity.  The association with HSP90, at least for some nuclear receptors (GR, MR and DR), 
seems essential for the stabilisation of the LBD in a conformation that can bind ligand (136).  Upon 
binding of an agonistic ligand, the conformational changes introduced in section 2.2.1.4 lead to 
dissociation of the HSP complex, thus relieving receptor repression.  As a result, the receptor translocates 
to the nucleus and binds to DNA as homodimers to the relevant hormone response elements.  Within the 
nucleus the AF-2 is recognised by transcriptional co-activator proteins via the α-helical LxxLL motif.  
The co-activator peptide is held in place within the hydrophobic groove of the nuclear receptor by 
hydrogen bonds formed between the hydrophobic residues of the LxxLL motif and two critically 
conserved receptor amino acid residues.  This charge clamp is formed between the three co-activator 
leucine residues and a lysine at the C-terminus of H3 and a glutamate in H12 of the LBD, resulting in 
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further stabilisation of the association between the two molecules.  A plethora of coactivator proteins that 
mediate nuclear receptor functioning have been characterised, including the p160 transcription 
intermediary factor/NR-coactivator/steroid receptor coactivator (TIF/NCoA/SRC) family of proteins 
(139).  Such co-activators generally contain multiple nuclear receptor box motifs and may exhibit 
variable cooperative or non-cooperative binding to nuclear receptors due to differing affinities for AF-2.  
Regardless, a key feature of nuclear receptor co-activators is their transcriptional-enhancing properties, 
which include the ability to recruit additional general or receptor/ligand-specific transcription factors, 
histone acetylation and chromatin remodelling via ATPase activity (140); resulting in the formation of 
the basal transcription machinery complex with RNA polymerase II which facilitates the polymerisation 
of mRNA. 
Class II receptors, exclusive of the steroid hormone receptors, contain all receptors that are known to be 
ligand dependent.  In contrast to the receptors of class I, these receptors heterodimerize with the RXR and 
bind to DNA via direct repeats or, to a lesser extent, via symmetrical repeats (119).  Moreover, in the 
absence of ligand, receptors of class II are constitutively bound to their respective HREs and are therefore 
retained within the nucleus.  In this state, H12 of the receptor stably interacts with the N-CoR (nuclear 
receptor corepressor) and SMRT (silencing mediator for retinoic acid and thyroid hormone receptors) 
containing corepressor complexes via two nuclear receptor interacting domains, ID1 and ID2, located at 
the C-terminus of the repressor.  These interactions are mediated by motifs within each ID similar to the 
LxxLL nuclear receptor box called LxxxIxxxI/L motif (CoRNR box) (120).  Unliganded, the DNA-
bound nuclear receptor-corepressor complex recruits transcriptional determinants containing specific 
histone deacetylase complexes (HDACs) which enforce target gene repression.  A critical determinant in 
the interaction between the nuclear receptor and co-activator is the formation of the charge clamp 
between AF-2 and the nuclear box.  Agonist binding promotes repositioning of H12 and disrupts the 
hydrophobic groove of AF-2.  The slight difference in length between the NR box and CoRNR box 
means that co-repressors cannot be accommodated in the hydrophobic groove of the receptor in the 
liganded state, resulting in an exchange of co-repressor for co-activator (141). 
Class III receptors primarily bind to DNA as homodimers via direct repeats, while receptors of class IV 
tend to bind extended core sites as monomers.  Some orphan receptors are categorised within class II and 
therefore heterodimerize with the RXR, yet the majority tend to fall into these last two groups.  Orphan 
receptors of class III are typically constitutive transactivators or transrepressors and can bind to either 
palindromic or direct repeat response elements which may overlap with recognition sequences of other 
hormone receptors.  These qualities suggest that they may be ligand independent transcription factors 
which may modulate known hormone signalling pathways (142). The monomeric orphan receptors of 
class IV binds to extended half-sites of the estrogen receptor class (AGGTCA).  Determination of the 
specificity towards individual receptors of this class is determined by sequence of A/T rich nucleotides 5’ 
of this binding site (143, 144).  Similar to receptors of class III, many of these orphan receptors display 
constitutive activity. 
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One group of orphan receptors are not readily placed in any of the categories mentioned above as they 
contain members that are lacking of either a DBD, as is the case with DAX-1, or an LBD.  For reviews 
on orphan receptor structure, function, discovered ligand and physiological roles, please refer to these 
references (145–148). 
2.2.2.1 Further control measures and nongenomic effects 
The central dogma of nuclear receptor mediated control over gene transcription involves interaction of 
the liganded receptor with its cognate response element, followed by recruitment of cofactors and 
chromatin remodelling, with subsequent assembly of the transcriptional machinery.  A pertinent question, 
therefore, is what happens to the activated receptors following these processes?  In contrast with a 
conventional view of nuclear receptor action (149, 150), the interaction between receptor and HRE does 
not appear to be static.  The recruitment of cofactors to the transcription machinery complex following 
binding of the receptor to the HRE occurs in a systematic, yet cyclical manner (151).  In vivo, chromatin 
immunoprecipitation (ChIP) has indicated that in the presence of continual hormonal stimulation regular 
assembly and disassembly of the transcriptional machinery occurs, providing a mechanism for continual 
assessment of the external environment (152, 153).  Phosphorylation of RNA polymerase II may lead to 
dissociation of the transcription complex, since inhibition of the cyclin-dependent protein kinases CDK7 
and CDK9, which are known to act upon the C-terminal domain of the large subunit of polymerase II, 
stabilises transcription of the ERα (152). 
Furthermore, nuclear receptors are themselves phosphoproteins.  Post-translational phosphorylation of 
the nuclear receptors by protein kinase A (PKA), protein kinase C (PKC), proline dependent kinases or 
mitogen-activated protein kinases (MAPKs) occur mainly in the A/B region, however, several residues 
within the DBD and LBD are also amenable to phosphorylation.  Such modifications may modulate 
transcriptional activity by influencing dimerization ability or co-activator recruitment (154–159).  Yet 
phosphorylation events may also be involved in the termination of the ligand response by the induction of 
DNA dissociation, decreasing receptor affinity for the ligand or by eliciting receptor degradation, since 
CDK7 protein kinase is also able to phosphorylate nuclear receptors (160, 161).  The phosphorylation of 
proteins is often a precursor to ubiquitylation (162) and subsequent degradation within the proteasome.  
Moreover, the regulatory cofactors to nuclear receptors may also be phosphorylated, impacting on their 
ability to exert control over transcriptional activity.  For example, phosphorylation of the corepressors 
SMRT and N-CoR results in the export of these proteins from the nucleus, making it unavailable to 
repress steroid receptor transcriptional activity (163). 
Over and above the regulation imposed on nuclear receptors by covalent modification such as 
phosphorylation, ubiquitylation, acetylation and sumoylation, other forms of nuclear receptor cross-talk 
are also known to occur.  As of late it has become apparent that extranuclear steroid receptors may 
activate non-nuclear pathways in various cell types via signalling cascades involving several kinases, 
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including phosphatidylinositol 3-kinase (PI3K), PKC and cAMP/PKA-dependent mechanisms, along 
with calcium and other second messengers (164, 165).  
According to Levin, additional steroid hormone receptor pools actively involved in such processes have 
been detected not only in cytosol, but also localised to the plasma membrane (166, 167).  Membrane 
bound ER, for example, is proposed to be involved in the rapid increases in cAMP levels and calcium 
responses observed in ovariectomised rats and endometrial cells following administration of 17β-estradiol 
[1,3,5(10)-estratriene-3,17β-diol; E2] (168, 169), which is not a function of the nuclear localised ER 
(170).  Such fast-acting membrane-initiated steroid signalling (MISS) has been implicated in reproductive 
organ development and function, cardiovascular responsiveness, and cancer biology (171–173).  MISS 
impacts on the regulation on gene expression via a variety of mechanisms of which the full integrative 
nature remains elusive. 
2.2.3 Focus on the sex steroid receptors 
Clearly the nuclear receptor superfamily is intricately involved in the regulation of the cellular 
environment in response to external stimuli, predominantly via particular cognate ligands.  However, due 
to the large number of nuclear receptors governing countless biological processes, the focus here will 
predominantly be on the sex steroid receptors.  Although the progesterone receptor is integral to the 
regulation of multiple reproductive processes, including follicular growth, oocyte maturation, ovulation, 
implantation and the maintenance of gestation, specific discussion will be limited to the androgen and 
estrogen receptors. 
2.2.3.1 Estrogen receptor 
The estrogens (Figure 2.4) are predominantly concerned with the development and maintenance of the 
female reproductive system and secondary sexual characteristics.  Moreover, they are also involved in a 
range of non-reproductive functions, including growth and bone density regulation, nervous system 
maturation and endothelial responsiveness.  The two major biologically active estrogens, E2 and estrone 
[3-hydroxy-1,3,5(10)-estratrien-17-one; E1], are synthesised via P450-mediated oxidative removal of the 
C-19 methyl group from the androgens testosterone and 4-androstene-3,17-dione, with subsequent 
aromatization of the A ring by the P450-dependent aromatase enzyme.  These two hormones can be 
interconverted by a redox reaction whilst estriol [1,3,5(10)-estratriene-3,16-α,17β-triol; E3], a third 
bioactive estrogen, is formed by the 16-hydroxylation and 17-reduction of E1.  E3 is the main estrogen 
during pregnancy, but plays no significant role in men or non-pregnant women. 
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Figure 2.4 Structures of the major estrogens, natural ligands to the estrogen receptor. 
The aromatisation of testosterone to E2 occurs primarily in ovaries and testes.  Small amounts, however, 
are also formed in the adrenal glands and some peripheral tissues, most notably adipose tissue.  By 
contrast, most of the circulating E1 is derived from the peripheral aromatisation of androstenedione 
originating in the adrenals.  E2 demonstrates far greater biological potency, as compared to E1, and is 
present in higher concentrations within the circulation of premenopausal, non-pregnant women.  
Following the onset of menopause, however, ovarian production of E2 ceases, resulting in a reversal of 
the ratio of E2:E1. 
The estrogens elicit their biological actions by binding to the estrogen receptor family of receptors.  
Traditionally, two ligand-activated transcription factors, the nuclear receptors ERα (174) and ERβ (175), 
were thought to be the soul mediators of estrogenic activity.  These two ERs are encoded by two genes 
located on different chromosomes (176) and exhibit diverging tissue distributions (177) with slightly 
altered affinities to E2 (178), and different ligand binding characteristics (179).  ERα is predominantly 
expressed in the uterus and mammary glands, and is intricately involved in reproductive events.  
Conversely, the distribution of ERβ is more general and seems to be relevant to the functioning of the 
central nervous system, the cardiovascular system and the skeletal system.  Its expression is also highly 
prevalent in the lungs, kidneys, colon, ovaries, testes and urogenital tract (175).  However, ERα and ERβ 
share significant homology in their DNA binding domains (95%) with identical P-box sequences; they 
therefore interact with the same EREs (180).  The ligand binding domains are less alike with only 56% 
homology of structure, yet the LBPs of these receptors are remarkably similar, differing by only two 
amino acid residues; Leu384 in the ERα is replaced by Met336 in ERβ, while Met421 in ERα corresponds to 
Ile373 in ERβ (181). 
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Synthetic estrogens (Figure 2.5), such as the SERMs raloxifene (RAL) or 4-hydroxytamoxifen (OHT), 
which exhibit agonism in a tissue-dependent manner, or the non-steroidal full agonist diethylstilbestrol 
(DES) bind to the ERα and ERβ in the same position as estrogen, resulting in similar molecular events.  
As with all the nuclear steroid receptors, binding of ligands results in the dissociation of ERs from their 
cytoplasmic chaperone partners, with a concomitant translocation to the nucleus.  Once bound to DNA, 
agonistic ligands promote the recruitment of cofactors which transmit regulatory information to the 
transcription complex, leading to transactivation.  ERα and ERβ, however, differ in their ability to 
activate genes when bound to the same ligands due to multiple reasons including alternative 
conformation upon ligand binding, distinct cofactor interaction (182), and discrete ERE binding patterns 
(183). 
 
Figure 2.5 Structures of synthetic compounds that interact with the estrogen receptor.  The actions of SERMs such as 
raloxifene and 4-hydroxytamoxifen is distinguisable from pure receptor agonists and antagonists.  These 
compounds selectively activate or repress the estrogen receptor, depending on tissue type involved.  Raloxifene 
and 4-hydroxytamoxifen both exhibit agonism in bone and antagonism in breast tissue.  However, whereas 
raloxifene acts as an antagonist in the uterus, the actions of 4-hydroxytamoxifen in this tissue is agonistic.  
Conversely, diethylstilbestrol is a non-selective full agonist to the ER. 
Furthermore, the A/B domain, containing the ligand-independent AF-1, of the 595 amino acid ERα 
protein, shares a mere 17% homology at amino acid level with the 530 residue ERβ.  Transcriptional 
activity of ERα relies on a synergistic effect between AF-1 of the N-terminal domain and the AF-2 
located within the C-terminal LBD.  The constitutively active AF-1 of ERα can bind to histone 
acetyltransferase-active transcription coactivators such as the CEBP binding protein/p300 and p160 
subfamilies, which include steroid receptor coactivator-1 (SRC-1) and the transcription intermediary 
factor TIF2 (184, 185).  Binding of E2 to ERα promotes an interaction between the B-domain at the N-
terminal of the receptor, and the LBD (184), a conformational change which directs the two domains 
closer together.  In response to agonist binding, p160 transcriptional factors also interact with the ERLBD 
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by docking to AF-2 via the nuclear box motif, resulting in enhanced transcriptional synergy between AF-
1 and AF-2.  For ERα, this synergy seems to be a requirement for the recruitment of RNA polymerase II 
to the transcription complex, as an inhibitory fragment of SRC-1, in the presence of E2, blocked RNA 
polymerase II activation (177).  The same does not hold true for ERβ and the same ligand-independent 
SRC-1-binding ability seen in murine ERβ AF-1 is not mirrored in the human homologue of the receptor 
(186).  However, E2-regulated genes may contain imperfect and nonpalindromic EREs that are still 
recognisable by activated ERs (187, 188).  As such, ERα and ERβ interaction with co-activators may be 
dependent on the specific sequence of the ERE that they are bound to.  Furthermore, ERs may indirectly 
interact with response elements other than the ERE by tethering to DNA bound transcription factors such 
as activation protein 1 (AP-1) and stimulating protein 1 (SP-1).  For example, in complex with SP-1, 
bound to the SP-1-directed promoter of the transforming growth factor β-inducible early gene-1 (TIEG) 
gene in human osteoblasts, ERβ is able to bind SRC-1, leading to transcription from TIEG in response to 
E2 via a nuclear ERE-independent mechanism (189). 
The classical receptor-DNA interaction of ERα and ERβ to EREs remains the best-characterised 
signalling mechanism for estrogen-mediated effects on cellular homeostasis.  However, within the last 
two decades it has become evident that estrogen can mediate rapid cellular responses by non-nuclear 
mechanisms in a variety of cell types, particularly in non-reproductive tissues such as the vascular 
smooth muscles, endothelial cells, neuronal tissue, osteoblasts and osteoclasts (190–193).  Subsets of 
ERs, capable of high affinity interaction with estrogenic compounds are localised not only in the nucleus 
or sequestered to the cytoplasm in association with HSP complexes, but also in, or proximal to, the 
plasma membranes of certain cells and distinct cytoplasmic organelles such as mitochondria and the 
endoplasmic reticulum (165, 194).  A variant of ERα, ERα36, cloned by Wang et al. (195) has been 
reported to be involved in cell proliferation due to cross-talk with the epidermal growth factor receptor 
pathway (196).  This 36 kDa truncated ER that lacks both activation domains AF-1 and AF-2 observed in 
its 66 kDa counterpart.  The absence of these transactivation domains means that ERα36 has no intrinsic 
transactivation activity (195), thus highlighting the role of E2 in non-genomic modulation of cell cycle 
control.  Other ER variants, such as the N-terminally truncated 46 kDa ERα isoform are known to be 
expressed in numerous cell types, including endothelium (197), osteoblasts (198), bone marrow stromal 
cells (199), endometrium (200) and breast tissue (173).  Gorosito et al. (201) reported a 52 kDa splice 
variant of ERα in hypothalamic tissue which localised to the plasma membrane upon treatment with E2; a 
result that was subsequently corroborated by Bondar et al. (202) and Dominguez and Micevych (193). 
The localisation and palmitoylation-status of ERs can potentially regulate ER ability to interact with 
intracellular kinases.  Trafficking of ER variants to the membrane occurs by association with membrane 
bound proteins within caveolae rafts (203).  It seems as if E2 can regulate the level of palmitoylation at a 
single amino acid residue in the ERα, Cys447 (204), modulating association with the membrane protein 
caveolin-1 (CAV1) and caveolin-3 (CAV3).  Within hippocampal neurons caveolin-bound ER is 
involved in two segregated signalling pathways (205, 206).  CAV1-bound ERα interacts with the 
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metabotropic glutamate receptor mGluR1a, stimulating activation of the Gq domain of this GPCR, which 
in turn leads to the phosphorylation of CREB (cAMP activated regulatory protein) via PLC/IP3/MAPK 
signalling.  Conversely, ERα or ERβ can activate the second pathway in which the CAV3-linked 
receptors stimulate mGluR2/3 to activate Gi/o signalling. Consequently, inhibition of PKA occurs which 
facilitates the attenuation of calcium channel-dependent CREB phosphorylation by a reduction in L-type 
calcium channel currents. 
Non-nuclear ER can therefore act upon signal transduction pathways via G-protein coupled receptors 
(GPCRs), phosphatases or signalling cascades, stimulating nongenomic effects (100, 196, 207).  Work by 
Garrido et al. (208) implicates rapid signalling by E2 in MCF-7 breast cancer cells in the translocation of 
GLUT4 to the plasma membrane.  The interaction of E2 with ERα46 may therefore indirectly stimulate 
glucose metabolism by exerting control over key steps modulated by p85 in the PI3K/Akt-signaling 
cascade, suggesting a link between glucose uptake and E2-mediated breast cancer proliferation.  
Conversely, the truncated splice-isoforms of ERα appear to activate multiple signalling cascades, 
including PI3K/Akt, in vascular smooth muscle cells (VSMc), all seemingly converging on the induction 
of epithelial nitric oxide synthase (eNOS) (209).  The resulting release of cardioprotective nitric oxide 
antagonises leukocyte adhesion and promotes endothelial cell growth and migration, while attenuating 
the growth and migration of VSMc (210).  Moreover, Kim et al. (192) proposed the localisation of 
ERα46 to the plasma membrane as a transmembrane receptor with an N-terminal ecto-domain.  
Transmembrane orientation seems to rely on critically specific amino acid residues since mutation of 
Ile386, located within the proposed transmembrane domain, to cysteine dramatically impaired E2-induced 
signalling in mutant ERα46Ile386Cys expressing cells.  Transmembrane receptors which influence the 
functioning of E2 activated intercellular pathways may be of great value as drug targets.  Molecules that 
cannot traverse the plasma membrane, yet alter cellular activities mediated by E2 signalling, could 
selectively influence the mechanisms controlling the initiation and progression of certain cancers and 
other undesirable physiological conditions. 
Several reports have, however, indicated that the rapid increase of second messengers following E2 
stimulation is mediated by a member of the largest group of cell-surface molecules, the GPCR 
superfamily (211).  Extremely diverse arrays of ligands, including neurotransmitters, hormones, lipids, a 
plethora of small molecules and even light stimulate cognate GPCRs to change conformation, leading to 
the exchange of an α-subunit bound GDP molecule for GTP (212).  GTP-bound GPCR α-subunits 
interact with a variety of intercellular signal transduction pathways which regulate the biochemistry of 
basal metabolism, cognition, environmental sensing and cell proliferation control.  The effects of GPCR 
signalling are mediated via second messengers that impact on phosphorylation and other regulatory 
activities.  The orphan receptor, G-protein coupled ER 1 (GPER1), or GPR30 as it was originally named 
(125), is thought to induce rapid non-genomic actions upon binding to estrogen.  The exact cellular 
location of this estrogen associated GPCR is still under dispute.  Some analyses indicate membrane or 
cytosolic association (213–216), while others point towards the localisation of the GPER1 to the 
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endoplasmic reticulum (217–219).  However the case may be, cloning of the GPER gene by Carmeci 
et al. (220) from an ER-positive breast carcinoma cell line (MCF7) and the subsequent transfection of 
this gene to estrogen-unresponsive MDA-MB-231 cells (221) substantiated a non-nuclear role of estrogen 
in signal transduction.  The underlying mechanisms of estrogen-GPER1 signalling is still disputed, 
although it is has been reported that the α-subunit of the receptor activates adenylyl cyclase which results 
in the production of cAMP (222).  Moreover, matrix metalloproteinase is activated to degrade pro-HB-
EGF by the G-protein βγ/Src/integrin-α5β1/Shc complex (223).  HB-EGF in turn binds to the EGFR 
leading to the mobilisation of intracellular calcium and the activation of PI3K and Erk-1/-2 pathways 
(224–227).  Reportedly, GPER1 is involved in mediating the actions of estrogen during testicular 
development and spermatogenesis.  It is expressed in the somatic cells (Sertoli and Leydig) as well as the 
spermatogonia, spermatocytes and spermatids.  However, GPER1 also seems to be prevalent in the 
development and growth of testicular cancers (211) and testicular germ cell tumours (TGCT) (95).  
Several reports have challenged the possible roles that GPER1 plays during estrogen-mediated non-
nuclear activities (171, 219, 228).  Kang et al. (196) found that ERα36 expression was augmented by 
GPER1 signalling by activation of the ERα36 promoter, and the authors concluded that the non-genomic 
activities ascribed to GPER1 are in fact mediated via this ER variant. 
The multiple mechanisms by which estrogen influences cellular homeostasis form an intricately 
connected network that converges at the regulation of gene transcription.  These numerous pathways are 
involved not only in normal reproductive physiology and other biological processes, but also impact on 
various human disease states, including breast and endometrial cancers, cardiovascular disease, 
osteoporosis, and Alzheimer’s disease. 
2.2.3.1 Androgen receptor 
Male fertility, indeed the whole of the vertebrate masculine phenotype, is primarily influenced by the 
cellular actions of androgenic hormones.  In mammals, some androgens are produced by the zona 
reticularis of the andrenal cortex (229).  However, in males androgenic steroid hormones are 
predominantly synthesised in the Leydig cells of the testes, while substantial amounts are produced by 
the ovarian theca and stromal cells of females; which prominently influence female secondary sexual 
characteristics and cellular differentiation.  Steroidogenesis of androgens from cholesterol-derived 
precursors may be accomplished via several cytochrome P450 controlled pathways (230, 231), resulting 
in the synthesis of molecules with divergent potencies towards the androgen receptor (AR).  Classically, 
testosterone (T) and its 5-alpha reduced form, 5α-dihydrotestosterone (DHT), have been identified as the 
endogenous ligands to the androgen receptor (232).  However, many other physiologically relevant 
androgenic hormones have been discovered which may influence cellular homeostasis via interaction 
with the AR, including the 11-keto or 11-hydroxylated forms (233) of these and other androgens, such as 
11β-hydroxyandrostenedione, which serves as a precursor to recognised and novel androgenic steroids 
(Figure 2.6) (234). 
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Figure 2.6 Some of the endogenous ligands known to activate the androgen receptor.  These molecules have varying 
potencies, indicating that small alterations to the molecular structure of agonists can induce slightly different 
conformational changes to the LBD of a nuclear receptor, thus affecting the interaction between AF-2 and co-
activator molecules. 
Androgens are well-known to play an important part in male embryonic differentiation, male sexual 
development and maturation, maintenance of spermatogenesis (235) and masculinisation of the brain 
(236).  Furthermore, several other biological processes, over and above the development and regulation 
of male reproductive physiology, are also enacted by the androgens.  These diverse actions include 
control over the hair follicle growth cycle (237), regulation of adipogenesis, lipolysis and fat distribution 
(238), bone remodelling and lean muscle maintenance.  However, due to the involvement of androgens in 
such processes, various physiologically-altered and pathological states, including male pattern hair loss, 
acne, spinal and bulbar atrophy, benign prostatic hyperplasia, androgen-insensitivity syndrome and the 
progression of prostate cancer are arbitrated via the AR (239). 
The AR is a ligand-dependent transcription factor which, like other steroid receptors, undergoes a 
conformational change upon ligand binding, translocates to the nucleus and interacts as homodimers with 
cognate hormonal response elements in the promoters of target genes.  Recruitment of coregulators and 
chromatin remodelling complexes at genomic loci results in the formation of the basal transcription 
machinery and transcription of AR controlled genes.  Canonical AREs are composed of 3-nt-spaced 
inverted repeats of 5’-TGTTCT-3’ half-sites and are essential for AR-mediated transcriptional activation 
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(240).  The domain structure of the AR is similar to the other members of the nuclear receptor 
superfamily.  The highly conserved DNA binding domain recognises androgen response elements (ARE) 
by means of two zinc-finger motifs. 
As with the ER and other nuclear hormone receptors, the autonomous AF-1 region is located within the 
N-terminal domain.  Unique to the AR, however, AF-1 contributes the majority share of activity to the 
ligand-bound-AR and is constitutively active when removed from the apo-protein in vitro.  Interaction 
between the NTD and the activation function, located within the LBD, seems to be required for agonist-
induced gene transcription or repression when bound by an antagonist (232).  The molecular alteration 
which occurs when the AR interacts with ligand is similar to the ER.  Upon ligand binding the receptor 
translocates to the nucleus where it forms homodimers, binds to ARE and regulates transcription in 
cooperation with a range of cofactors.  The conformational change involves translocation of H12 to a 
position covering the LBP which stabilises receptor-ligand interaction.  Along with H3 and H4, the 
hydrophobic groove of AF-2 is thus formed on the surface of the LBD (241).  This groove is crucial for 
coactivator recruitment as well as the intermolecular interaction of the NTD with the LBD.  In this 
regard, the AR varies from other steroid receptors due to the ability of AF-1 to regulate ligand-bound 
receptor activity in the process of N/C interaction (242).  Within the A/B domain of the AR, two LxxLL-
related sequences, have been found to mediate the molecular interchange between the NTD and LBD 
when bound by ligand.  Therefore, N/C interaction is required for full transcriptional activation of the AR 
and is enhanced by multiple coactivators, including CREB binding protein (CBP), the proto-oncogene 
c-Jun, and the p160 family of cofactors (241).  However, in contrast to other steroid receptors, the AF-2 
of the AR exhibits relatively low affinity to most LxxLL motifs (243).  The agonist bound AR transforms 
its conformation in such a way that the hydrophobic groove which is AF-2 is elongated, deeper and 
narrower than those of its homologue receptor counterparts. As a result, AF-2 is recognised preferentially 
by aromatic residue-containing LxxLL-related motifs.  Two such motifs, FxxLF and WxxLF are located 
in the A/B domain and can bind to AF-2.  AR specific coregulators, such as ARA54 and ARA70, also 
feature the FxxLF recognition motif. 
Dissociation of the ligand is slowed due to stabilisation of H12 by N/C interaction (244, 245).  Bound to 
DNA, however, the importance of this association is weakened (246), thus providing a mechanism for 
transient binding to the ARE of AR controlled gene promoter regions.  Depending on its nature, a ligand 
to the AR can influence the binding stability of the AR/DNA.  Consequently, loss of the bound ligand 
leads to nuclear export of the AR to the cytoplasm where reassociation with stabilising heat shock 
proteins occurs.  AR antagonists such as bicalutamide and hydroxyflutamide induce the recruitment of 
corepressors due to their inability to facilitate N/C interaction.  However, continued exposure to such 
substances has been shown to result in the development of androgen resistance due to cellular 
modifications or the inclusion of point mutations in the AR gene. 
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Furthermore, the AR can be covalently modified to influence its agonist or antagonistic behaviour.  
Various non-genomic actions of the AR include modulation of multiple signalling molecules at the 
plasma membrane.  The PI3K pathway is activated by direct interaction of the AR with the p85 
regulatory subunit of the kinase.  Numerous other biochemical routes, including Src, ERK1/2, MAPK 
and Akt pathways are impacted upon by ligand binding to the AR or act upon the AR via extracellular 
stimulation by cytokines, mitogens, hormones or possibly disruptive exogenous molecules (247). 
Regulation of these intricately connected pathways is an important function towards the maintenance of 
controlled cellular differentiation and homeostasis.  The androgens present during foetal development 
direct sexual development because of its proportionality with estrogen, following aromatisation by P450 
aromatase.  Disruption of the androgen/estrogen ratio, by mutation or by exogenous chemical 
modulation, may lead to a reduction in developmental prowess or the manifestation of hermaphroditism.  
Furthermore, with over 500 putative protein kinase and more than 90 annotated tyrosine kinase genes in 
the human genome (248) it is clear that phosphoproteins, such as the AR, are subject to myriads of 
biochemical signals which may alter its activity towards oncogenic or tumour-producing functions.  Such 
an intricate network of interconnected signalling cascades allows for the dysregulation of protein-protein 
interaction via multiple mechanisms.  
2.3 A BRIEF OVERVIEW OF MAJOR HETEROLOGOUS PROTEIN EXPRESSION 
SYSTEMS 
The development of protein production platforms have become an important cornerstone of therapeutic 
applications in pharmacology, academia and biotechnology.  Proteins are being characterised at the 
molecular level by exploiting recombinant techniques in the expression and purification of biological 
macromolecules.  The ability to compare large datasets at the genomic level in the delineation of a 
diverse protein cohort has been a valuable tool in the study of protein interaction.  However, structural 
analyses by various biophysical methods require substantial quantities of protein (249).  Purification of 
many proteins from their native hosts is often impeded by the low amounts present in such source 
materials.  However, knowledge of how to manipulate cells for the overexpression of heterologous 
proteins has been steadily compiling since the first bacterial transformation with a recombinant plasmid 
by Cohen et al. in 1973 (250) and the subsequent production of somatostatin from a transgenic bacterium 
by Genetech, Inc. (251), followed by the market release of bacterially produced human insulin, 
Humulin™, in 1982 (252).  Advances in expression technology have increased the recovery of 
heterologously expressed proteins in a variety of host systems, leading to a surge in biotechnological and 
therapeutic applications (253).  The success of any biological construction, however, relies heavily on the 
approach taken and several considerations must be met in selection of an expression platform (254).  
Depending on the application and scale of the intended project specific attention must be given to 
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productivity, process economics, product quality and safety, production stability, lead times, scalability, 
and regulatory acceptance. 
2.3.1 Bacterial expression systems 
Expression of recombinant proteins in bacterial systems, of which Escherichia coli is the most well-
known, is often the preferred choice in the synthesis of non-glycosylated proteins for a variety of reasons.  
The host metabolic needs are well characterised and cultures can rapidly achieve high biomass, it is 
inexpensive and has the ability to generate high protein yields. 
Apart from E. coli, other prokaryotic organisms have also been employed in heterologous protein 
expression.  Bacillus is the second most utilised prokaryote for expression studies and are often 
successfully utilised in the production of pharmaceutically relevant proteins.  In part, this is because these 
Gram-positive organisms do not contain lipopolysaccharides in their outer membranes, conferring to 
them generally regarded as safe (GRAS) status (255).  What is more, however, is that the complete 
genomes of certain Bacillus have been sequenced (256, 257).  Organisms such as Bacillus subtilis, 
Brevibacillus choshinensis and Bacillus megaterium all exhibit naturally high secretion capacity and are 
therefore well-suited to the generation of toxins and exo-enzymes.  Many of the excreted proteins are 
correctly folded, soluble and active and, under certain conditions, yields of up to 3 g recombinant protein 
per litre have been reported (258).  Furthermore, some bacilli inherently have low levels of extracellular 
proteases (259), in the case of B. subtilis efforts to characterise or reduce endospore formation resulted in 
the generation of protease-deficient strains, thus increasing the stability of secreted proteins (260).  Some 
of the regulatory elements of these species have also been characterised to potentiate transcript 
stabilisation (261).  However, compared to E. coli, the transformation of bacilli have been arduous, often 
requiring polyethylene glycol-mediated protoplasting (262), use of minimal-media protocols, or host 
strain alterations (263).  The lack of suitable expression vectors and producer strains has been addressed 
in the last decade (264), yet plasmid instability and misfolding in more complex proteins has maintained 
reservations to the use of bacilli as expression hosts. 
In theory, all bacterial cells could be used for the production of heterologous proteins.  Many examples of 
alternative prokaryotic cells as expression hosts exists, including Staphylococcus carnosus (265), 
Pseudomonas spp. (266, 267), Ralstonia eutropha (268) and Methylobacterium extorquens (269), have 
been shown to be capable of effective recombinant protein production.  As with Bacillus strains, the 
nisin-inducible controlled gene expression system (NICE) of Lactococcus lactis have also recently 
emerged as an attractive alternative due to its GRAS status, lack of endotoxins and ability towards 
extracellular protein production (270).  However, compared to E. coli, these systems are still poorly 
characterised in literature and little support with regard to vectors and promoter are available.  As a result, 
such hosts are rarely investigated as a means of protein synthesis alternatives and only 1% of therapeutic 
protein products are produced in bacteria other than E. coli (271).  However, as more information is 
gathered regarding the growth requirements and genetic regulation of these organisms, with concomitant 
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availability of commercial support, a new generation of prokaryotes may come to rival E. coli as 
expression systems. 
Until such time, however, E. coli will most likely remain the most prevalent prokaryotic host for the 
heterologous expression of proteins.  In 2013, Férnandez and Vega estimated that 88.6% of distinct 
protein chain entries in the Protein Data Bank (PDB) indicated E. coli as expression host (264).  Decades 
of research pertaining to the genetics of E. coli, and its use as propagation host for DNA used in nearly all 
cloning and expression systems, have secured this bacterium as a firm favourite of many protein 
biochemists.  However, as the complexity of proteins increases, as is commonly seen with mammalian 
proteins, the use of E. coli is faced with certain constraints.  Proteins which require post-translational 
modification, such as glycosylation, acetylation or even phosphorylation, or those that depend on correct 
disulphide bond formation for structure or function are often challenging in E. coli expression systems.  
Furthermore, the evolutionary selective use of codon triplets in different organisms further complicates 
the overexpression of protein in any heterologous system.  Nevertheless, multiple strategies have been 
designed to counter such problems.  Codon bias has been successfully addressed by site-directed 
mutagenesis, the use of specialised strains such as Rosetta-gami (272) or the incorporation of plasmids 
such as pRIG, pRARE, pACYC or pSC101 (273).  Directing protein expression to the periplasm and the 
co- or pre-expression of protein disulphide isomerase (PDI), sulphydryl oxidases or disulphide bond 
formation catalysts (Dsbs) have, in some cases, relieved issues arising from the reductive nature of the 
E. coli cytoplasmic environment (274, 275).  Even the appreciable inability of E. coli to produce 
glycosylated proteins has been addressed following the identification, and subsequent transfer, of N-
linked glycosylation systems in the Gram-negative bacterium Campylobacter jejuni (276) and, recently, 
the δ-proteobacterium Actinobacillus pleuropheumoniae (277).  Structurally the bacterial N-glycans 
differ from their eukaryotic counterparts.  Still, they provide the basis for the engineering of a bacterial 
glycosylation system capable of replicating mammalian glycan structures. 
2.3.2 Yeast expression systems 
With a mere 35% of heterologous proteins produced in E. coli being sufficiently soluble and correctly 
folded for biological studies (278), the sometimes limited success with bacterial expression systems 
restricts the use of these organisms as expression host for certain proteins.  Increasing knowledge of the 
cellular regulation at the transcriptional and translational levels of different organisms presents a means 
of selecting appropriate expression hosts on the basis of codon usage and a possible necessity for post-
translational modifications. 
As with bacterial cells, the development time from gene to final product is significantly shorter than 
higher eukaryotic expression systems.  Yet the expression of soluble, active protein is often achievable to 
higher degrees in yeast than in E. coli, especially if the product is secreted from the host cell to the 
cultivation media (279).  Furthermore, many eukaryotic proteins fail to produce properly in E. coli due to 
particular requirements for key interaction partners which facilitate proper folding and effective structural 
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additions to peptide chains.  Unicellular, eukaryotic fungi contain many of the cellular machinery 
necessary for the overexpression of a broad range of proteins with such requirements.  Modifications to 
the protein structure, carried out in the endoplasmic reticulum following translation, are almost identical 
in lower and higher eukaryotes, since the processing reactions in this organelle are highly conserved.  
However, restructuring of N-glycan moieties in the Golgi apparatus differs between species and is cell 
specific (280, 281).  As a result the glycosylation patterns of proteins, heterologously synthesised in 
yeast, may differ from their human or mammalian counterparts, thus affecting biological activity or 
eliciting immunogenic responses in therapeutic milieus.  Considerable effort have therefore been exerted 
in engineering yeast strains that produce aglycosylated peptide chains such as the recombinant human 
serine protease ocriplasmin, produced under the brandname Jetrea
®
 (ThromboGenics) (282).  This 
biotherapeutic product, for treatment of symptomatic vitreomacular adhesion, is expressed in the 
methylotropic yeast Pichia pastoris.  Moreover, N-glycan engineering in yeast was pioneered in 
P. pastoris (syn. Komagataella pastoris) during the last decade (283) by limiting the yeast ability to 
mannosylate while introducing glycosyltransferases which can produce complex oligosaccharide terminal 
sugars such as galactose, sialic acid and acetylglucosamine (GlcNAc) (284).  The humanisation of 
glycosylation in P. pastoris has facilitated the production of various yeast-derived therapeutic proteins 
and antibodies as heterologous products.  Furthermore, other yeast strains, including Saccharomyces 
cerevisiae (285, 286), Hansenula polymorpha (syn. Ogataea parapolymorpha) (287–289), Yarrowia 
lipolytica (290, 291) and Kluyveromyces lactis (292), have since been reported as systems capable of 
synthesising heterologous proteins.  According to Bill (293) 11% of publications entered into the PubMed 
Central database relating to recombinant gene expression during 2013 indicated P. pastoris as expression 
host.  Currently, 20% of biopharmaceutic proteins are synthesised in yeasts (294).  
2.3.3 Mammalian expression systems 
However, within the pharmaceutical sector mammalian expression systems are still the dominant choice 
for the production of bio-pharmaceutically relevant proteins. With market approved therapeutic proteins 
produced in such systems exceeding 50% (253) there is a clear mandate for stringent mimicry of human-
like biologicals.  Recent optimisations to media formulation, population selection and process control 
have improved cell line development to the point where upwards of 10 g/l mAb/Fc-fusion proteins have 
been produced in 100 litre bioreactor cultures of Chinese hamster ovarian cells (CHO) (295).  The 
production of complex protein therapeutics, with monoclonal antibodies being the most prevalent and 
rapidly developing sector, are preferably performed in mammalian systems due to highly human 
compatible posttranslational modifications and pharmacokinetic functionalities (296).  Predominantly, the 
attraction to mammalian culture is centred on the capability to add composite carbohydrates to 
synthesised proteins.  The extensive posttranscriptional metabolic machinery, required to functionalise 
humanoid proteins, are simply unavailable in prokaryotic bacteria and are mostly inadequate in lower 
eukaryotic cells such as fungi or unmodified yeasts (297, 298).  CHO cells are therefore readily used to 
produce about 35% of the therapeutic proteins on the market (271) since the glycosylation patterns 
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produced by these cells are similar to those in humans (299).  CHO, and its derivatives, and the murine 
derived myeloma cell line NS0 have traditionally been the predominant choices for heterologous gene 
expression in mammalian cells due to known productivity profiles and safety concerns (296, 300).  Other 
cell types include human embryonic kidney (HEK-293) cells, baby hamster kidney (BHK-21) cells, and 
the myeloma lymphoblastoid-like cell line Sp2/0-Ag14. 
2.3.4 Baculovirus and insect cell expression systems 
Ten years ago the pharmaceutical companies GlaxoSmithKline (301, 302) and Merck (303–305) both 
invested in and produced vaccines to protect against cervical cancer.  These vaccines, licenced under the 
trade names Cervarix™ and Gardasil®, respectively, were constructed by producing the L1 protein of the 
human papillomavirus viral capsid in heterologous systems.  While Merck produced these viral proteins 
(HPV-6/11/16/18 L1) in yeast, the bivalent HPV-16/18 L1 vaccine by GlaxoSmithKline was a product of 
the baculovirus expression vector system (BEVS).  The 2007 European Medicines Agency (EMA) and 
2009 US Food and Drug Administration (US FDA) market authorisations of Cervarix™ was a critical 
milestone in the approval of baculovirus-derived vaccines.  Various other BEVS vaccines have been 
approved for use in humans or animals, and many clinical trials for the introduction of new vaccines are 
currently underway (306). 
Following the expression of the first foreign gene, human beta interferon β (IFN-β) (307), in Spodoptera 
frugiperda cells, the BEVS gained prominence for the production of eukaryotic protein targets for a 
variety of reasons.  Baculoviruses are insect pathogens which exhibit considerable host-tropism.  Their 
limited transmission range therefore means that they are considered safe for use in vertebrates.  Wild-type 
and recombinant viral particles cannot replicate in eukaryotes other than their insect cell hosts.  An 
increase of laboratory biosafety levels is generally not required.  Furthermore, lepidopteran cell lines are 
relatively easy to culture and can be adapted to growth in suspension.  The system is therefore easily 
amenable to bioreactor scale expansion. 
The large, double-stranded, circular DNA genomes of baculoviruses are generally stable and can 
accommodate large heterologous inserts.  With few exceptions, baculovirus mRNAs do not require 
intron-splicing and mammalian cDNA is generally used for heterologous expression.  Notwithstanding, 
examples of the expression of efficiently spliced mammalian transcripts in insect cells have been 
published (308, 309).  Chen constructed a baculovirus polyhedrin promoter within an artificial intron and 
inserted it into a coding sequence, resulting in functional expression of genes with overlapping open 
reading frames (310).  A major attraction, however, is the post-translational capacity exhibited by the 
system.  Insect cells, being eukaryotes, follow the same initial steps during glycosylation of proteins.  
Within the endoplasmic reticulum Asn-X-Ser/Thr glycosylation sites are recognised on the nascent 
peptide-chain and oligosaccharide branches are added to the asparagine residue in this motif, as with 
mammalian cells.  Yet carbohydrate additions to these branches following mannosidase trimming differ 
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slightly between insects and mammals.  Native insect proteins contain simple oligo-mannose moieties, 
while mammalian cell proteins may contain complex sugars with terminal sialic acid groups (311). 
Two baculoviruses, Autographa californica multiple nuleopolyherovirus (AcMNPV) and Bombyx mori 
NPV (BmNPV) are commonly used in BEVS for heterologous gene expression.  AcMNPV are generally 
used to infect cells derived from the fall army worm, Spodoptera frugiperda, or the cabbage looper, 
Trichoplusia ni, while BmNPV is used, to a lesser extent, during the infection of Bombyx mori silk worm 
larvae (312).  The genus Alphabaculovirus, to which AcMNPV, the genus type species, and BmNPV 
belong, produce two different virion types during its infectious cycle (313, 314).  Budded virus (BV) 
disseminates the infection in the host organism by budding from the cell membrane of one cell and fusing 
with the membrane of another.  This type of virus is produced early in the infection and is enclosed 
within a viral protein-modified envelope.  Conversely, occlusion derived virus (ODV) is entirely encased 
in a proteinaceous matrix within the nucleus of infected host cells.  MNPV ODV comprises of multiple 
viral particles within a polyhedral shaped occlusion body (OB) that consists of the viral protein 
polyhedrin.  Contrary to BV, parts of the nuclear membrane are used during the construction of the ODV 
envelope at the nuclear stages of infection and are more complex in its protein content (315).  OBs are 
highly stable structures, responsible for the protection of virions from damage in the environment. 
Baculoviral proteins are expressed in four temporally distinct stages.  During the first phase of infection, 
the early stage, host RNA polymerase II in association with host transcription factors transcribes 
immediate early proteins from promoters in the viral genome (ie-genes).  This phase of infection is 
characterised by the translation of proteins involved in the transcription of genes during the delayed early 
stage.  Consequently, the late expression factors (LEFs) required for viral DNA replication, and 
transcription during the late stage, are expressed.  Host gene transcription shutoff correlates with 
progression of infection to the late stage (316).  During the late and very late stages of infection, viral 
genes are transcribed by a virus-encoded RNA polymerase.  Viral synthesis starts following the delayed 
early stage.  Within the nucleus, viral particles are replicated by poorly understood mechanisms within 
the electron-dense, chromatin-like viral stroma (317).  Multiple sequences, known as hrs regions, behave 
as functional origins of replication and some evidence that replication may occur by a recombinant-
dependent mechanism, a rolling circle mechanism, or by a means which incorporate characteristics of 
both, exist (318).  Between 6 and 24 hours post infection (hpi) late genes are expressed, followed by 
rampant expression of the very late genes starting at 18 hpi.  At approximately 10 hpi the GP64 fusion 
protein is targeted to the cell membrane where it facilitates membrane fusion and the release of BV (319, 
320).  Interestingly, structural proteins and GP64 is transcribed during the late stage of infection, yet it 
has been reported that virions become associated with the membrane between two to four hpi.  The 
suggestion is that a cohort of the original virus inoculum immediately translocates to the nucleus, initiates 
replication and prepares the membrane for budding by means of GP64, while some virions pass through 
the cytoplasm to infect adjacent cells (321), possibly by a mechanism involving microtubules consisting 
of host α- and β-tubulin (322). 
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Proteins involved in ODV formation are maximally expressed following the essential viral replication 
phase, i.e. during the very late stages of infection.  Throughout this phase, two proteins, polyhedrin and 
p10, are expressed at extremely high amounts.  Within the natural environment, the filamentous p10 
protein is involved with the release of ODV from the cells by means of the controlled disintegration of 
the host cellular structure (323).  Expression of virally encoded polyhedrin and p10 proteins from the 
very strong polh and p10 promoters are under the control of an essential baculovirus core gene transcript, 
very late factor-1 (VLF-1).  However, neither p10, nor polyhedrin are essential for the generation of 
infectious particles. 
The BEVS exploits the presence of these very strong viral promoters by inserting heterologous coding 
sequences to downstream loci, in lieu of the non-essential native genes.  Under the control of polh, 
heterologous proteins produced in BEVS can achieve up to 50% of the total cellular content (324).  The 
large baculoviral genome, however, complicates direct manipulation of native genes or the insertion of 
foreign DNA.  Therefore, two methods of baculovirus engineering are commonly employed in the 
production of recombinant infectious viral particles.  The first method utilises the transferral of a gene of 
interest from a donor plasmid to the baculovirus genome by means of homologous recombination (307).  
Sequences flanking the heterologous gene cassette correspond to identical sequences up- and downstream 
of the site of insertion.  Co-transfection of insect cells, generally the S. frugiperda clonal isolate Sf9, with 
the donor plasmid and baculovirus DNA facilitates an exchange of genetic material between the two 
molecules, thus introducing the foreign DNA to the baculovirus genome.  This classical method of 
producing recombinant viruses generally resulted in the creation of recombinant viral particles at an 
efficiency of less than 1% which could be identified by altered plaque morphology.  However, 
improvements to the system by Kitts and Possee (325, 326) during the 1990’s significantly increased the 
effectivity of the process.  Linearisation of the baculovirus genome and the subsequent introduction of 
three novel Bsu36I endonuclease recognition sites, which disrupt the essential Orf1629 gene, increased 
the recovery rate to approximately 30% and ~100%, respectively. 
The alternative method of combining foreign DNA with the baculovirus genome was developed in 
parallel with linearizable DNA by Luckow et al. (327).  Expression of heterologous protein is achieved 
by the introduction of a recombinant bacmid to a suitable insect host.  The F-Bacmid is a recombinant 
baculovirus that can replicate autonomously in E. coli DH10β and to which attTn7, the target site for 
bacterial Tn7, has been introduced.  Foreign genes are transposed to the bacmid in E. coli cells when 
flanked by the left and right ends of Tn7.  Creation of recombinant bacmids is easily verified by PCR 
prior to its transfection into insect cells.  BV particles can be harvested from the culture media following 
translation of the baculoviral genes involved in replication.  Viral titres are then easily increased by 
infection of new cells with the bacmid-derived BV.  However, recombinant bacmids can be unstable and 
some parental bacmid background often occurs.  An improved method for the creation and maintenance 
of recombinant bacmids by transposition was described by Airenne et al (328) called BVBoost.  The 
transfer plasmid has been engineered to express the negative selection marker sacB from Bacillus 
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amyloliquefaciens.  E. coli cells containing transfer plasmids that did not undergo transposition will 
express the product of sacB, levansucrase.  Levan, which is converted by this enzyme (EC 2.4.1.10) from 
sucrose accumulates in the cytoplasm and is lethal to E. coli (329).  Occupation of the chromosomal 
cryptic attTn7 site of E. coli DH10β with an Amp resistance cassette resulted in the creation of a new 
E. coli strain (DH10 BacΔTn7) which, upon selection with sucrose, yields recombinant viral particles 
with negligible parental background (330). 
The potential to achieve high levels of heterologously expressed protein in BEVS rivals that of E. coli.  
Since its inception, many advances have been made in BEVS.  Not only has the system been optimised 
for rapid selection and purification of recombinant baculoviruses, several viral expression vectors have 
been designed for the expression of folding aides, such as calreticulin, PDI and calnexin (331).  
Furthermore, efficient systems of directing heterologous proteins to the cell surface have been 
successfully implemented.  The differences in glycosylation patterns between mammals and insects have 
also been addressed by the creation of stably transfected insect cell lines which express mammalian 
glycosylation enzymes (332, 333).  Owing to these advances, recent unique entries to the PDB, with less 
than 90% sequence identity to other entries, have been dominated by the BEVS (334). 
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CHAPTER 3 
EXPRESSION AND PURIFICATION OF BACTERIALLY 
PRODUCED ANDROGEN AND ESTROGEN RECEPTOR LIGAND 
BINDING DOMAINS 
The detrimental effects imposed on human and animal health by EDCs provide impetus for the 
development of methodologies capable of their rapid detection within our environment.  Since EDCs can 
modulate the regulatory mechanisms of the endocrine system by interaction with nuclear receptors, the 
production of receptor proteins by heterologous gene expression will provide biological molecules with 
which EDCs are known to interact.  If available, these proteins may be used to fashion a novel means to 
determine the presence of natural and synthetic endocrine-active substances within the environment by 
the immunohistochemical detection of conformational changes induced to the receptor LBDs upon ligand 
binding. 
Heterologous protein production refers to the phenomena of recombining DNA from various sources with 
the goal to express proteins in organisms which do not naturally produce them.  To this end many 
systems have been developed over the course of the last few decades, exploiting a variety of host 
organisms, each contributing a unique set of challenges and advantages (335).  However, considering the 
broad array of cloning vectors available, along with the vast amounts of literature that have accumulated 
regarding prokaryotic physiology and genetics, it is easy to understand why E. coli is the most widely 
used expression host for both structural analysis and screening of protein targets (19–21) and why it is 
generally regarded as a first tier host for the production of heterologous proteins (336). 
A challenging step in the expression of any protein or protein fragment, however, is predicting whether 
such a construct can be produced in large, active quantities considering many heterologous proteins 
express poorly or fold improperly.  Small variations in the length of recombinant constructs or alterations 
to the amino acid sequence can alter the expression profile of proteins in host organisms.  Nevertheless, 
despite all the data generated by various groups that focus on expression and purification of recombinant 
proteins for therapeutic, structural or academic research, a means of predicting which proteins will 
readily express and purify, based on amino acid sequence alone, is still lacking (337, 338).  There are, 
however, many reviews that focus on possible strategies to enhance active heterologous proteins recovery 
in E. coli by discussing the host genetic milieu, fermentation conditions, lysis environments and 
purification strategies (259, 273, 339). 
Historically, purification of nuclear receptors or their ligand binding domains to high concentration and 
purity have been hampered by low solubility and instability of the heterologously expressed proteins 
(340, 341).  This chapter describes efforts to increase the solubility of a recombinant construct for the 
human androgen receptor ligand binding domain (ARLBD) produced in E. coli, with reference to media 
additives and lysis buffer composition.  Specific mention is made of the influence of buffering, osmotic, 
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stabilising and solubilising additives.  Attention to these parameters led to a net increase in soluble 
recombinant protein.  Furthermore, purification of the human receptor LBDs for both androgens and 
estrogens, via immobilised metal affinity chromatography (IMAC) and immobilised ligand affinity 
chromatography, is discussed. 
3.1 METHODOLOGY 
3.1.1 Cell lines and vectors 
The gene sequences encoding the ligand binding domains of the human androgen (ARLBD) and estrogen 
(ERαLBD) receptor major isoforms have been cloned previously (342).  cDNA of the ERαLBD is 
contained within two expression vectors, pTrcHis and pET-15b.  DNA encoding the ARLBD has been 
inserted to only the pTrcHis vector.  pTrcHis/ARLBD and pTrchis/ERαLBD vectors have been 
transformed into the E. coli TOP10 strain.  The pET-15b/ERαLBD vector was transformed into the 
BL21(DE3)pLysS strain. 
Prior to all experiments, cells from cryogenic storage were routinely and aseptically streaked onto 1.5% 
Luria Bertani (LB)-agar plates containing 100 μg/mL ampicillin.  Plates were incubated at 37°C until 
well defined single colonies of ± 2 mm in diameter had formed.  Unless stated differently, single colonies 
were then inoculated in 5 mL LB media, with antibiotics, and incubated at 37°C with agitation at 
235 RPM for 12 – 16 hours as initial cultures. 
3.1.1.1 Extraction of plasmid DNA 
Plasmid DNA was extracted using a Zyppy™ Plasmid Miniprep Kit (Zymo Research), following the 
classical centrifuge-based procedure according to the manufacturer’s protocol.  In brief, cells from 3 mL 
bacterial cultures, cultivated overnight at 37°C, were collected by centrifugation in a Heraeus Biofuge 
fresco microfuge at maximum speed.  Following cell lysis and precipitation of genomic DNA, proteins 
and other cellular constituents, the soluble supernatants were transferred to Zymo-Spin™ IIN column, 
washed and eluted with 45 μL Zippy™ elution buffer. 
3.1.1.2 Verification of construct identity 
DNA sequencing was performed by the Central Analytical Facility (CAF) at the University of 
Stellenbosch.  A primer that anneals to the T7 gene promoter region (5’-TAATACGACTCACTAT-3’) of 
the pET15b-ERαLBD plasmid was used to determine the forward coding sequence of the ERαLBD 
insert.  pTrc vectors were not sequenced as the data for these vectors were available. 
3.1.2 Establishment of a bacterial growth curve 
TOP10/pTrcHisARLBD initial cultures were diluted one hundredfold to 400 mL LB medium containing 
50 μg/mL ampicillin.  The culture was then incubated for 26 hours during which time 1.6 mL aliquots 
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were collected hourly, frozen in liquid nitrogen and stored at -20°C until further analysis.  Subsequently, 
all samples were thawed and kept on ice.  After homogenisation by inversion, 100 μL of each collected 
aliquot was pipetted in triplicate into the wells of a 96 well plate and the optical density was measured at 
600 nm using a PowerWave 340 plate reader spectrophotometer (BioTek Instruments, Inc.) under the 
control of the software package Gen5, version 1.05.11.  The OD600 of aliquots pertaining to the 
exponential phase of bacterial growth was consequently determined using a cuvette with a 1 cm light 
path. 
3.1.3 Optimisation of parameters for ARLBD production 
3.1.3.1 Cultivation media formulations 
To assess the effect of media formulation on ARLBD production bacterial cells from initial cultures were 
diluted one hundredfold to 400 mL with either LB, LB media buffered with 30 mM sodium/potassium 
phosphate (bLB), or buffered LB containing 0.5% glucose (bLBg).  Protein expression was induced at an 
OD600 of 0.75 by the addition of isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of 
0.3 mM.  Cells grown in bLBg were harvested and resuspended in bLB prior to induction.  After 1 hour 
at 37°C the cells were collected by centrifugation at 5,000 xg for 15 minutes at 4°C in a Beckman 
Avanti
®
 J-E centrifuge.  After aspiration of media the cells were resuspended in chilled phosphate lysis 
buffer (50 mM sodium phosphate (pH 8.0), 300 mM NaCl, 10 mM imidazole, 0.1% Nonidet P-40, 
5 mM sodium metabisulphite (NMBS)) at 3 mL/mg wet cells.  Lysis was achieved by enzymatic cell wall 
degradation using lysozyme at 1 mg/mL at 37°C for 1 hour, followed by ten 1 minute sonication duty 
cycles at 60% in an ice bath with a Sonicator™ Cell Disruptor; model W-225 (Heat Systems – 
Ultrasonics, Inc.).  Cellular debris was then pelleted by centrifugation at 15,000 xg, 4°C, for 20 minutes.  
The supernatant was transferred to clean 50 mL conical tubes prior to resuspension of the cell debris in a 
volume equal to the supernatant. 
3.1.3.2 Duration of protein expression trials 
To 396 mL LB medium, containing 50 μg/mL ampicillin, 4 mL of TOP10/pTrcHisARLBD initial culture 
was added.  At hourly intervals 1.6 mL aliquots were collected, frozen in liquid nitrogen and stored 
at -20°C until further analysis.  Protein expression was induced by the addition of 0.3 mM IPTG to the 
growth media when the culture reached an OD600 of 0.75.  Following sample collection cell aliquots were 
thawed and kept on ice, prior to cell harvest by centrifugation at 12,250 xg, 4°C, for 15 minutes in a 
Heraeus Biofuge fresco microfuge.  After removal of the supernatants, cells were resuspended in 150 μL 
chilled phosphate lysis buffer.  Cells were lysed by 25 sonication pulses using a Sonicator™ Cell 
disruptor, model W-10 (Heat Systems – Ultrasonics, Inc.), followed by five freeze/thaw cycles.  Cellular 
debris was separated from the supernatant by centrifugation at 12,250 xg, 4°C, for 20 minutes.  Where 
applicable the protein concentrations of the supernatants were adjusted to 1.9 mg/mL.  Of these 
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supernatants 10 μL was blotted on a nitrocellulose membrane.  Proteins containing histidine tags were 
visualised with HisProbe™-HRP (Thermo Scientific). 
3.1.4 Expression of nuclear receptor LBDs 
Initial cultures were used to inoculate larger volumes of bLB media in baffled shaker flasks at a ratio of 
1:100.  Expression was induced during the mid-exponential growth phase by the addition of 0.3 mM 
IPTG.  Induction of ARLBD expressing cells was maintained at 37°C with agitation at 235 RPM for 
1 hour.  ERαLBD expressing cells were induced to express heterologous protein for 16 hours under 
similar conditions.  Cultures were immediately placed on ice at the completion of induction, prior to cell 
harvest by centrifugation. 
3.1.5 Determination of protein concentrations 
Protein concentration determination of the lysate fractions was accomplished by means of the Pierce
®
 
BCA Protein Assay Kit (Thermo Scientific).  Bovine serum albumin (BSA) standards were prepared by 
the standard test tube protocol and microplate procedure as described in the manufacturer’s instructional 
document.  Of all the standards and samples 10 μL were pipetted in triplicate into the wells of a 96 well 
microtitre plate.  To each well 200 μL BCA working reagent was added using a multi-channel pipette.  
Plates were then incubated at 37°C for 30 minutes.  After allowing the plates to cool to room temperature 
absorbance was measured at 540 nm with a Multiskan EX plate reader spectrophotometer (Thermo 
Scientific). 
3.1.6 Densitometric analysis 
Densitometric analysis of SDS-PAGE gels and Western blots was carried out using the software package 
UN-SCAN-IT gel™, version 6.1 (Silk Scientific Corporation).  All images were converted to greyscale 
for analysis and all analyses were performed with a single region background subtraction correction 
factor.  Optical density calculation was set to linear with saturation checking. 
3.1.7 Optimisation of lysis conditions 
The environment into which a recombinant protein is released upon cell lysis is an important 
consideration for the maintenance of protein stability and activity.  Hydrophobic interactions between 
proteins with especially high grand average of hydropathy indexes may be markedly enhanced within the 
extracellular environment, as compared to the cell interior.  Lysis conditions affecting the solubility of the 
ARLBD protein were investigated with regards to pH, salt concentration, known stabilising agents and a 
range of detergents and surfactants. 
As before, TOP10/pTrcHisARLBD initial cultures were diluted one hundredfold to 400 mL antibiotic 
containing bLB and incubated at 37°C.  Upon reaching mid-logarithmic growth 0.3 mM IPTG was added 
to induce heterologous gene expression.  Induction was maintained for 1 hour after which the culture was 
Stellenbosch University  https://scholar.sun.ac.za
40 
 
placed on ice.  Subsequently, 3.5 mL aliquots were collected and centrifuged in a Heraeus Biofuge fresco 
microfuge at 2,600 xg, 4°C for 25 minutes.  After aspiration the pelleted cells were frozen in liquid 
nitrogen and stored at -80°C until further analysis.  Thawed samples were resuspended in 350 μL chilled 
buffer as described in Table 3.1.  Following a 10 minute incubation period on ice, the resuspended cells 
were subjected to sonication with a Sonicator™ Cell Disruptor; model W-10 (Heat Systems – Ultrasonics, 
Inc.) for three 15 second bursts with 10 second cooling intervals in a wet ice bath.  The cellular debris 
was then separated from the supernatant by centrifugation at 12,250 xg at 4°C for 20 minutes in a 
Heraeus Biofuge fresco microfuge.  After transferral of the supernatant to clean micro centrifuge tubes 
the cellular debris was resuspended in 500 μL of the previously employed lysis buffers. 
Samples were prepared for SDS-PAGE and 15 μL of each was loaded on to 12% SDS-PAGE gels.  After 
transferral to Pall nitrocellulose membranes, histidine tagged proteins were visualised with HisProbe-
HRP.  Densitometric analyses of the resulting blots were carried out by means of the software package 
UN-SCAN-IT gel version 6.1.  Signals were normalised against the sum of the average pixel densities 
obtained for the supernatant and cellular debris of individual lysates. 
3.1.8 Radioligand binding studies for the ARLBD construct 
Determination of whole cell ligand binding ability was assessed by means of a competitive radioligand 
binding assay.  E. coli Top10/pTrcHisARLBD and untransformed E. coli Top10 cells were grown as 
before and induced to express recombinant protein.  As the recombinant bacteria exhibited slower growth 
than their untransformed counterparts, Top10 cells were diluted to OD600 equivalent to that of 
Top10/pTrcHisARLBD post protein expression induction.  The cells were harvested by centrifugation at 
6,000 xg at 4°C for 20 minutes.  The LB medium supernatant was subsequently aspirated and the cells 
were washed by resuspension in 20 mL PBS (pH 7.5), followed by centrifugation at 6,000 xg at 4°C for 
20 minutes.  The PBS wash buffer was subsequently aspirated and the cells were resuspended in 10 mL 
PBS (pH 7.5).  Cell aliquots (95 μL) were incubated overnight with decreasing concentrations of 
3
H-testosterone (range 75 nm to 1 nm).  To determine non-specific binding cell aliquots were incubated 
with 
3
H-testosterone with a thousand fold excess of unlabelled testosterone whilst agitating.  The 
following morning ligand-incubated cells were harvested by centrifugation in a bench top centrifuge at 
6,000 xg for 5 minutes.  The resulting supernatant was transferred to 4 mL Flo-Scint™ III scintillation 
fluid (Perkin Elmer) and the cells were washed by resuspension in 100 μL PBS (pH 7.5).  After 
centrifugation for 10 minutes in a bench top centrifuge at 6,000 xg, the wash buffer was transferred into 
4 mL scintillation fluid.  The pellet was subsequently resuspended in 100 μL PBS and then transferred 
into 4 mL scintillation fluid.  Radioactivity was counted using a Perkin Elmer scintillation counter. 
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Table 3.1 Formulations of buffers used during the optimisation of TOP10/pTrcHisARLBD to increase solubilisation of the recombinant ARLBD .  pH calibration was performed at 4°C.  All 
buffers included 250 μg/mL lysozyme and 0.1% PMSF, which was added from stock immediately prior to use. 
 Designation pH Buffer Salts Stabilisers Detergents/Surfactants 
p
H
 S
cr
e
en
 
P7.0 7.0 50 mM Sodium phosphate 
50 mM NaCl None None 
P7.5 7.5 50 mM Sodium phosphate 
T8.0 8.0 50 mM Tris 
T8.5 8.5 50 mM Tris 
H8.0 8.0 50 mM HEPES 
H8.5 8.5 50 mM HEPES 
HdG8.0 8.0 30 mM HEPES + 30 mM glycylglycine 
HdG8.5 8.5 30 mM HEPES + 30 mM glycylglycine 
 
S
a
lt
 S
cr
e
en
 
S0.05 
8.0 30 mM HEPES + 30 mM glycylglycine 
50 mM NaCl 
None None 
S0.25 250 mM NaCl 
S0.50 500 mM NaCl 
S0.75 750 mM NaCl 
S1.00 1 M NaCl 
S0.05 A0.010 
50 mM NaCl 
10 mM (NH4)2SO4  
S0.05 A0.025 
50 mM NaCl 
25 mM (NH4)2SO4 
S0.05 A0.50 
50 mM NaCl 
50 mM (NH4)2SO4 
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 Designation pH Buffer Salts Stabilisers Detergents/Surfactants 
O
sm
o
ly
te
 S
cr
e
en
 
- 
8.0 30 mM HEPES + 30 mM glycylglycine 250 mM NaCl 
No stabilisers 
None 
5% Glycerol 5% Glycerol 
10% Glycerol 10% Glycerol 
Glucose 25 mM Glucose 
Sucrose 25 mM Sucrose 
Maltose 25 mM Maltose 
Lactose 25 mM Lactose 
Galactose 25 mM Galactose 
Glucose/Glycerol 25 mM Glucose 
5% Glycerol 
  
D
et
er
g
en
t 
S
cr
e
en
 
- 
8.0 30 mM HEPES + 30 mM glycylglycine 250 mM NaCl None 
No detergents 
Propylene glycol 0.5% Propylene glycol 
Nonidet P-40 0.5% Nonidet P-40 
Triton X-100 0.5% Triton X-100 
Emulgen 913 0.5% Emulgen 913 
Poly-ethylene glycol 0.5% Poly-ethylene glycol 
Tween-20 0.5% Tween-20 
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3.1.9 Purification of receptor LBDs produced in bacterial expression 
system 
3.1.9.1 Immobilised metal affinity chromatography 
For purification of the ARLBD from E. coli, 400 mL bacterial cultures, in LB medium, was induced to 
express heterologous protein for 1 hour by addition of 0.3 mM IPTG when an OD600 of 0.75 was reached.  
Cells were collected by centrifugation at 5,000 xg at 4°C for 15 minutes and lysed in 35 mL chilled HDI20 
buffer (30 mM HEPES, 30 mM glycylglycine (pH 8.0), 20 mM imidazole, 250 mM NaCl, 0.5% emulgen 
913, 5 mM NMBS, 2 mM DTT, 0.25 mg/mL lysozyme, 1 mM PMSF) by ten cycles of sonication in an 
ice bath with 1 minute bursts using a Sonicator™ Cell Disruptor, model W-225 fitted with an H-1 probe 
(Heat Systems – Ultrasonics, Inc.), set to 60% duty cycle, with one minute cooling periods. 
Cells expressing the ERαLBD were lysed following the procedure outlined above, following 
resuspension in phosphate lysis buffer containing estradiol (50 mM sodium phosphate (pH 8.0), 300 mM 
NaCl, 10 mM imidazole, 5 mM NMBS, 0.1% Nonidet P-40, 10 μM 17β-estradiol, 0.1 mM PMSF).  After 
clarification by centrifugation at 15,000 xg at 4°C for 15 minutes, the supernatant was filtered through a 
0.45 μm pore size syringe filter.  Of the resulting ARLBD containing filtrate, 30 mL was applied to a 
5 mL HiTrap Chelating HP column (GE Healthcare), of which the iminodiacetate moieties had been 
charged with Ni
2+
 ions.  The column was previously equilibrated with a wash/equilibration buffer 
containing 30 mM HEPES, 20 mM imidazole, and 5 mM NMBS.  Removal of proteins rich in histidine 
and other chelating amino acids was facilitated by raising the imidazole concentration to 92 mM (15% 
elution buffer).  Elution of the recombinant protein from the IMAC column was achieved by increasing 
the concentration of imidazole to 500 mM (100% elution buffer).  The fractionated eluent was collected 
in tubes containing, at final concentrations, 5 mM ethylene diamine tetra-acetic acid (EDTA) and 0.2% 
(v/v) emulgen 913 (Kao Chemical Corporation). 
IMAC of ERαLBD containing samples was approached in a similar fashion as for the ARLBD, but the 
column was equilibrated with buffer containing 50 mM sodium phosphate (pH 8.0), 300 mM NaCl, 
20 mM imidazole, 5 mM NMBS, 20 mM β-mercaptoethanol and 10% glycerol. 
3.1.9.2 Desalting of collected IMAC fractions 
Fractions collected during IMAC containing proteins of interest were desalted by gel permeation 
chromatography.  ARLBD containing samples were applied to a 5 mL Sephadex G-25 desalting column 
equilibrated with H-GPC buffer (30 mM HEPES (pH 8.0), 250 mM NaCl, 5 mM NMBS).  Samples 
containing the ERαLBD were desalted with a 25 mL Superose-12 GPC column equilibrated with EPE 
buffer (10 mM sodium/potassium phosphate (pH 7.4), 135 mM NaCl, 3 mM KCl, 2% emulgen 913, and 
2.5 mM EDTA). 
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3.1.9.3 Affinity chromatography 
Affinity chromatography to purify nuclear receptor LBDs from bacterial lysates was performed using 
nortestosterone- or 17β-estradiol-Sepharose 6B resin in 1 mL columns.  Of the filtered cell lysates 20 mL 
was applied to the ligand-immobilised columns which had been equilibrated with AF buffer (30 mM 
HEPES (pH 8.0), 250 mM NaCl, 200 mM Sucrose, 1 mM EDTA) and eluted with a linear gradient with 
final concentration at 100% of 500 μM testosterone (ARLBD) or 17β-estradiol (ERαLBD) using a Bio-
Rad FPLC system. 
3.1.10 Determination of protein identity 
3.1.10.1 SDS-PAGE and Western Blot analysis 
SDS-PAGE analysis was carried out at each stage of the purification process according to the procedure 
of Laemmli (343).  Polyacrylamide gels (12%) were hand-cast and samples were electrophoresed with a 
Bio-Rad Mini-PROTEAN system at 4°C, 150 V.  Western blot procedures were performed after 
overnight transferral of proteins from SDS-PAGE gels to BioTrace NT pure nitrocellulose blotting 
membrane (Pall Life Sciences) at 4°C, 10 V.  Detection of proteins containing histidine-tags was 
performed using HisProbe-HRP (Thermo Scientific).  Rat anti-oestrogen receptor monoclonal IgG 
(Thermo Scientific) was used as primary antibody for the detection of the ERαLBD, whilst peroxidase 
labelled goat anti-rat IgG (Kirkegaard & Perry Laboratories) served as secondary antibody.  All Western 
blots were developed using either Pierce ECL (Thermo Scientific) or Clarity ECL (Bio-Rad) and exposed 
on Fuji medical X-ray film (Fuji Photo Film Co.). 
3.1.10.2 Peptide analysis via mass spectrometry 
In gel trypsin digestion 
Protein bands were excised from SDS-PAGE gels, cut into smaller pieces and washed twice with water.  
The gel pieces were then incubated in 50% (v/v) acetonitrile for ten minutes.  The acetonitrile was 
replaced with 50 mM ammonium bicarbonate and incubated for a further ten minutes.  This procedure 
was repeated twice.  After incubation in 100% acetonitrile until they turned white, the gel pieces were 
dried in vacuo. 
Dried gel pieces were then treated with 10 mM DTT at 57°C for 1 hour to reduce the contained proteins.  
The gel pieces were then briefly washed with 50 mM ammonium bicarbonate, followed by 50% 
acetonitrile.  Proteins were subsequently alkylated with 50 mM iodoacetamide for 1 hour in the dark.  
Following alkylation the gel pieces were washed with ammonium bicarbonate for ten minutes and then 
50% acetonitrile for twenty minutes.  The gel pieces were dried in vacuo and digested with 200 ng 
sequencing grade trypsin (Promega) at 37⁰C.  Following overnight incubation the gel pieces were treated 
twice with 70% acetonitrile in 0.1% formic acid for 30 minutes.  The pooled supernatants of these washes 
were then dried and stored at -20⁰C. 
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Liquid chromatography/mass spectrometry 
The dried peptides, dissolved in 5% acetonitrile in 0.1% formic acid, were analysed on a Thermo 
Scientific EASY-nLC II liquid chromatograph connected to a LTQ Orbitrap Velos mass spectrometer 
(Thermo Scientific, Bremen, Germany) equipped with a nano-electrospray source.  Injections of 10 µL 
were made. 
Liquid chromatography of pET15b-derived ERαLBD samples was performed, at a flow rate of 
300 nL/min, on an EASY-Column (2 cm, 100 µm ID, 5 µm, C18) pre-column, followed by an EASY-
column (10 cm, 75 µm ID, 3 µm, C18).  For analysis of ARLBD samples an XBridge BEH130 NanoEase 
column (15 cm, ID 75 µm, 3.5 µm, C18) was used.  Peptides were eluted with a gradient of 5 – 40% 
solvent B (100% acetonitrile in 0.1% formic acid) in 20 minutes, 40 – 80 % solvent B over 5 minutes, 
and then isocratic for 10 minutes.  Solvent A was water containing 0.1% formic acid. 
Mass spectrometry was performed at 1.5 kV, capillary temperature of 200°C, with no sheath and 
auxiliary flow, and the ion selection threshold set to 500 counts for MS/MS.  An activation Q-value of 
0.25 and activation time of 10 milliseconds were also applied for MS/MS. 
Automated database searching (Mascot, Matrix Science, London, UK and Sequest) of all tandem mass 
spectra against the Swissprot 57.15 and UNIPROT human databases was performed by using Thermo 
Proteome Discoverer 1.3 (Thermo Scientific, Bremen, Germany) to identify proteins.  Carbamidomethyl 
cysteine was set as fixed modification, while oxidized methionine, N-acetylation and deamidation (NQ) 
was used as variable modifications.  The precursor mass tolerance was set to 10 ppm, and fragment mass 
tolerance set to 0.8 Da.  Two missed tryptic cleavages were allowed.  Proteins were considered positively 
identified when they were identified with at least 2 tryptic peptides per proteins with a Mascot score of 
more than p < 0.05, as determined by Proteome Discoverer 1.3. 
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3.2 RESULTS AND DISCUSSION 
3.2.1 Cell lines and vectors for the expression of nuclear receptor LBD 
The expression cassette of the pTrcHis–TOPO cloning vector is indicated in Figure 3.1.  Transcription of 
heterologous protein coding sequences to mRNA is under the control of the strong E. coli trc promoter.  
This hybrid between the -35 region of the trpB and the -10 region from the lacUV5 (344, 345) promoters 
is located upstream of a lac operator which is normally bound by the lac repressor protein (LRP).  LRP is 
the product of the lacI
q
 gene.  The repressor protein suppresses transcription by inhibiting host RNA 
polymerase from binding to the trc promoter.  Upon availability of allolactose, or allolactose analogues 
such as IPTG, repression is lifted and recombinant protein expression is induced.  The plasmid also 
contains a pBR322 derived origin of replication and the ampicillin resistance gene, bla, which encodes 
for the expression of β-lactamase as a selective marker.  The T1 transcription terminator from the E. coli 
rrnB gene occurs 16 bp downstream of the inserted gene.  Upstream from the encoded hexahistidine tag 
the ribosomal binding site of the transcribed mRNA includes the Shine Dalgarno sequence 
(TAAGGAGG) and the canonical ATG translation initiation codon. 
 
Figure 3.1 Multiple cloning site, downstream termination region and 5’ regulatory map of the pTrcHis-TOPO cloning 
vector.  Heterologous genes are placed under the control of the pTrc promotor and expressed as fusion proteins 
with an N-terminal hexahistidine tag.  The DNA coding for such recombinant proteins are amplified with 
polymerases that adds adenylates the 3’ of PCR products, which are then ligated to the linearised cloning site, 
downstream of an enterokinase digestion site. 
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As with the pTrcHis system described above, the pET-15b vector expresses proteins with an N-terminal 
6xHis tag which confers metal chelating capability to the molecule, such proteins may therefore be 
purified by means of IMAC.  Also, the lac operator is present in the region 5’ of the multiple cloning site 
(Figure 3.2) and in the absence of lactose analogues is bound by the repressor, inhibiting the formation of 
transcription complexes at the upstream promoter region. Expression of these heterologous proteins, 
however, occurs under the control of the T7 promoter, which is not recognised by the host RNA 
polymerase. 
Bacterial hosts such as the BL21(DE3)pLysS strain of E. coli contain a chromosomal copy of the T7 
RNA polymerase from the λ-lysogen DE3 phage.  The expression of this bacteriophage polymerase is 
controlled by the E. coli lacUV5 promoter and its expression can therefore be controlled by the addition 
of IPTG.  Also, derivatives of the BL21 strain lack the lon and OmpT proteases which increases the  
stability of heterologous proteins expressed in these cell lines (273).  Furthermore, the BL21(DE3)pLysS 
cells express T7 lysozyme which serves to inhibit T7 RNA polymerase prior to induction of protein 
expression.  The presence of this protein enhances cell lysis by increasing cell wall degradation under 
milder conditions (337). 
As with the pTrcHis vectors, this plasmid contains a pBR322 origin of replication which ensures high 
maintenance of plasmid stability and a bla coding sequence, which imparts selectivity by antibiotic 
resistance. 
 
Figure 3.2 pET-15b cloning/expression region.  Recombinant proteins are transcribed from the T7 promotor in the 
presence of the inducer molecule, IPTG.  Presence of IPTG activates the expression of bacteriophage T7 RNA 
polymerase and relieves the repression of heterologous gene transcription. 
3.2.2 Heterologous expression and recovery of proteins in E. coli 
3.2.2.1 Initial expression analysis 
The E. coli system is well known and widely employed as a means of heterologous protein synthesis.  
Cases of recombinant proteins, directed at expression in the cytoplasm, which encompass up to 30% of 
the biomass in this host have been reported (20, 339).  Yet the converse is also true, several proteins have 
proven problematic when expressed in prokaryotic systems (346–348).  Initial small scale induction 
experiments indicated that the heterologous hexahistidine fused receptor LBDs are expressed by the 
bacterial host cells.  However, for both the androgen and estrogen constructs the majority of the 
expressed protein was sequestered to the cellular debris (Figure 3.3 and Figure 3.4). 
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Figure 3.3 Image of a 10% SDS-PAGE gel indicating the expression a recombinant hexahistidine-tagged ARLBD protein 
produced in E. coli TOP10/ARLBD.  Panel A: lane one contains 7.5 μg Kaleidoscope protein standard.  Each of 
lanes two to four were loaded with 20 μg of the supernatants of cultures induced with IPTG to express 
heterologous protein for four hours.  In lane 5 uninduced culture supernatant was loaded (20 μg).  Lanes six to 
eight contains the cellular debris of triplicate cultures (11.5 μg, 8.3 μg and 8.4 μg, respectively).  Lane nine 
contains 9.2 μg of the cellular debris of an uninduced culture.  Panel B: an image of a duplicate western blot 
indicating the presence of a  his-tag fusion protein. 
 
Figure 3.4 Samples from a four hour induction of E. coli BL21(DE3)/ERαLBD cells with IPTG resolved by SDS-PAGE 
(10%).  Panel A: lane one contains 7.5 μg Kaleidoscope molecular marker.  Lanes two to four each contain 20 μg 
of proteins from the soluble fraction of induced cultures.  The supernatant from an uninduced culture was 
loaded in lane five (20 μg).  The insoluble fractions of induced cultures were loaded to lanes six to eight (9.6 μg, 
9.6 μg and 9.4 μg, respectively).  In lane nine the cellular debris of from an uninduced culture was loaded 
(9.5 μg).  Panel B: an image of a duplicate western blot indicating the presence of a his-tag fusion protein. 
The images above indicate that a significant amount of the heterologous proteins, expressed by the 
bacterial cells, are not liberated into the supernatant during cell lysis, but is mostly confined to the 
insoluble fraction.  On average, about 90% of the total chemiluminescent signal observed for the ARLBD 
was confined to the insoluble component (p < 0.001). The ERαLBD, however, contained substantially 
(p < 0.05) more recombinant protein in the supernatant; averaging at approximately 40%.  
Several heterologous proteins overexpressed in E. coli often accumulate in accumulated, insoluble 
structures known as inclusion bodies.  The formation of these dense aggregates can be a significant 
hindrance in obtaining soluble, active protein in some situations.  It has been postulated that the proteins 
in inclusion bodies have native-like secondary structures (349) and are formed from intermediates of the 
folding pathway (350).  Therefore, a possible strategy is the solubilisation of inclusion bodies by 
denaturing conditions, but subsequent refolding of proteins into active proteins may prove difficult (349, 
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351–355).  Many strategies have been developed to address the problem of inclusion body formation at a 
genetic level (21), yet inhibition of the formation of these aggregates must virtually always, to some 
extent, be addressed by optimisation of growth and lysis conditions.  Induction temperature, addition of 
various small molecules, co-expression with chaperones and concentration of inducer are all parameters 
that may be modulated to optimise protein production.  Furthermore, the maximum obtainable yields of 
heterologous proteins may also be influenced by the time and duration of expression induction (356).  
Long induction times may lead to exhaustion of available nutrients in the culture. 
Marked expression of the receptor LBDs, in the absence of induction by IPTG, can be detected for both 
the ARLBD and ERαLBD constructs.  Interestingly, the signal observed in the soluble phase of ERαLBD 
containing lysate was three times as much as for the cellular debris (Figure 3.4, insert lane 5).  Many 
promoters suffer from basal level activation, even in the absence of inducer due to incomplete repression.  
Promoters based on the lac promoter, such as trc and lacUV5, suffer from higher basal transcription 
levels in the absence of glucose due to elevated levels of cyclic-AMP (cAMP) (357).  A general approach 
to reducing incomplete repression is by the inclusion of glucose to the pre-induction cultivation medium 
as E. coli preferentially uses this sugar as a carbon source until it is exhausted.  This strategy decreases 
intracellular levels of cAMP.  If present, cAMP induces a conformational change in catabolite activator 
protein (CAP), thus allowing it’s binding to regulatory elements upstream of lac-derived promoters, 
leading to the initiation of transcription (356).  Control over heterologous gene expression in E. coli, prior 
to induction, is important since the overexpression of such genes impose a high metabolic burden on the 
host cells (21, 358).  The energy requirements of cells expressing recombinant protein, even at basal 
level, may therefore impact negatively on the growth rate, since heterologous protein synthesis and 
specific growth rate is inversely correlated (358). 
Many protocols that focus on the expression of recombinant proteins in E. coli recommend that induction 
should be initiated during the exponential growth phase (359–362).  Figure 3.5 shows the growth 
characteristics of the pTrcHis-ARLBD transformed bacterial strain indicating that the logarithmic growth 
phase for these cells under culture conditions occurs roughly 2 – 6 hours after inoculation.  During this 
phase of fast bacterial growth cells are actively replicating and increasing the culture biomass.  
Transcription of the four ribosomal RNAs is pronounced (363), with much of the cytoplasm being 
occupied with ribosomes to facilitate elevated levels of protein synthesis. 
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Figure 3.5 Growth curve for the E. coli TOP10/pTrcHisARLBD strain cultivated in LB media at 37°C in baffled shaker 
flasks.  Active bacterial gowth occurs between two and six hours post inoculation  with mid-exponential growth 
at approximately four and a half hours under culture conditions.  The OD600 in a 1 cm cuvette at the midpoint of 
growth is ± 0.75. 
There is interplay between the synthesis and degradation of recombinant proteins in vivo depending on 
the rate of mRNA translation by the ribosomes, sequestration to insoluble inclusion bodies and 
degradation by bacterial proteolytic enzymes.  Hourly detection of recombinant protein after induction of 
bacterial cells to express ARLBD indicated that the optimal duration of expression is one hour post-
induction (Figure 3.6, A6).  A gradual decrease in signal is noticeable in aliquots taken during the 
sequential hours. 
 
Figure 3.6 Dotblot of proteins extracted from E. coli TOP10/pTrcHisARLBD cells.  Induction of protein expression 
occurred 4 hours after inoculation of the growth media with initial cultures (A5, red overlay).  Hourly aliquots 
were blotted and developed with HisProbe HRP. 
For the ERαLBD protein, however, a steady increase in signal strength can be observed on a Western blot 
(Figure 3.7) of aliquots taken at hourly intervals after induction of a BL21(DE3)pLysS/ERαLBD culture 
with 0.3 mM IPTG.  Overnight induction markedly increases the intensity of the protein band, compared 
to induction periods of five hours or less. 
 
Figure 3.7 Western blot of of induced BL21(DE3)/ERαLBD cells at time of induction (lane one), hourly intervals post 
induction (lanes two to six) and at sixteen hours post induction (lane seven) developed with rabbit anti-estrogen 
receptor alpha monoclonal IgG.  
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3.2.2.2 Effects of buffering and glucose inclusion in growth media 
Due to its ability to support fast growth and high cellular yields LB is the most widely used rich medium 
for the cultivation of a variety of prokaryotes.  Even though growth in LB is not as good as in more 
nutrient rich formulations such as terrific broth, high cell densities are often achieved.  However, high 
cell density could theoretically promote a variety of problems, including plasmid loss, limited 
oxygenation of the environment and decreases in pH due to elevated cellular metabolism (364), all of 
which could potentially reduce the maximal achievable amount of recombinant protein within the system.  
According to Strandberg and Enfors (365) the total and relative amounts of inclusion bodies formed 
during fermentation increases with a reduction in pH.  Indeed, a decrease of 0.2 pH units as recorded for 
cultures grown in LB medium without the addition of a buffering system, whilst no such change was 
recorded for cultures to which 30 mM sodium/potassium phosphate was added.  Control of the internal 
pH is important for optimal growth of E. coli.  Cytoplasmic pH in its natural habitat, the human 
gastrointestinal tract, is maintained between 7.2 and 7.8 (366) due to active and passive mechanisms, 
such as ATPase transporter system and the buffering effect provided by the cell’s metabolic pool.  In a 
paper discussing the physiology of E. coli cultivated in LB, Sezonov et al. (367) reports that the pH of the 
medium at growth arrest is routinely near nine.  Cells inoculated into spent media did not grow.  
However, upon the addition of glucose such media could support growth in a dose dependant manner, 
revealing that depletion of essential carbon sources affecting cellular metabolism, rather than toxification 
of the environment, results in arrest of growth.  Inclusion of glucose in growth media therefore tends to 
lead to higher cell densities of E. coli, which often results in higher levels of expressed soluble protein 
(368, 369).  Furthermore, as discussed in the previous section, the presence of glucose in the cultivation 
medium of cells expressing protein under lac derived promoters, prior to induction, alleviates the 
metabolic burdens associated with protein overexpression. 
Indeed, the addition of a buffer to the growth medium led to a significant increase (p < 0.001) in the 
amount of protein that was released into the soluble fraction of bacterial lysates.  Moreover, the addition 
of 0.5% glucose to the medium led to further significant (p < 0.001) total protein concentrations within 
lysate supernatants (Figure 3.8). 
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Figure 3.8 Effect of media formulation on total protein content produced by TOP10/pTrcHisARLBD cells induced to 
express heterologous protein.  Total protein concentrations contained within each fraction of lysates from cells 
incubated in growth medium with or without supplementation with a phosphate buffering system or glucose is 
presented in panel A.  These concentrations are normalised against the concentration of the supernatant from 
cells grown in unmodified LB medium in panel B.  Percentage shift from LB is indicated above the bars. 
The results of SDS-PAGE electrophoreses of cell cultures induced to express recombinant ARLBD are 
presented in Figure 3.9.  Interestingly, alterations to media composition, to withstand pH fluctuations, had 
no significant impact on the production of heterologous ARLBD in E. coli in this trial (Figure 3.10), as 
determined by two-way ANOVA.  Moreover, the substantial increase in soluble protein observed upon 
the addition of glucose to the medium did not result in increases in soluble ARLBD.  In fact, in relation to 
unmodified LB media, significantly more recombinant protein was obtained in the insoluble fraction of 
cell lysates from cultures grown in bLBg. 
 
Figure 3.9 SDS-PAGE gel image of TOP10/pTrcHisARLBD bacterial lysates produced under different growth media 
conditions.  In lane one, 6 μg Kaleidoscope protein marker (Bio-Rad) was loaded.  E. coli negative lysate control 
(Pierce) was loaded in lane two (30 μL).  To lanes three to five, 20 μL of prepared LB supernatant, bLB 
supernatant and bLBg supernatant was respectively loaded.  Of the prepared cellular debris 20 μL was loaded 
into lanes six to eight. 
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Figure 3.10 Relative distribution of E. coli produced ARLBD between the supernatant and cell debris of cell lysates is 
indicated in the graph to the left.  A comparison between the SDS-PAGE band densities for the fractionated 
protein, obtained with differing media formulations, indicates no significant change in the signal provided by the 
recombinant protein between LB and bLB.  There is, however a highly significant increase (p < 0.001) in the 
insoluble ARLBD produced with media containing glucose.  Also, there is a significant decrease in the amount of 
soluble ARLBD obtained. 
It is implausible that catabolite repression would reduce the metabolic burden and therefore lead to 
increased levels of proteins seen in Figure 3.8.  Arguably, the reason for higher levels of protein is 
increased cell density due to higher metabolic turnover provided by a more nutritious environment.  
Increased rates of protein synthesis may therefore lead to enhanced sequestration of misfolded 
recombinant protein intermediates to the bacterial inclusion bodies due to high local concentrations 
within the cytosol. 
3.2.2.3 Preparation and optimization of bacterial cell lysates 
According to Leibly et al. (278) a mere 35% of recombinant proteins produced in E. coli are adequately 
soluble and properly folded to be purified in acceptable quantities for procedures such as crystallisation.  
Cell lysis is the first step in the fractionation of cellular constituents.  Within the cell interior molecules 
are protected from degradation by harsh extracellular conditions.  Lysis of cells disrupts a carefully 
controlled environment, which allows the unregulated release of endogenous proteases and phosphatases.  
The potential for a protein of interest to be degraded or modified therefore increases.  When the goal of 
cell lysis is to purify or test the function of a particular protein, special attention must be given to the 
effects of the lysis reagents on the stability and function of the protein of interest.  This is especially true 
for proteins that are inherently hydrophobic, since the stability provided by cellular compartmentalisation 
is removed upon lysis.  It is, however, also important to consider any downstream procedures, such as 
protein purification, when making allowances for alterations in the parameters of the buffering systems 
employed.  In the current study, the lysing conditions pertaining to pH, salt, stabilisers and detergents 
were optimised. 
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It has been well documented by several authors (370, 371) that proteins become insoluble at their 
respective pI’s, even though the protein may be soluble in the native conformation.  At these pH values 
the interaction between proteins increases because the electrostatic forces of the molecules are at a 
minimum.  As a consequence less water interacts with protein molecules, resulting in favourable 
conditions for protein aggregation and subsequent precipitation.  Conversely, proteins have net negative 
or positive charges above and below the pI.  The net charged state of the protein leads to increases in 
charge repulsion between proteins, diminishing protein-protein interaction.  Furthermore, more water can 
interact with charged, solvent accessible residues, thus contributing to greater protein solubility.  The 
phenomenon of isoelectric precipitation has been successfully exploited in isolation of particular target 
proteins from complex mixtures (372–374).  However, it is also known that a decrease in solubility 
leading to aggregation negatively impacts on protein functionality (375, 376) especially when subsequent 
dissolution of such aggregates and refolding of proteins into the native form is inadequate.  It is therefore 
essential to control the pH of the lysis environment, since it is generally assumed that over-expression of 
heterologous proteins, especially proteins with a high degree of hydrophobicity, is more prone to lead to 
the accumulation of inclusion bodies in E. coli (349). 
The ARLBD, as with the other nuclear receptor LBDs, consists mainly of hydrophobic residues arranged 
in twelve helices folded into a three-layered, antiparallel helical sandwich (133).  The calculated 
theoretical isoelectric point for the current ARLBD protein, according to the SIB ExPASy Bioformatics 
Resources Portal, is 6.73 (377).  In agreement with the argument above, solubility should therefore be 
negatively impacted at this pH.  The relative solubility of the recombinant protein was therefore assessed 
over a range of pHs between 7.0 and 8.5, at 0.5 increments (Figure 3.11).  Densitometric analysis 
indicated an optimal pH of 8.0 utilizing a HEPES/glycylglycine buffering system. 
 
Figure 3.11 Comparison between the relative distribution of recombinant ARLBD between the soluble and insoluble phases 
of E. coli lysates obtained from lysis in buffers consisting of either sodium phosphate, Tris, HEPES or HEPES 
and glycylglycine at a pH range of 7.0 to 8.5.  Responses that indicate significantly less soluble protein in the 
supernatants were analysed against 50 mM HEPES (pH 8.5), which gave the highest response.  The visualised 
protein blots were digitised and the relative pixel obtained were expressed as percentage distribution between 
the cell debris (top) and supernatant (bottom) of the bar graphs.  
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Control of pH is a prominent factor to consider in the solubility of proteins.  However, of equal 
importance is the ionic strength of the solution to which proteins are released upon cell lysis and should 
not be ignored.  The processes of salting in and salting out are common practice in many biological 
laboratories and are useful techniques in the isolation and purification of a variety of proteins.  Salt can 
have different effects on proteins in solution, depending on the concentration added.  Low ionic strength 
tends to lead to increases in solubility.  However, depending on the nature of the salt employed, as the 
concentration is increased past a certain point, solubility may be affected differentially by either 
stabilisation or denaturation of the proteins in question (378).  The general theory explaining the 
phenomenon of salting out is that the free ions in solution compete with proteins for hydration by water.  
If the concentration of salt reaches a certain threshold, proteins become unable to compete and are forced 
from the solvent (379).  Salting in, on the other hand, may be explained by the Debye-Hückel theory.  
Ions in electrically neutral solutions are not uniformly distributed but are surrounded by higher local 
concentrations of counter ions.  This ionic atmosphere shields the ion from similarly charged ions.  In this 
manner the electrostatic free energy of proteins, surrounded by counter ions, are concealed, thus 
increasing the activity of the solvent; and by extension leads to an increase in solubility (380). 
The relative distribution of the ARLBD in cell lysates was not significantly increased towards the soluble 
fraction by increasing the concentration of NaCl (Figure 3.12), nor did the addition of low levels of 
ammonium sulphate.  Increasing NaCl concentrations to 750 mM and above, however, significantly 
affected the solubility of the recombinant protein and skewed the distribution towards the cellular debris. 
 
Figure 3.12 Relative distribution of recombinant ARLBD between the soluble and insoluble fractions of E. coli lysates 
containing varying concentrations of NaCl and ammonium sulphate.  Reductions of solubility at NaCl 
concentrations above 750 mM, as expressed by the digitised products of the obtained Western blots (bar 
graphs), were seen to be significant. 
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The inclusion of certain monosaccharides, amino acids or polyols has been shown to affect solubilisation 
of proteins in E. coli by stabilisation (278, 376).  High concentrations of macromolecules within the 
cytosol are rapidly diluted upon cell lysis and may lead to protein aggregation due to hydrophobic 
interactions.  Osmolytes, such as sugars and polyhydric alcohols, have greater interaction with the polar 
residues of proteins than water (381), leading to the displacement of water from these hydrophilic sites 
whilst simultaneously repelling nonpolar substances and interacting favourably with water.  As a result, 
water and osmolytes are redistributed around the hydrophobic moieties of proteins in such a manner as to 
minimise unfavourable contacts.  This solvophobic effect leads to an exchange reaction at hydrophobic 
loci on the surface of proteins which is favourable to water.  Therefore, osmotic stabilisers exert eﬀects 
by destabilising aggregates and enhancing native protein stability.  The inclusion of such stabilisers in 
lysis conditions, however, did not significantly impact on the solubilisation of the protein of interest in 
the current investigation (Figure 3.13). 
 
Figure 3.13 Effects of osmolyte addition to lysis buffers on the solubility of bacterially expressed ARLBD.  No significant 
difference could be observed between lysates obtained from buffers, containing different osmolyte additions, 
following digitisation of Western blots (bar graphs) and analyses of relative pixel densities. 
The addition of surfactants or detergents to homogenisation buffers enhances cellular lysis by disruption 
of membranes and has been used in the refolding of proteins from isolated and denatured bacterial 
inclusion bodies (354).  Moreover, the amphipathic properties of detergent molecules have been 
extensively exploited in the isolation of membrane proteins which generally exhibit low solubility (382).  
The hydrophilic moieties of detergent molecules interact with the polar solvent, forming hydrogen bonds, 
while the hydrophobic tails form highly organised globular structures called micelles. In this manner, the 
cellular membranes are mimicked by the detergent, facilitating solubilisation of the protein of interest.  
The high degree of hydrophobicity exhibited by nuclear receptors, especially the ligand binding domain, 
require that such proteins be shielded from the aqueous environment to diminish possible hydrophobic 
effects which would result in aggregation.  The hydrophobic tails of detergents associate with 
hydrophobic amino acid residues located on the protein exterior, while the polar heads interact with the 
dipoles of water molecules. 
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The extraction of recombinant protein into cell lysates prepared with buffers to which detergents or 
surfactants were added are presented in Figure 3.14.  Addition of the non-ionic detergent Nonidet P-40 or 
the surfactant Triton X-100 significantly (p < 0.01) raised the amount of recombinant protein that could 
be liberated to the soluble supernatant of cell lysates.  Very significant increases (p < 0.001) in the 
distribution of the ARLBD to the soluble fraction of cell lysates were, however, obtained by inclusion of 
the non-ionic polyoxyethylene nonyl phenol ether detergent emulgen 913 and the polysorbate surfactant 
Tween-20. 
 
Figure 3.14 Densitometric comparison of the relative distibution of heterologously expressed ARLBD between the soluble 
and insoluble phases of E. coli lysates.  As shown in the bar graphs, the product of the digitisation of the 
accompanying Western blots, significant increases in solubility of the recombinant protein could be achieved 
upon cell lysis by the addition of Nonidet P-40, Triton X-100, Emulgen 913 and Tween-20. 
3.2.2.4 Inclusion of glycylglycine in growth and induction media 
The use of small molecules such as L-arginine (383, 384), sorbitol (384, 385), glycylglycine (386), 
among others, have been reported to enhance the solubility of proteins during protein expression or 
refolding experiments.  In this study glycylglycine was added to cultivation media, with subsequent 
protein expression induction when cultures reached the mid-logarithmic growth stages.  Noticeable 
reduction in doubling times could be observed for cultures grown in media to which 250 mM 
glycylglycine had been added (Figure 3.15). 
 
Figure 3.15 Growth curves of TOP10 cell lines containing pTrcHis vectors expressing the ARLBD and ERαLBD constructs.  
The addition of glycylglycine markedly decreased doubling time of the bacterial cells, but did not affect the 
maximum cell density reached.  
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Addition of the dipeptide at this concentration did not appear to enhance the expression of the sex steroid 
ligand binding domains in the bacterial cells.  In fact, the results (Figure 3.16) indicate that 
supplementation of the media with the dipeptide impacted negatively on the solubility of the proteins. 
 
Figure 3.16 Dot blot of cell lysates from E. coli cells induced to express heterologous nuclear receptor ligand binding 
domains.  Induction of ARLBD and ERαLBD expression in the absense of glycylglycine was initiated at 4 hours 
post inoculation.  Cultures to which glycylglycine had been added were induced to express the recombinant 
protein at 6 hours post induction during the mid-exponential growth phase. 
It is notable that, in comparison to the initial expression duration trial depicted in Figure 3.6, expression 
of the ARLBD could be detected for several hours after induction.  Optimisation of lysis conditions may 
explain why increased levels of the recombinant protein were extracted to the soluble supernatant fraction 
of the lysate, enabling visualisation of the protein via immunodetection.  However, the strongest signal 
for the ARLBD was again detected at one hour post induction.  The signal obtained for the ERαLBD, 
also, was weaker in blots of aliquots taken hourly from cultures induced to express protein in the 
presence of glycylglycine.  A degree of basal heterologous protein expression could be detected prior to 
induction of transcription from the trc promoter by IPTG for both constructs under all conditions.  No 
glucose was added to the cultivation media prior to induction, thus incomplete repression of the promoter 
region allowed transcription to occur in the absence of the inducer molecule. 
3.2.3 Purification 
Metal affinity chromatography was first introduced in the 1970’s and has remained the form of affinity 
chromatography with the broadest application in protein biochemistry.  The incorporation of histidine-
tags to the C- or N-terminus of proteins has become an increasingly popular method of protein 
purification due to the dative covalent bonds which form between metal chelating amino acid residue 
configurations and divalent metal ions, such as those of nickel, cobalt, copper and iron.  The recombinant 
proteins transcribed and translated from the vectors encoding the ARLBD and ERαLBD have been 
engineered to contain an N-terminal hexahistidine tag.  Hence, purification of the bacterially produced 
sex steroid receptor LBDs from the filtered lysate supernatant was approached via a two-step 
chromatographic process.  First, IMAC was used to isolate heterologous protein from bacterial lysates 
and the obtained eluents were then desalted via gel permeation chromatography. 
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3.2.3.1 Isolation of the ARLBD 
Immobilised metal affinity chromatography 
Initial attempts to purify the ARLBD, however, did not give positive results on chromatograms obtained 
during IMAC separations.  None of the 20 amino acids found in proteins absorb light within the visible 
range.  Three aromatic ring containing residues, however, significantly absorb in the ultraviolet.  
Phenylalanine weakly absorbs light at this wavelength, with a major peak at 257.5 nm.  Tryptophan, 
however, absorbs strongly at 280 nm due to its absorbance maximum at 278 nm.  Tyrosine, which 
naturally occurs at a higher frequency in proteins than tryptophan, the residue of least abundance, absorbs 
less strongly at 280 nm, with an absorbance maximum at 274.25 nm.  As a result proteins are amenable to 
detection when absorbance at 280 nm is measured.  However, proteins which contain few of these amino 
acids are therefore expected to have little absorbance at 280 nm. 
The recombinant ARLBD protein contains four tryptophan (1.3%), nine tyrosine (2.9%) and seventeen 
(5.5%) phenylalanine residues.  The theoretical extinction coefficient of the ARLBD, as calculated by a 
modified Edelhoch method which utilises the coefficients of Trp and Tyr determined by Pace et al. (387), 
is 35410 M
-1
 cm
-1
.  Consequently a 1 mg/mL solution should have an absorbance of 0.997 in water at 
standard 1 cm light pathlength, assuming all cysteine residues are reduced.  The initial purification 
conditions included emulgen 913 in the chromatographic buffers as a means to maintain solubility of the 
ARLBD during isolation.  However, it was found that this detergent absorbs light at 280 nm, leading to 
high background and diminished resolution after subtraction.  Moreover, imidazole at the elution 
concentration of 500 mM has an A280 of 0.5.  The chromatographic mobile phase system therefore 
markedly contributed to the inability to resolve the presence of the recombinant protein in the eluent via 
UV absorption (Figure 3.17). 
 
Figure 3.17 Chromatograms obtained during the initial ARLBD purification conditions.  The left panel indicates the full 
chromatographic run from sample application to completion.  Note the drop in absorption upon removal of the 
mobile phase.  The panel to the right zooms in on the expected elution volume of the ARLBD, a peak indicating 
the elution of the target protein could not be obtained due to high background interference from the 
chromatographic buffers.  
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Nevertheless, collection of the fractions surrounding the expected elution volume, with subsequent 
blotting of these fractions onto nitrocellulose membrane and visualisation with antibodies against the 
HisG epitope (Figure 3.18, B4), revealed that the protein was indeed being retained on the column. 
 
Figure 3.18 Dot blots of selected fractions from IMAC developed with HisProbe HRP.  The response in block B4 indicates 
that the column does retain the hexahistidine tagged protein. 
Removal of interfering UV absorptive substances markedly increased the resolution obtained on the 
chromatograms during IMAC purification of the ARLBD (Figure 3.19).  A peak at 90.22 mL, near to the 
expected elution volume of the target protein was collected and analysed by SDS-PAGE (Figure 3.20).  
Some contaminating E. coli proteins co-eluted with the protein of interest and can be seen as bands 
occurring at higher and lower molecular masses on the gel image than the ARLBD. 
 
Figure 3.19 IMAC chromatogram of indicating elution of metal chelating proteins from a 1 mL HisTrap chelating column.  
The major peak at 65.89 mL is the result of proteins rich in amino acid residues such as histidine, cysteine and 
tryptophan.  The peak at 90.22 mL, indicated with a red arrow, contains the hexahistidine tagged ARLBD 
protein. 
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Figure 3.20 Image of a 12% SDS-PAGE gel containing resolved fractions collected during IMAC seperation of E. coli 
TOP10/pTrcHisARLBD lysate supernatant.  Lane one contains Kaleidoscope marker (Bio-Rad).  Of the filtered 
supernatant a volume containing 20 μg was loaded in lane two.  Lanes three to six contains fractions collected 
during the elution of proteins rich in histidine and other metal chelating amino acid residues.  In lanes seven to 
ten the fractions collected during the elution of the protein of interest was loaded.  Protein concentrations of 
collected fractions could not be determined due to the high concentration of imidazole which interferes with the 
BCA protein assay. 
The results could successfully be reproduced during multiple purifications utilising similar conditions 
(Figure 3.21).  Attempts were made to diminish the co-elution of E. coli proteins from the column by 
increasing the duration of isocratic elution at 15% elution buffer, and by incorporation of a gradient 
elution step from 15% to 100% elution buffer as shown in run number two and three in Figure 3.21, 
respectively.  These alterations did not markedly affect the separation of the recombinant protein from the 
contaminating proteins, nor did raising the imidazole concentration in the wash and equilibration buffers 
to 40 mM (Figure 3.21, chromatogram 4). 
 
Figure 3.21 Overlay of IMAC chromatograms obtained during the purification of the ARLBDb protein from E. coli lysate.  
The retention time of purification number 1 was adjusted to the elution volume for the heterologous protein 
peak of the subsequent purifications (red arrow). 
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Desalting of IMAC samples by gel permeation chromatography 
Determination of the concentration of proteins that occur in fractions obtained during the elution phase of 
immobilised metal affinity chromatography was not possible without prior removal of the high 
concentration of imidazole.  Various options, such as dialysis, protein precipitation and buffer exchange, 
may be employed for the removal of excess salts from proteinaceous mixtures. 
Gel permeation chromatography was used during the current study to remove excess imidazole from 
protein samples.  The chromatogram in Figure 3.22 was obtained after desalting of collected ARLBD 
containing IMAC fractions, with a Sephadex G-25 column.  Elution of the protein from the column 
yielded a large peak of nearly 1,000 mAu, indicating successful purification of the recombinant protein.  
The removal of excess imidazole from these fractions can be seen by the increase in conductivity on the 
chromatogram. 
 
Figure 3.22 Chromatogram indicating desalting of IMAC fraction containing the ARLBD.  The rise in conductivity indicates 
elution of imidazole from the Sephadex G-25 column. 
 
Figure 3.23 Image of an SDS-PAGE gel of fractions collected after desalting of collected IMAC fraction.  Panel A: lanes one 
contains 6 μg of Kaleidoscope marker.  In lane two 20 μg of TOP10/pTrcHis-ARLBDb lysate (7.12 mg/mL) was 
loaded.  In lanes three to ten 25 μL (with 2x sample buffer) of GPC fractions 1 – 8 were loaded.  Panel B:  Image 
of a duplicate SDS-PAGE developed as a Western blot with anti-AR antibodies following transferral to a 
nitrocellulose membrane. 
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Removal of excess imidazole from the protein containing IMAC samples allowed the determination of 
protein concentrations by the BCA method.  A total of 2.68 mg protein was recovered from the gel 
permeation column.  Densitometric analysis of the fraction loaded in lane four (Figure 3.23, A), which 
yielded the highest visual response representing the ARLBD, indicated that 57% of the protein 
complement in this fraction is the recombinant receptor.  Inferring from densitometry (Table 3.2), a total 
of 1.71 mg ARLBD was produced in the E. coli expression system. 
Table 3.2 Densitometric analysis of the SDS-PAGE gel presented in Figure 3.23 (lanes 3 – 6).  Highlighted values pertain 
to the bands on the gel image that are associated with the ARLBD protein. 
Elution 
Volume 
mL 
Fraction 
Concentration 
μg mL
-1 
Calculated 
Molecular Mass 
Da 
Segment 
Pixel Total 
 
Percentage 
of Pixel 
Total 
Estimated 
Concentration 
μg mL
-1 
3.0 862.08 
58399.87 3·1 792 0.89 7.67 
53887.63 3·2 34101 38.37 330.78 
33121.83 3·3 46225 52.01 448.37 
20618.34 3·4 7764 8.74 75.35 
4.0 948.75 
58399.87 4·1 2651 1.03 9.77 
53433.42 4·2 71164 27.68 262.61 
32842.65 4·3 147409 57.34 544.01 
20444.55 4·4 35847 13.94 132.26 
5.0 872.08 
57419.54 5·1 2857 1.72 15.00 
53660.05 5·2 39053 23.48 204.77 
32842.65 5·3 101339 60.92 531.27 
20444.55 5·4 23103 13.89 121.13 
6.0 552.08 
53660.05 6·1 37258 59.98 331.14 
32703.95 6·2 21494 34.60 191.02 
20186.61 6·3 3369 5.42 29.92 
 
3.2.3.2 Isolation of the ERαLBD 
Immobilised metal affinity chromatography 
Co-purification of bacterial proteins during IMAC is not an uncommon occurrence and is especially 
problematic when contaminating metal chelating E. coli proteins are of similar molecular size to target 
proteins, or when such proteins are expressed at a high level (388, 389).  Bolanos-Garcia and Davies  
(390) have proposed a classification of the most commonly co-purified protein, concluding that the 
majority of these contaminants are stress-responsive in nature.  Proteins that co-elute with 6xHis tagged 
heterologous proteins either possess native metal binding capabilities as a function of their cellular 
machinery, or surface accessible histidine clusters are present which confer metal binding capabilities.  
Moreover, hydrophobic proteins may interact with the scaffold matrix by hydrophobic interactions. 
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These contaminating proteins were also observed to co-elute with the protein of interest during 
purification of the ERαLBD from BL21(DE3)pLysS/ERαLBD lysates (Figure 3.26).  Nevertheless, 
comparatively, the elution of recombinant histidine-tagged protein from the IMAC column with free 
imidazole at 500 mM could be detected (Figure 3.24) considerably easier than for the AR counterpart. 
 
Figure 3.24 Chromatogram indicating the purification of the bacterially produced ERαLBD protein.  Elution of the protein 
of interest occurred at 85.93 mL, with E. coli proteins rich in metal chelating residues eluting with 92 mM 
imidazole at 70.17 mL and 74.18 mL. 
Desalting and clean-up of ERαLBD by gel permeation chromatography 
 
Figure 3.25 Chromatogram of desalting of a fraction obtained from IMAC of bacterial lysates containing recombinant 
ERαLBD.  Elution of the target protein from the Sepharose-12 column occurred at 11.87 mL.  Removal of excess 
imidazole is evident as a rise in conductivity following elution of the ERαLBD. 
The removal of salts from the IMAC purified fractions could again be seen in a sharp raise of 
conductivity of the eluent following elution of a major absorbance peak at 11.87 mL.  Smaller peaks 
earlier and later on the chromatogram indicate elution of the higher and lower molecular weight E. coli 
contaminating proteins from the column.  With this method 832 μg of the ERαLBD protein could be 
obtained at high homogeneity (Figure 3.26, lane 8). 
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Figure 3.26 Panel A: SDS-PAGE image indicating the purification of the ERαLBD from E. coli.  Lane one contains 6 μg 
Kaleidoscope molecular marker.  E. coli negative control lysate (25 μL) and lysozyme (20 μg) was loaded to lanes 
two and three, respectively.  To lanes four and five 20 μg of crude lysates were added, respectively from 
uninduced and IPTG induced cultures.  In lane six 20 μg of the resuspended cell debris from an induced culture 
was added.  The fraction of eluent from IMAC which contains the recombinant ERαLBD was loaded in lane 
seven (12.5 μL).  In lane six 4.1 μg of purified bacterially produced ERαLBD was loaded.  Panel B: Western blot 
of a duplicate gel developed with rat anti-ERα IgG. 
3.2.3.3 Protein identification 
Bands excised from SDS-PAGE could be successfully identified by tryptic digest LC-MS/MS as 
derivatives of the human androgen receptor, isoform 2.  Three unique peptides were detected (accession 
P10275-2) with 28.35% coverage and a Mascot/Sequest score of 535.41.  A protein derived from the 
human estrogen receptor, alpha isoform, could also be identified with six unique peptides, coverage of 
13.95% and a score of 1449.76. 
3.2.3.4 Affinity chromatography 
For the purification of both the ARLBD and ERαLBD a high degree of homogeneity could be achieved 
by the application of metal affinity chromatography.  To obtain a near pure protein sample, however, 
requires at least one step.  Contaminants could be removed from ERαLBD containing IMAC fractions by 
gel permeation chromatography.  The ARLBD proved more challenging in this regard due to the 
comparatively lower levels of stability in solution.  The imidazole in both LBD preparations could be 
removed, which was important for downstream analyses and applications. 
Although IMAC is an effective affinity isolation technique, further processing to eliminate contaminants 
from fractionated ARLBD containing lysates generally resulted in the loss of the protein in dilution.  An 
alternative approach for one-step purification, therefore, is to employ another form of affinity 
chromatography to purify the receptor LBD’s.  Ligands to the receptors, immobilised to a stationary 
matrix, is a highly specific form of affinity chromatography that depends upon protein-ligand interaction.  
Figure 3.27, A and B, shows dot blots of fractions obtained after affinity chromatography performed on 
E. coli lysates containing, respectively, recombinant ARLBD and ERαLBD, with Sepharose 6B resin, 
coupled to either nortestosterone or 17β-estradiol. 
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Figure 3.27 Dot blot of fractions collected during multiple injections of TOP10/pTrcHis-ARLBD (panel A) and 
TOP10/pTrcHis-ERαLBD (panel B) lysate supernatants to 1 mL nortestosterone-Sepharose 6B and 1 mL 17β-
estradiol-Sepharose 6B affinity columns.  The majority of the proteins did not bind to the column and eluted 
during the application and wash steps of the chromatographic runs.  Minor binding of the bacterially produced 
receptor LBD’s occurred and was eluted by the addition of free testosterone or 17β-estradiol (red arrows).  The 
top rows contains 2 μL spots of the lysate as control. 
Several attempts were made at isolation of the recombinant receptor LBDs with these systems.  However, 
no peaks indicating the elution of protein from the columns could be resolved during treatment with free 
ligand.  Apart from a single detection of the ERαLBD and minute amounts for the ARLBD in two runs, 
indicating poor retention of the LBDs on the columns (Figure 3.27, red arrows), the sex steroid receptor 
ligand binding domains could not be purified by affinity chromatography.  The majority of the 
recombinant proteins did not interact with the resin matrix, but eluted in the wash. 
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3.2.4 Binding studies 
The inability of ligand-immobilised affinity columns to retain the target proteins cast doubt on the ligand 
binding capabilities of the bacterially expressed human sex steroid receptor LBD’s.  Radioligand 
saturation binding is a sensitive means to assess the activity of receptor proteins in in vivo and in vitro 
systems by means of scintillation counting.  Poor retention of the recombinant LBD’s to immobilised 
ligand chromatography matrixes provided impetus for the investigation of ligand binding capabilities via 
radioligand assays. 
 
Figure 3.28 Saturation binding plots of whole cell radioligand binding experiments performed with 3H-testosterone (green) 
and excess non-radioactive ligand (red).  Results of the TOP10/pTrcHisARLBD experiment is presented in panel 
A, with results of the control, untrasformed TOP10 cells in panel B. 
Previous radioactive binding experiments (342) of the ARLBD and ERαLBD expressed as fusion 
proteins with maltose binding protein (MBP) indicated a measure of biospecific capture of radioligands 
by immobilised receptors produced in E. coli.  To a large degree, however, non-specific binding was 
observed during these studies. 
The lipophilic natures of steroids allow these molecules to cross cellular membranes by simple diffusion.  
Therefore, in the current study a whole cell saturation binding assay was used to evaluate the binding 
capabilities of recombinant ARLBLD.  Intact cells are easily pelleted by centrifugation and therefore 
permit facile separation of bound and free ligand.  Furthermore, the use of intact cells to assess binding, 
prior to purification, allows an assessment of the maximal concentration of functionally expressed 
receptors produced that bind 
3
H-testosterone as a function of the total protein complement.  No 
distinction could, however, be made between the total binding of tritiated ligand to expressed receptors 
and binding that occurs non-specifically to other surfaces available during the assay (p = 0.8707).  
Results in Figure 3.28 indicate that the functionality of the majority of receptors produced in the bacterial 
system may be impaired.  
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3.3 CONCLUSION 
6xHis-tagged proteins containing the correct primary structures of the human sex steroid receptor LBD’s 
were purified to near homogeneity by means of IMAC and GPC.  However, these recombinant proteins 
could not be isolated from bacterial lysates to quantifiable levels by immobilised ligand affinity 
chromatography.  Nevertheless, a small population of the receptor LBD produced in this system may be 
correctly folded and active if one considers the results obtained during affinity chromatography since 
faint chemiluminescent signals were observed during elution with free ligand.  The majority of the 
recombinant protein, however, eluted during application and washing.  Furthermore, whole cell 
radioligand saturation assays pertaining to the ARLBD corroborated that the heterologously expressed 
protein exhibits insignificant binding activity towards a natural ligand of the androgen receptor. 
However, nuclear receptors and their respective ligand binding domains from various species have been 
successfully cloned and expressed in bacterial systems with a variety of fusion tags (391–394), many 
structural works with regards to these proteins have been carried out in E. coli (395).  Nonetheless, as is 
well known, there are many parameters that must be considered when attempting to produce eukaryotic 
proteins in a prokaryotic expression system.  For one, not all strains of E. coli are equally suited to 
express certain proteins.  For instance, the level of connate amino-acylated tRNAs available in the 
cytoplasm reflects the usage of codons by E. coli (21).  Certain codons occur infrequently in the genetic 
material of bacterial host cells, these minor codons are generally distributed to genes that are expressed at 
low levels.  However, preferences for such codons are often abundant in heterologous genes from 
eukaryotes, archaea and other prokaryotes distant from E. coli (396).  The presence of such rare codons in 
highly transcribed mRNA could lead to translational errors such as amino acid substitutions, 
frameshifting events, or premature translational termination (397) due to ribosomal stalling when minor 
codon tRNAs carrying the required amino acid is absent (397–399).  Kane et al. (400) reported on a 
single disfavoured AGA codon which caused a two codon shift during E. coli synthesis of bovine 
placental lactogen.  The expression of heterologous proteins of seemingly the correct length may 
therefore be ambiguous due to poor translational integrity.  Problems such as these may be addressed by 
site directed mutagenesis, thus abolishing aberrant protein variants, yet this approach is only viable if the 
rare codons in question do not affect protein activity or mRNA stability.  Furthermore, alterations to all 
rare codon positions may become a lengthy process, depending on their frequency within the specific 
gene.  Alternative approaches include the co-transformation of bacterial cells with plasmids encoding the 
necessary rare tRNAs or utilisation of strains of E. coli, such as Rosetta-gami (EMD-Novagen) which 
contain increased pools of rare tRNAs and, as with the Origami™ strain, possesses a greatly enhanced 
ability at disulphide bond formation due to trxB and gor gene mutations (273).  The ARLBD contains a 
total eighteen rare codons, nine arginine (AGG, AGA, CGA), seven proline (CCC) and two leucine 
(CTA).  Within the coding sequence of the ERαLBD fifteen rare codons are present, six of which codes 
for arginine, four for proline, four for leucine and one for isoleucine (ATA). 
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The choice of promoter may also influence the quality of protein produced within the bacterial system.  
mRNA of proteins expressed under control of the strong trc promoter contain the Shine-Dalgarno 
sequence which facilitates optimal translation initiation.  Moreover, the trc promoter binds the host 
transcription machinery more efficiently (344) than promoters such as the 2.5-fold promoter-up mutant, 
lacUV5 (401), resulting in high levels of mRNA from recombinant origin.  Although high-level 
expression of heterologous nuclear receptor LBD can be obtained, optimising the yield of properly folded 
protein might require a reduction in the induction level.  Over synthesis of mRNA may lead to the 
accumulation of misfolded protein in the cytosol, increasing molecular crowding, thus driving protein 
aggregation due to elevated macromolecular association constants (402). 
Several experimental approaches may also be followed to reduce the formation of aggregates in vivo.  
Lowering of the temperature at which expression is induced (346, 403, 404), expression in the late (405) 
or early (403) exponential phase, increasing the intracellular concentration of molecular and chemical 
chaperones (347), lowering of inducer molecule concentration (406) and the use of cold inducible 
expression systems (360, 407, 408) have all been shown to affect protein solubility and activity.  Along 
with the alterations to growth and induction parameters, countless variables influence the stability and 
solubility of heterologous proteins during cell lysis.  Many of these variables may be manipulated to 
improve recombinant protein recovery, over and above the approaches took in this work.  However, such 
approaches are mostly cumbersome, difficult to interpret and subject to a large degree of experimental 
error and bias.  High-throughput techniques should therefore not only be based on representative sample 
sizes, but must also be sensitive enough to distinguish between results. 
E. coli is an attractive expression host for a variety of reasons (273) and many strategies exist to 
maximise the production of heterologous proteins in prokaryotes at minimal cost (337, 409).  The 
diversity of genetically engineered strains, expression vectors, induction strategies, broad cultivation 
parameters and general ease of use all contribute to the popularity of prokaryotic systems.  Unfortunately, 
not all proteins are amenable to heterologous expression in E. coli, either due to toxicity to the organism 
or by the nature of the protein itself.  As a consequence there will be circumstances when the choice of 
expression host will not be obvious and therefore several alternative expression hosts must be evaluated. 
Owing to high degrees of intrinsic hydrophobicity, resulting in instability and subsequent precipitation 
from solution upon purification, the human nuclear receptor LBDs present such a circumstance.  The 
inability of E. coli to correctly fold the human-derived proteins to the correct conformations, along with 
low production yields of functional protein achieved with this system require that substitutions to this 
form of heterologous gene expression be considered.  In the following section an alternative means to 
produce nuclear receptor LBDs by utilisation of an insect cell/baculovirus expression system is described. 
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CHAPTER 4 
CLONING, EXPRESSION AND PURIFICATION OF THE HUMAN 
ANDROGEN AND ESTROGEN RECEPTOR LIGAND BINDING 
DOMAINS WITH THE BACULOVIRUS EXPRESSION VECTOR 
SYSTEM 
The difficulties associated with the purification of active forms of bacterially produced human sex steroid 
receptor LBDs, along with the inability of these proteins to specifically bind natural ligands to these 
receptors necessitated an investigation into an alternative heterologous expression system. 
Members of the Baculoviridae are the most prominent entomopathogenic viruses.  However, individual 
baculovirus isolates normally infect only closely related species of arthropods.  Particularly, species of 
the orders Lepidoptera, Hymenoptera, Diptera, Neuroptera, Coleoptera, Trichoptera, Thysanura, 
Siphonoptera and some Crustaceae have been known to serve as hosts for the rod shaped, double stranded 
DNA viruses (410).  Many of the insects in these orders cause devastation to fruit, vegetable and crop 
fields during their reproductive cycles.  As a result, baculoviruses have been studied for use as biological 
pest controlling agents and have successfully been employed for the protection of apples, soybean and 
cotton from, respectively, the codling moth (Cydia pomonella), the velvet bean caterpillar (Anticarsia 
gemmatalis) and the cotton bollworm (Helicoverpa armigera) (411).  Growing public concerns over 
genetically modified crops, along with known detrimental effects of synthetic pesticides on humans and 
animals, provides impetus for the production of safe and economical alternative means of crop protection 
against insect pests.  Nevertheless, most wild-type baculoviruses are not sufficient to replace chemical 
insecticides due to latent infectious cycles that may take between five and ten days to kill the host, with 
decimation of crops during this period due to continued insect feeding.  Recombinant protein technology 
has, however, provided a mechanism of reducing the time between virus application, feeding cessation 
and death.  Transgenic baculoviruses expressing toxic genes from, among other organisms, spiders (412), 
scorpions (413), bees, bacteria (414) and fungi (415) have successfully improved insecticidal activity.  
Thus, in addition to the use of these viruses as possible insecticides, baculovirus expression vectors are 
used extensively to produce a variety of recombinant proteins in vitro.  Modern methods of DNA 
manipulation have massively increased the ease of use associated with transgenic baculovirus generation.  
In this study, one of the methods used to transfer genetic materials to the viral genome is presented.  A 
double homologous recombination event between a donor plasmid and linearised viral DNA is utilised to 
incorporate two human genes into the polyhedrin locus of an AcMNPV-derived baculovirus genome.  
This resulted in the creation of three recombinant viruses.  One expresses the human ARLBD, the other 
two viruses express derivatives of the human alpha estrogen receptor LBD, hERαLBD, which encodes 
for the E domain of the receptor, and hERαLBD-f, a protein containing both the E and F domains of the 
hERα. 
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4.1 METHODOLOGY 
4.1.1 The pSV.ARo and pSG5ERα mammalian expression vectors 
The DNA encoding isoform 2 of the human androgen receptor (hAR, NCBI accession: M20132.1) was 
obtained from the 2751 nucleotide cDNA of the full length protein contained in the mammalian 
expression vector pSV.ARo (416).  E. coli DH5α cells, transformed with the mammalian expression 
vector pSG5ERα (417), was donated by the Louw/Africander laboratory (Department of Biochemistry, 
Stellenbosch University).  The plasmid contains the full cDNA sequence encoding the alpha isoform of 
the human estrogen receptor (hERα, NCBI accession: NM_000125.3) with a molecular mass of 66 kDa. 
4.1.2 Transformation of E. coli JM109 with pSV.ARo 
4.1.2.1 Production of chemically competent cells with a method involving CaCl2 
E. coli JM109, regarded as an all-purpose cloning strain suited to the generation of high quality plasmid 
DNA (418), was transformed with the pSV.ARo plasmid.  Cells from cryogenic storage were streaked 
out on non-selective LB plates and incubated at 37°C for 36 hours.  A single bacterial colony was 
selected from these plates, inoculated into 5 mL LB and incubated at 37°C with agitation at 235 RPM.  
After sixteen hours, 1 mL of this culture was diluted to 100 mL LB media in a 500 mL baffled 
Erlenmeyer flask.  Incubation continued until an OD600 of 0.4 was reached, at which point the culture was 
placed on ice for 10 minutes.  Cells were then collected by centrifugation at 2,800 xg, 4°C, for 
10 minutes.  After aspiration of the supernatant the tubes were kept inverted for 1 minute after which 
cells were gently resuspended in 10 mL chilled 75 mM CaCl2.  Following 30 minutes on ice the cells 
were collected as before and resuspended in 2 mL chilled 75 mM CaCl2.  The resultant chemically 
competent cells were immediately transferred to ice cold 15 mL conical tubes as 200 μL aliquots. 
4.1.2.2 Transformation E. coli JM109 with of pSV.ARo 
To 200 μL chemically competent E. coli JM109 cells 36.4 ng of pSV.ARo was added.  Following 
30 minute incubation on ice the cells were heat shocked at 42°C for exactly 90 seconds.  Subsequently, 
the tubes were placed on ice for 90 seconds after which 800 μL SOC medium (2% (w/v) bacto-tryptone, 
0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose) 
was added to each.  Cell suspensions were then incubated for one hour at 37°C with shaking at 235 RPM.  
Subsequently, 100 μL of the transformation reactions were spread out on LB agar plates and incubated at 
37°C.  Single colonies from these transformation plates were inoculated into 5 mL LB, containing 
100 μg/μL ampicillin, and cultured overnight.  Plasmid DNA extraction was performed on all 
transformation cultures, followed by agarose gel electrophoreses to establish the presence of the 
pSV.ARo pDNA. 
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4.1.3 Extraction of DNA from bacterial cells 
Zyppy™ Plasmid Miniprep Kits (Zymo Research) was used in the isolation of plasmid DNA from 
bacterial cells.  Plasmid-containing bacteria were cultivated overnight in LB medium, containing the 
relevant antibiotic for selection, at 37°C with agitation at 235 RPM.  Of these cultures 3 mL was 
centrifuged in a Heraeus Biofuge fresco microfuge at maximum speed for one minute.  Following 
aspiration of the growth media the cells were lysed and treated as per the manufacturer’s instructions to 
obtain the purified pDNA. 
4.1.4 Agarose gel electrophoreses 
Agarose gel electrophoreses of PCR fragments and extracted plasmids were performed with either 0.8% 
or 1% molecular grade agarose D1 LE (Whitehead Scientific, Brackenfell, RSA) in TAE buffer.  DNA 
samples were mixed in a ratio of 5:4 with Ficoll Orange loading dye (0.1% Orange G, 20% Ficoll, 
10 mM EDTA).  No more than 450 ng of DNA was loaded to the wells of agarose gels.  Electrophoreses 
was carried out at 75 V after entrance of DNA samples to the gel matrix at 110 V.  In all cases the 1 kb 
DNA ladder by Promega was employed as a molecular size marker.  Following electrophoreses, agarose 
gels were stained with 0.01% GR Green (Excellgen, Inc., Rockville, MD, USA) in TAE buffer for 
25 minutes, visualised with a UV transilluminator and analysed with E-Capt, version 12.9 for Windows 
(Vilber Lourmat, Marne-la-Vallée, France). 
4.1.5 Cloning of cDNA to the pAB6xHis baculovirus transfer plasmid 
The baculovirus transfer plasmid, pAB6xHis, was obtained from AB Vector (San Diego, CA, USA).  The 
plasmid allows for the transferral of heterologous DNA to the baculovirus genome by double 
homologous recombination.  The multiple cloning site is located downstream of a polyhedrin promoter 
region and sequences expressing a 6xHis affinity tag and a thrombin recognition site. 
4.1.5.1 Primer design 
Primers for the amplification of the human AR and ER ligand binding domains (hARLBD and 
hERαLBD) were obtained from Inqaba Biotec (Muckleneuk, Pretoria, RSA) (Table 4.1).  The 
mammalian expression vector, pSV.ARo, was used as template for the amplification of the hARLBD 
coding region corresponding to bases 2319 to 3136 of the human androgen receptor CDS.  Recognition 
sequences for the restriction enzymes XbaI and PstI were introduced at the 5’-ends of the hARLBD left 
primer and right primer, respectively, facilitating insertion of the DNA into the polylinker of pAB6xHis 
at these restriction sites.  DNA encoding the hERαLBD, and the hERαLBD including the C-terminal 
F-domain was amplified from the mammalian expression vector pSG5ERα.  Two pairs of primers were 
designed for the amplification of the hERαLBD; bases 1266 to 2006 were amplified by the primer pair 
hERαLBD LP and hERαLBD RP, and bases 1266 to 2156 were amplified by the hERαLBD RP and 
hERαLBD-f RP.  To the 5’-end of the shared hERαLBD left primer a recognition sites for the restriction 
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enzyme Cfr9I was added.  The hERαLBD RP introduces a stop codon to the hERαLBD protein.  Both of 
the right primers introduce the recognition site for the restriction enzyme EcoRI. 
Table 4.1 Primers for the amplification of the human sex steroid receptors’ LBDs into the pAB-6xHis vector.  Required 
stop codons are highlighted in  blue.  Sequences in red refers to additional nucleotides needed to encode for 
restriction endonuclease recognition sites (
↓ 
denotes a cleavage position).  Nucleotides indicated in black 5’ of 
endonuclease recognition sites were added to facilitate restriction enzyme docking following PCR amplification. 
Primer Sequence Endonuclease Overhang type 
hARLBD LP 5’-GCT↓CTAGAGGAGACAACCCAGAAGCTGACAG-3’ XbaI 5’ 
hARLBD RP 5’-AACTGCA↓GGTTTCCAATGCTTCACTGGGTGTG-3’ PstI 3’ 
hERαLBD LP 5’-TCTAC↓CCGGGAAGAAGAACAGCCTGGCCTTGTC-3’ Cfr9I 5’ 
hERαLBD RP 5’-AAG↓AATTCTCATAGGCGGTGGGCGTCCAG-3’ EcoRI 5’ 
hERαLBD-f RP 5’-AAG↓AATTCGAGCTCTCAGACCGTGGCAGG-3’ EcoRI 5’ 
 
4.1.5.2 Amplification of hNRLBD coding regions by polymerase chain reaction 
Amplification of LBD coding regions was carried out with a Thermo Hybaid PCR Express Thermal 
Cycler (Thermo Scientific, Waltham, MA, USA) using Pfu DNA polymerase.  To each PCR reaction 
tube 4.0 mM MgCl2, 10 mM deoxyribonucleotide triphosphates mix, 1.25 U Pfu polymerase and either 
76.56 ng pSV.ARo or 19.14 ng pSG5ERα was added in 1x Pfu PCR buffer.  All reactions were initiated 
by denaturation of the template DNA at 95°C for 120 seconds, followed by four cycles of denaturation at 
95°C for 30 seconds, primer annealing at 58°C for 30 seconds and string elongation at 72°C for 
60 seconds.  Following these four cycles the annealing temperature for the pSV.ARo and pSG5ERα 
reactions was raised to 62°C and 64°C, respectively, for 35 cycles.  The temperature was maintained at 
72°C for 15 minutes to ensure final elongation of amplified PCR products.  Following successful 
amplification, PCR products were purified using the Wizard SV Gel and PCR Clean Up System. 
4.1.5.3 Dephosphorylation of host plasmids 
Dephosphorylation of host plasmids was performed with rAPid Alkaline Phosphatase (Roche).  
Linearised pAB 6xHis plasmid DNA, prepared for the insertion of the hARLBD PCR, contained 
recessive 5’ ends due to the activity of PstI.  Subsequently, dephosphorylation reactions pertaining to 
these plasmids were carried out by incubation with the enzyme at 37°C for 30 minutes (419).  pAB-6xHis 
plasmids, to which the hERαLBD or hERαLBD-f PCR fragments were ligated, were dephosphorylated at 
37°C for 10 minutes.  Following incubation, the reactions were arrested by transferral of tubes to a water 
bath set to 75°C for three minutes. 
4.1.5.4 Ligation of digested PCR fragments and dephosphorylated host plasmids 
Prepared PCR fragments were ligated to 50 ng dephosphorylated pAB-6xHis plasmids by incubation at 
ambient temperature for 5 minutes in the presence of T4 DNA ligase.  Incubations were carried out with 
an insert to vector ratio of either 5:1 or 3:1.  Subsequently, ligated plasmids were stored at -20°C until 
transformation into E. coli cells. 
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4.1.6 DNA Sequencing of PCR fragments and transfer plasmids 
The three purified amplicons of the genes of interest were sent to the Central Analytical Facility, 
Stellenbosch University, for sequencing.  All fragments were diluted to a concentration of 10 ng/μL, 
whilst PCR primers used for amplification were provided to CAF at 1.1 pmol/μL. 
Recombinant baculovirus transfer vectors, extracted from E. coli propagation hosts following 
transformation, were diluted to a concentration of 100 ng/μL and sequenced with the phF 
(5’-AGACGCACAAACTAATATCACAAACTGGA-3’) and mR (5’-CGTGTCGGGTTTAACATTACGGATT-3’) primers 
(Inqaba Biotec).  All sequencing reactions were performed on a 3730XL DNA Analyzer (Applied 
Biosystems). 
4.1.7 Transformation of E. coli cells with baculovirus transfer plasmids. 
4.1.7.1 Preparation of chemically competent cells 
Chemically competent E. coli cells were prepared according to the protocol by Inoue et al. (420).  Briefly, 
E. coli DH5α and E. coli JM109 colonies were cultured on non-selective LB-agar plates at 37°C.  Twelve 
colonies (2 mm to 3 mm in diameter) were subsequently inoculated to 250 mL SOB media (2% (w/v) 
bacto-tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4).  
Filter-sterilised Mg
2+
 constituents were added to the media after sterilization by autoclaving.  Cells were 
incubated at 18°C in a 2 litre baffled shaker flask with constant agitation at 235 RPM.  Upon reaching an 
OD600 of 0.6 the flask was removed and incubated on ice for 10 minutes.  Cells were then harvested by 
centrifugation at 2,500 xg, 4°C, for 10 minutes.  After aspiration of growth media the cells were gently 
resuspended in 80 mL cold TB buffer (10 mM PIPES, 15 mM CaCl2, 250 mM KCl, 55 mM MnCl2).  
MnCl2 was added to the buffer only after the pH was set to 6.7.  Resuspended cells were subsequently 
incubated in an ice bath for 10 minutes prior to centrifugation at 2,500 xg, 4°C, for 10 minutes.  
Following aspiration of the supernatant the pelleted cells were gently resuspended in 20 mL cold TB 
buffer.  Dimethyl sulphoxide (DMSO) was subsequently added to a final concentration of 7% while 
gently swirling the resuspended cells.  After incubation in an ice bath the cells were frozen with liquid 
nitrogen in 1 mL aliquots prior to cryogenic storage at -80°C. 
4.1.7.2 Transformation of cells with recombinant plasmids 
Frozen competent cells were thawed at room temperature and immediately placed on ice.  Cells were then 
dispensed as 200 μL aliquots into chilled 15 mL conical tubes using chilled pipette tips.  To these cells 
2 μL of the ligated plasmids were added and the mixture was incubated for 30 minutes in an ice bath.  
After incubation in the ice bath, the cells were heat shocked at 42°C for exactly 30 seconds after which 
the tubes were immediately transferred to an ice bath for 2 minutes.  To each tube 800 μL SOC media 
(SOB with 20 mM glucose) was added prior to incubation at 37°C with vigorous shaking.  Subsequently, 
50 μL, 100 μL and 200 μL of the reactions were added to 3 mL 0.65% soft LB-agar, containing 75 μg/mL 
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ampicillin, which had been pre-incubated at 47°C.  The mixture was then overlaid on LB-agar containing 
60 μg/mL ampicillin.  Transformation plates were incubated inverted at 37°C. 
4.1.8 Restriction endonuclease digest 
Prior to the amplification of target gene sequences by PCR the integrity of the template DNA was 
assessed by restriction enzyme digest.  All reactions were performed with five units of the respective 
restriction endonucleases in 2x Tango™ buffer at 37°C for 2 hours.  pSV.ARo (484 ng) was digested with 
BamHI and HindIII, whilst pSG5ERα (638 ng) was digested with HindIII and SalI.  For insertion of the 
obtained PCR fragments into the polylinker of the pAB-6xHis host vector 1 μg of pDNA and 1 μg of the 
respective inserts were prepared by restriction enzyme digest.  For the ARLBD the amplicon and 
baculovirus transfer plasmid was digested with XbaI (10 U) and PstI (20 U) in 1x Tango buffer.  
hERαLBD and hERαLBD-f PCR fragments and host vectors were prepared for cloning with Cfr9I (10 U) 
and EcoRI (5 U) in 1x Cfr9I buffer.  All reactions were incubated at 37°C for 3 hours. 
Of the pAB-6xHis/hARLBD and pAB-6xHis/ERαLBD baculovirus transfer plasmids extracted from 
potential transformants 1 μg was analysed with HindIII in 1x buffer R.  The pAB-6xHis/ERαLBD-f 
plasmids were digested with 5 U SalI in 1x SuRE/Cut Buffer H. 
4.1.9 Culturing of insect host cell lines 
4.1.9.1 Monolayer cultures 
Spodoptera frugiperda (Sf9) and Trichoplusia ni BTI-TN-5B1-4 (T. ni) cells were obtained from Allele 
Biotechnology and Pharmaceuticals/Orbigen (San Diego, CA, USA).  These cells were initially grown as 
monolayers in a non-humidified, ambient air-regulated incubator set to 27°C in complete TNM-FH 
medium consisting of Grace’s insect cell culture medium (Gibco®, Life Technologies) supplemented with 
yeastolate (3.330 g/L), lactalbumin hydrolysate (3.303 g/L), sodium bicarbonate (0.35 g/L), 10% foetal 
bovine serum (FBS), 100 U penicillin, 100 μg/mL streptomycin, 10 μg/mL gentamycin and 2.5 mg/mL 
amphotericin B.  Cells were counted by means of a haemocytometer to assess cell density and viability 
was assessed by the Trypan Blue exclusion method (421).  Passages of monolayers were performed at 
90 – 95% confluency; cells were subsequently plated at seeding densities of 5 x 104 viable cells/cm2. 
4.1.9.2 Suspension cultures 
Sf9 cells were transferred to suspension culture once regular exponential growth was obtained at a 
sustained cell viability of greater than 90%.  Cells were suspended in 100 mL complete TNM-FH in 
sterile 250 mL polycarbonate Erlenmeyer flasks at constant agitation of 100 RPM at 27°C.  Pluronic F-68 
was added at a final concentration of 0.1% to reduce cell shearing.  Cells were routinely passaged to a 
cell density of 2 x 10
5
 viable cells per millilitre when the culture reached a density of > 2 x 10
6
 viable 
cells per millilitre. 
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4.1.9.3 Adaptation of T. ni cells to suspension cultures 
T. ni cells require adaptation to suspension culture conditions upon initial transferral from monolayers.  
Cells from two confluent 175 cm
2
 flasks of adherent cells were collected and used to inoculate 100 mL 
complete TNM-FH at a seeding density of 2.25 x 10
6
 viable cells/mL in polycarbonate Erlenmeyer flasks.  
To reduce aggregation of cells in suspension, 10 U heparin per mL culture volume was added during the 
initial phases of transferral of cells from monolayers to suspension.  Cells were considered adapted to 
suspension growth conditions when viability exceeded 98%, doubling times of 18 – 24 hours were 
reached and clumping was reduced to less than ten cells per aggregate. 
4.1.10 Co-transfections and viral rescue by homologous recombination 
4.1.10.1 Preparation of Sf9 cells for co-transfection 
Sf9 monolayers were prepared by seeding 9.6 cm
2
 polypropylene dishes with 2.5 mL complete TNM-FH 
medium containing 1 x 10
5
 viable cells/cm
2
.  Cells were left to adhere at 27°C for 1 hour.  The adhered 
cells were then washed twice with sterile 1x PBS to remove antibiotics and FBS.  Subsequently, 2 mL 
incomplete TNM-FH (no FBS), containing no antibiotics, was added to each well. 
4.1.10.2 Generation of recombinant baculovirus 
Recombinant baculoviruses were generated by co-transfection of Sf9 cells in 9.6 cm
2
 dishes with 
linearized baculovirus DNA and the pAB-6xHis transfer plasmids containing human sex steroid receptor 
LBD cDNA in the polyhedrin locus.  In brief, 10% ProFectin™ (AB Vector) transfection reagent was 
added dropwise to a mixture of 100 ng of the respective pAB-6xHis/hNRLBD transfer pDNA and 5 μL 
linearized ProFold™-C1 baculovirus DNA (AB Vector) and incubated for 15 minutes at ambient 
temperature.  The DNA-ProFectin emulsion was then added dropwise to Sf9 monolayers and incubated at 
27°C.  Three days after co-transfection the virus containing media was collected and centrifuged at 
1,500 xg for 5 minutes.  The supernatant, containing P0 virus stock, was transferred to sterile 
polypropylene tubes and stored at 4°C, protected from light. 
4.1.10.3 Confirmation of protein production 
Following the generation of P0 virus stocks small scale infections of Sf9 cells were carried out to assess 
recombinant protein production.  Triplicate wells of 9.6 cm
2
 dishes were seeded with Sf9 cells at 90% 
confluency and allowed to settle for one hour at 27°C.  These cells were then infected with 200 μL P0 
ProFold™-C1/hARLBD, ProFold™-C1/hERαLBD or ProFold™-C1/hERαLBD-f virus stocks.  Cells from 
these infections were collected by centrifugation at 48 hpi, 60 hpi and 72 hpi (hours post induction) and 
resuspended in 100 μL TNN buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM EDTA, 0.5% 
Nonidet P-40).  Lysis was accomplished by osmotic shock and shear force by agitation with a bench 
vortex.  The cell debris was separated from the supernatant and resuspended in 100 μL TNN buffer.  
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After treatment with 2x sample buffer (343) at 95°C for 10 minutes the supernatant and cell debris 
samples were analysed by SDS-PAGE and Western blot. 
4.1.11 Expansion of virus stocks and titration 
4.1.11.1 Virus propagation – increase of titer 
The initial P0 virus stocks are of a titer which is too low for protein expression studies and must therefore 
be amplified.  Towards this end, 500 μL of each recombinant virus was added directly to 75 cm2 Sf9 
monolayers at 25% confluency in complete TNM-FH.  Four days post infection (dpi) ProFold™-
C1/hNRLBD infected cells were divided into two 75 cm
2
 flasks with an equal volume of fresh complete 
TNM-FH.  At 7 dpi all infected cultures exhibited clear signs of enlargement and non-adherence (Figure 
4.1).  At this time the media supernatant of these cultures, containing P1 virus stock, was collected by 
centrifugation at 1,500 RPM for 5 minutes and stored, protected from light at 4°C. 
 
Figure 4.1 Photographs (100x magnification) of Sf9 cells infected with P0 ProFold™/hERαLBD P0 cells showing clear signs 
of infection (panel B) as compared to an non-infected control culture.  Infected cells appear larger and are less 
prone to adherence.  At later stages of infection cell debris becomes higly evident as cells rapidly deteriorate. 
For the generation of larger volumes of recombinant P2 viral stock 100 mL Sf9 suspension cell cultures, 
at a density of 4 x 10
5
 cells/mL, were infected with 100 μL of the respective P1 virus stocks.  After seven 
days’ incubation at 27°C with constant shaking at 100 RPM, cultures were centrifuged at 1,500 xg for 
5 minutes.  The supernatant of these cultures was stored under the same conditions as for the P1 stocks. 
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4.1.11.2 Determination of viral titer with Green Control 
Green Control, a titrated baculovirus stock (10
8
 pfu/mL) was obtained from AB Vector.  Titration of 
virus stocks was accomplished by terminal green dilution.  Duplicate serial dilutions (1:1 – 1:32) of 
recombinant viral stocks and Green Control were made in black low auto-fluorescence 96-well plates.  
The virus dilutions were then subjected to fluorometry at an excitation wavelength of 395 nm, with 
detection of emission at 509 nm.  Obtained emission values were plotted against the dilution factor.  
Virus titres were approximated as the mean of the fold decrease observed for 1:1 and 1:2 dilutions of the 
recombinant against Green Control. 
4.1.12 Expression of heterologous proteins 
4.1.12.2 Comparison of protein expression in Sf-9 and T. ni cells 
To determine the relative levels of recombinant protein production in T. ni, as compared to Sf9 cell 
cultures, triplicate 9.6 cm
2
 wells were seeded at ± 95% confluency with these cell lines in 2.5 mL 
complete TNM-FH.  The cells were allowed to settle in the medium and adhere to the bottom of the wells 
prior to infection with 200 μL of the three P2 recombinant virus stocks.  Following incubation at 27°C for 
60 hours, the infected cells were harvested by centrifugation at 1,500 xg for 3 minutes at 4°C and 
resuspended in 100 μL TNNB buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM NMBS, 
0.5% Nonidet P-40, 5 mM β-mercaptoethanol, 0.1 mM PMSF).  Cells were then lysed by osmotic shock 
and shear force, by agitation with a bench vortex.  The cellular debris was subsequently separated from 
the soluble fraction of the lysate by centrifugation in a Hereaus Biofuge fresco microfuge at 12,250 xg for 
30 minutes at 4°C.  The fractions were resolved on SDS-PAGE gels and analysed by Western blot. 
4.1.12.1 Determination of optimal protein expression duration 
To analyse the optimal expression period for the production of recombinant nuclear receptor LBD’s 
produced with the BEVS, an expression time course was carried out.  Nine 9.6 cm
2
 wells were seeded at 
± 95% confluency with T. ni cells and allowed to adhere as before.  To triplicate wells, 200 μL of 
recombinant ProFold™-C1/hARLBD, ProFold™-C1/hERαLBD or ProFold™-C1/hERαLBD-f was added.  
Cells were then incubated at 27°C.  At 48 hpi, 60 hpi and 72 hpi cells were washed from the wells with 
the growth media, transferred to 2 mL microcentrifuge tubes and harvested.  After aspiration of the 
media, cells were resuspended in 100 μL TNNB buffer, lysed and analysed by Western blot as before.   
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4.1.13 Purification of recombinant protein produced in insect cells via 
immobilised metal affinity chromatography 
4.1.13.1 Initial protein purification studies 
For initial protein purification studies T. ni cells were grown in 75 cm
2
 culture flasks and infected at 
± 85% confluency with ProFold™-C1/hERαLBD at a multiplicity of infection (MOI)1 of > 5 and > 10.  
These cells were then incubated for 60 hours at 27°C.  Subsequently, the infected cells were collected by 
washing with the growth media.  The flask was rinsed with 2 mL PBS which was added to the collected 
cells.  After centrifugation at 1,500 xg for 10 minutes the supernatant was aspirated and cells were 
resuspended in 4 mL TNNI buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM NMBS, 0.5% NP40, 
10 mM imidazole, 5 mM β-mercaptoethanol, 0.1 mM PMSF).  Cells were lysed by osmotic shock and 
sonication for 5 seconds with a Sonicator™ Cell disruptor (model W-225R, Heat Systems – Ultrasonics, 
Inc.), fitted with a H-1 probe, after which cellular debris was separated from the soluble fraction by 
centrifugation at 3,500 xg for 25 minutes.  The supernatant was then filtered with a 0.45 μm pore size, 
low protein binding Sartorius syringe filter.  Of this filtrate, 2 mL was injected onto a 1 mL HisTrap 
column (GE Healthcare), connected to an ÄKTAprime purification system.  The column had been 
equilibrated with NP-IMAC buffer (50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 5 mM NMBS, 0.1% 
NP40, 20 mM imidazole, 5 mM β-ME and 0.1 mM PMSF).  Histidine-tagged proteins were eluted from 
the column by raising the concentration of free imidazole in the buffer to 500 mM. 
4.1.13.2 Protein purification 
Following initial studies, the cell lysis buffer was adapted by inclusion of 25 mM sucrose and 5% 
glycerol as stabilizing agents (TNNI+ buffer).  Furthermore, 0.6 μg/mL pepstatin A, 6.5 μg/mL aprotinin, 
6.5 μg/mL leupeptin and 6.5 μg/mL antipain was added to the lysis buffer as additional protease 
inhibitors.  For larger scale protein purification 200 mL suspension cultures of T. ni cells, exhibiting 
viabilities of over 99%, were infected with recombinant baculovirus at an MOI higher than 10.  After 
60 hours incubation at 27°C infected cells were collected by centrifugation at 15,000 xg, 4°C, for 
                                                          
1
 Multiplicity of infection is an important concept in the BEVS production process.  The MOI is defined as the 
number of infective particles (pfu) added to a culture per insect cell.  At low MOI (<< 1 pfu/cell) there are not 
enough infective particles present to allow every cell to take up at least one viral particle, therefore only a small 
population of the cells in culture will be infected.  However, infected cells cease to divide and instead become 
factories for the generation of additional virus.  Uninfected cells, on the other hand, continue to grow until enough 
progeny virus has budded from infected cells to be able to infect the rest of the non-infected population.  Current 
strategies for the amplification of baculovirus vectors therefore rely on infecting low cell densities with low MOI 
(502).  This approach is preferred because it is presumed that beyond the first round of infection the remaining 
cells in culture will be infected synchronously via the budded progeny virus.  As a result, the occurrence of 
defective interfering particles (DIPs) is diminished.  These defective viral particles may contain several mutations 
or deletions in their genome, ultimately increasing their rate of replication over that of the intact recombinant 
virus.  DIP formation reduces the quality of recombinant baculovirus stock and leads to a reduction in recombinant 
protein production (503).  Adequate DIP replication, however, requires the help of the complete virus.  
Asynchronous infection at a low MOI is therefore advantageous, since the probability of a DIP and an intact virus 
infecting the same cell is very low. 
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20 minutes.  Following aspiration of the media, the obtained cell pellets were respectively resuspended in 
33 mL chilled TNNI+ buffer.  Cells were lysed by osmotic shock and brief sonication with 20 pulses at 
duty cycle 50, adjustment 7 using a Sonicator™ Cell disruptor, model W-225R (Heat Systems – 
Ultrasonics, Inc.) fitted with an H-1 probe.  The cell lysate was then cleared by centrifugation at 
16,000 xg, 4°C for 15 minutes.  Collected lysate supernatants were subsequently stored at -80°C after 
flash freezing in liquid nitrogen.   
The buffering system utilised during IMAC was altered by the substitution of NP40 with 0.15% CHAPS 
(C-IMAC buffer).  Lysate supernatants were thawed, filtered with 0.45 μm pore size Sartorius syringe 
filters and kept on ice prior to chromatography.  IMAC was carried out with an ÄKTAprime protein 
purification system by injection of protein samples on to 1 mL HisTrap Chelating columns equilibrated 
with C-IMAC buffer.  During purification of the hARLBD, 20 mL of the filtrate was applied undiluted 
(9.62 mg/mL) to the column.  The protein concentration of lysates containing the hERαLBD 
(11.24 mg/mL) and hERαLBD-f (10.47 mg/mL), however, were adjusted to approximately 5.5 mg/mL 
and then filtered with 0.45 μm pore size Sartorius syringe filters prior to commencement of 
chromatography.  Following application of protein samples the column was washed with C-IMAC buffer.  
The imidazole concentration was then increased to 92 mM to remove contaminating metal chelating 
proteins.  Elution of the target proteins from the column was achieved by raising the concentration of 
imidazole to 500 mM. 
4.1.13.3 Dialysis of IMAC purified protein 
Following IMAC, fractions containing the protein of interest were dialysed overnight at 4°C against CD 
buffer (50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 5 mM NMBS, 0.15% CHAPS, 7.5 mM DTT and 
1 mM PMSF) in a ratio of no less than 1:200. 
4.1.14 Identification of proteins 
4.1.14.1 SDS-PAGE and Western Blot 
Hand-cast 12% SDS-PAGE gels were routinely used to separate proteins according to size.  Protein 
samples were diluted in 2x SDS-PAGE sample buffer according to Laemmli (125 mM Tris-HCl (pH 6.8), 
4% SDS, 20% glycerol, 10% β-mercaptoethanol, 0.001% bromophenol blue) (343).  Electrophoresis was 
performed with a Bio-Rad Mini-PROTEAN system at 4°C, 150 V.  After electrophoresis, proteins were 
visualised by gel staining with Coomassie Brilliant Blue R-250, prior to fixing and destaining with glacial 
acetic acid and methanol. 
To determine the optimal duration of expression and as a comparison between Sf9 and T. ni cells an equal 
volume of lysate supernatant was mixed with 2x sample buffer and heated at 95°C for 10 minutes.  Of 
each prepared sample, 15 μL was then loaded into the wells of SDS-PAGE gels and electrophoresed at 
150 V until the bromophenol blue front reached the bottom of the matrix.  The resolved proteins were 
then transferred to BioTrace NT pure nitrocellulose blotting membrane (Pall Life Sciences) at a constant 
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amperage of 400 mA for one and a half hours.  The membranes were subsequently blocked overnight in 
casein buffer (10 mM Tris (pH 7.6), 0.15 M NaCl, 0.5% Casein) at 4°C with gentle shaking.  Afterwards 
the membranes were incubated at 37°C in a working solution of rabbit anti-hAR (Santa Cruz 
Biotecnology, Inc., Santa Cruz, CA, USA) or rat anti-ERα IgG (Thermo Scientific) in casein buffer 
(1:1,000).  Following washing with TBST, the membranes were incubated at 37°C in a working solution 
of HRP conjugated goat anti-rabbit (Sigma) or goat anti-rat (Kirkegaard & Perry Laboratories, Inc., 
Gaithersburg, MD, USA) IgG (1:10,000) in casein buffer.  The membranes were again washed with 
TBST prior to incubation at room temperature for 5 minutes in Clarity ECL substrate (Bio-Rad).  The 
blot was then exposed on Fuji medical X-ray film (Fuji Photo Film Co.) and developed with AXIM X-ray 
developer and fixer (Africa X-ray Industrial & Medical (Pty) Ltd.). 
4.1.14.2 Mass spectrometry 
SDS-PAGE gels containing bands corresponding to positive identification of the target proteins by 
Western blotting were submitted to the Stellenbosch University Central Analytical Facility at Tygerberg 
Medical Campus, Cape Town, for analysis by mass spectrometry.  All reagents used in analysis were of 
analytical grade or equivalent. 
In-gel trypsin digest 
Identified protein bands were excised from SDS-PAGE gels and transferred to 1.5 mL microfuge tubes 
and destained with 200 mM NH4HCO3:Acetonitrile 50:50 (Sigma) until clear.  Samples were then 
dehydrated with desiccant prior to reduction with 2 mM triscarboxyethyl phosphine (TCEP, Fluka) in 
25 mM NH4HCO3 for 15 minutes at room temperature with agitation.  Following removal of excess 
TCEP, the gel pieces were again dehydrated.  Subsequently, 20 mM iodoacetamide (Sigma) in 25 mM 
NH4HCO3 were added and the gel pieces were incubated in the dark for 30 minutes at room temperature 
to carbamidomethylate cysteine residues.  The gel pieces were then dried and washed with 25 mM 
NH4HCO3 followed by another dehydration step.  Proteins were digested overnight at 37°C by addition of 
sequencing grade trypsin (Promega) solution (20 ng/μL).  Following tryptic digest, the gel pieces were 
treated once with 50 μL water and once with 50% acetonitrile to extract peptides from the matrix. The 
pooled supernatants of these washes were then dried and the resulting peptides were resuspended in 
30 L 2% acetonitrile in water containing 0.05% trifluoroacetic acid (TFA). 
Residual reagents from tryptic digests were removed with C18 stage tips (CAF, Tygerberg, RSA).  These 
tips were activated with 30 μL methanol (Sigma) and equilibrated with 30 μL 2% acetonitrile in water 
containing 0.05% TFA.  Peptides were loaded onto the tips and then washed with 30 μL 2% acetonitrile 
in water containing 0.05% TFA before elution with 30 μL 50% acetonitrile in water containing 0.05% 
TFA.  The eluate was then dried by evaporation and the dried peptides were reconstituted in 2% 
acetonitrile in water containing 0.1% formic acid for LC-MS analysis. 
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Liquid chromatography 
Liquid chromatography was performed on a Thermo Scientific Dionex UltiMate 3000 Rapid Separation 
Liquid Chromatography system equipped with a 2 cm x 100 m C18 trap column and a 25 cm x 75 m 
Pepmap C18 analytical column.  Solvent A consisted of 2% acetonitrile in water containing 0.1% formic 
acid and solvent B consisted of 100% acetonitrile containing 0.1% formic acid.  Samples were loaded 
from a temperature controlled autosampler, set to 7°C, onto the trap column with solvent A at a flow rate 
of 5 μL/min for 10 minutes.  Samples were then eluted to the analytical column with a gradient at 
250 nL/min consisting of 2.5% solvent A for 10 minutes, then 2.5% to 30% solvent B for 30 minutes, 
followed by 30% to 50% solvent B for 15 minutes (using Chromeleon non-linear gradient 6), after which 
the gradient was raised from 50% to 80% solvent B.  Solvent B was then kept constant at 80% for 
5 minutes. Re-equilibration of the column was performed for 10 minutes between chromatographic runs.  
Chromatography was performed at 50°C and the outflow delivered to the mass spectrometer through a 
stainless steel nano-bore emitter. 
Mass spectrometry 
A Thermo Scientific Fusion mass spectrometer was used for all mass spectrometric analyses.  Data was 
acquired in positive mode using a Nanospray Flex (Thermo Scientific) nano-ESI source with spray 
voltage set to 1700 V and ion transfer tube temperature set to 275°C.  MS1 scans were recorded in the 
Orbitrap mass analyser set to 120,000 resolution over the scan range m/z = 350 – 1,650 with a fill time of 
100 ms or until adaptive gain control (AGC) target of 2e
5
 were reached.  All spectra were internally 
calibrated using the polysiloxane ion at m/z = 371.10024.  Ion filter criteria were set to mono-isotopic 
precursors only with charge state 2 – 7 and dynamic exclusion of 1 over 45 s with mass tolerance of 
10 ppm. Precursor selection was performed in Top Speed data dependent mode with the most intense 
precursor selected first with a cut off intensity higher than 50,000. 
Precursor selection was performed using the quadrupole mass analyser, with an isolation window of 
m/z = 2, prior to higher-energy collisional dissociation (HCD) fragmentation.  HCD collision energy was 
set to 30%. Detection was performed in the orbitrap mass analyser with an ion injection time of 35 ms 
and resolution 30,000 or until an AGC target of 5e
4
 was reached.  
Data Analysis 
The RAW files generated by the mass spectrometer were imported into Proteome Discoverer, version 1.3 
(Thermo Scientific) and processed using the Mascot 2.3.1 (Matrix Science) and Sequest (Thermo 
Scientific) algorithms.  Database interrogation was performed against IPI human database with trypsin 
cleavage allowing for 2 missed cleavages.  Precursor mass tolerance was set to 10 ppm and fragment 
mass tolerance set to 0.8 Da. Protein N-terminal acetylation, deamidation (NQ) and oxidation (M) was 
allowed as dynamic modifications and carbamidomethylation of cysteine residues as static modification.  
Peptide validation was performed using the peptide validator node set to search against a decoy database 
with strict false discovery rate at 1%. 
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4.1.15 Radioligand binding assay 
To assess the biofunctionality of the recombinant nuclear receptor LBDs, radioligand binding assays 
were conducted using 1β,2β-3H(N)-testosterone (3H-T; Du Pont: NEN® Products, Boston, MA) and 
2,4,6,7-
3
H(N)-estradiol (
3
H-E2; Perkin Elmer: NEN
®
 Radiochemicals, Boston, MA).  The wells of a 
48-well plate (Costar
®
, Cambridge, MA) were coated with 1.5 mL blocking buffer (1.5% BSA in TBST 
(pH 7.6); 33 mM HEPES, 100 mM NaCl, 6.5% imidazole) for 1 hour at 4°C.  Following coating, the 
wells were washed three times with TBST, after which 400 μL equilibration buffer (100 mM HEPES 
(pH 8.0), 300 mM NaCl, 20 mM imidazole) was added to each well.  To each well, 100 μL of a 
10 mg/mL SiMAG-IDA/Nickel magnetic particle suspension (Chemicell GmbH, Germany) was added 
and the beads were washed thrice with 1 mL equilibration buffer.  The magnetic nanoparticles were then 
suspended in 480 μL binding buffer (100 mM HEPES (pH 8.0), 300 mM NaCl, 20 mM imidazole, 0.2% 
Tween-20).  To triplicate wells, 20 μL of purified 6xHis-LBD or 6xHis-β-galactosidase were added to 
saturate the Ni
2+
-binding sites of the particles with hexahistidine-tagged protein.  The plate was then 
incubated for 30 minutes at ambient temperature with constant mixing following which the protein-
immobilised particles were washed twice with 500 μL binding buffer.  The beads were again resuspended 
in 490 μL binding buffer and to each well 10 μL of 3H-T or 3H-E2, containing approximately 
100,000 CPM, was added, with subsequent incubation for 30 minutes at ambient temperature.  
Subsequently, the supernatant was aspirated and the beads were washed twice with 500 μL binding 
buffer.  Protein was then removed from the beads by incubation for two periods of 5 minutes at ambient 
temperature in 500 μL elution buffer (100 mM HEPES (pH 8.0), 300 mM NaCl, 500 mM imidazole, 
0.2% Tween-20).  The 500 μL steroid supernatants, binding wash buffers and eluted proteins were 
transferred to 4 mL scintillation fluid in individual vials.  Radioactivity of each sample was then 
measured in triplicate with a Tri-Carb
®
 2810 TR Liquid Scintillation Analyzer (Perkin Elmer) as counts 
per minute (CPM) over periods of 5 minutes. 
4.1.16 Statistical analysis 
Statistical differences between different treatment groups were determined by ANOVA and Bonferroni 
post-tests to compare replicate means.  The data were presented as mean standard deviation for at least 
three separate determinations for each treatment.  All analyses were performed by the software package 
Prism 5, version 5.00 for Window (GraphPad Software, Inc). 
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4.2 RESULTS AND DISCUSSION 
4.2.1 Confirmation of template cDNA identity and integrity 
Prior to commencement of a cloning strategy for the amplification of the hARLBD and hERαLBD(-f) 
coding regions, the integrity of the template DNA was assessed by digestion with restriction 
endonucleases, followed by agarose gel electrophoresis (Figure 4.2).  The pSV.ARo expression vector is 
a 7219 bp DNA molecule containing two recognition sites for HindIII and one for BamHI.  pSG5ERα, on 
the other hand, is 5864 bp in length and contains one recognition site for HindIII and two for SalI. 
 
Figure 4.2 Image of a 0.8% agarose gel following electrophoresis of the mammalian expression vectors pSV.ARo and 
pSG5ERα.  Lane one contains a 1 kb DNA ladder (Promega).  In lane two 204 ng pSV.ARo, digested with 
HindIII and BamHI, was loaded with 351 ng of the undigested plasmid in lane three.  The pSG5ERα, digested 
with SalI and HindIII, was loaded to lane four (263 ng), with 452 ng of undigested pSG5ERα in lane five. 
Results observed following agarose gel electrophoreses correlated well with the expected fragments from 
endonuclease restriction.  A comparison between the expected and the obtained fragment sizes is 
presented in Table 4.2. 
Table 4.2 Comparative results of expected fragment sizes to experimentally obtained bands on agarose gel following 
electrophoresis of uncut and endonuclease digested mammalian expression vectors, pSV.ARo and pSG5ERα. 
DNA molecule Expected fragment size Gel fragment size 
pSV.ARo 
4182 bp 
1687 bp 
1350 bp 
4053 bp 
1856 bp 
1159 bp 
pSG5ERα 
2874 bp 
2063 bp 
927 bp 
2673 bp 
1938 bp 
939 bp 
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4.2.2 Cloning of nuclear receptor ligand binding domains 
4.2.2.1 Amplification of target cDNA and the generation of transfer plasmids 
Direct manipulation of AcMNPV DNA (NCBI accession: NC_001623) is a complex endeavour due to its 
134 kb size and frequency of restriction endonuclease sensitive sites (325).  The insertion of foreign 
genes into the baculoviral genome, in contrast to bacterial plasmids, is therefore difficult to accomplish.  
Prior to the production of any recombinant baculovirus, the gene of interest must be cloned into a plasmid 
designed for the transferral of genetic elements into the baculovirus genome.  The construction of such a 
transfer vector is performed by routine techniques involving the design of primers for the amplification of 
a gene of interest along with the introduction of endonuclease recognition sites to the 5’ and 3’ ends of 
resulting PCR fragment, the restriction of this fragment and a host plasmid with the relevant enzymes, 
followed by ligation of the two molecules. 
Depending on the transfer vector employed recombinant genes may be placed under a variety of 
temporally distinct promoters in the BEVS (422).  The pAB-6xHis™ baculovirus transfer vector (Figure 
4.3) is designed for expression of proteins with N-terminal 6xHis tags under the control of the strong 
polyhedrin promoter.  The polyhedrin promoter provides for transcription of the maximum level of RNA 
encoding the protein of interest during the very late stages of infection.  Downstream of this promoter the 
pAB-6xHis polylinker contains six unique endonuclease restriction sites (SmaI, XbaI, EcoRI, NotI, PstI, 
BglII) for insertion of a PCR fragment encoding a gene of interest.  A sequence encoding a thrombin 
(LVPRGS) site occurs directly upstream of the polylinker and, as such, the 6xHis tag can be cleaved from 
the expressed protein after purification by IMAC, if so desired.  The vector contains the bla gene which 
expresses β-lactamase and confers resistance to ampicillin, carbenicillin and related antibiotics.  The 
high-copy-number pBR322 bacterial origin of replication is also present for propagation of the plasmid in 
E. coli. 
 
Figure 4.3 Map of the baculovirus transfer vector, pAB-6xHis™ indicating the multiple cloning site downstream of a 
sequence encoding a 6xHis metal affinity tag.  The baculovirus recombination regions ORF 1629 and 
lef2/ORF603 mediate transferral of the inserted gene of interest to the AcMNPV genome.  
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The target sequences of the hAR and hERα LBDs were successfully amplified by PCR.  Furthermore, 
restriction endonuclease recognition sites were introduced at each end of the molecules and the reverse 
primer to the hERαLBD sequence inserted the translation stop codon ‘TGA’ to the amplified region.  
Additional nucleotides to the 5’-ends of the primers were added to increase the docking platform for 
endonuclease interaction with the DNA.  The expected outcome for the amplification of the hARLBD 
gene sequence, along with the extra nucleotides needed for insertion to the baculovirus transfer plasmid, 
is an 830 bp PCR fragment.  For the amplification of the two ERαLBD genetic sequences, the expected 
fragment sizes are 765 bp and 909 bp, respectively for the E-domain and E/F-domain constructs.  The 
successful amplification of these coding regions were confirmed by agarose gel electrophoreses (Figure 
4.4) and direct DNA sequencing. 
 
Figure 4.4 Image of a 1% agarose gel confirming the successful amplification of the gene sequences encoding the hARLBD 
in lane two, the hERαLBD in lane two and the hERαLBD-f in lane three.  Negative controls to these PCR 
amplifications containing no template DNA were loaded to lanes five to seven.  A 1 kb DNA ladder (Promega) 
was loaded in lane one. 
After dephosphorylation of the linearized host plasmid, ligation of endonuclease treated pAB-6xHis™ 
with similarly prepared amplicons resulted in the generation of the pAB-6xHis/hARLBD, pAB-
6xHis/hERαLBD pAB-6xHis/hERαLBD-f baculovirus transfer plasmids.  These new vectors, which 
facilitate the transferral of genetic material to the baculovirus genome, were successfully transformed to 
E. coli propagation hosts DH5α and JM109.  Subsequent to bacterial replication, the plasmids were 
extracted and assessed by restriction enzyme digest with the endonucleases HindIII or SalI.  
Electrophoreses of the digested plasmids and subsequent visualisation affirmed insertion of the nuclear 
receptor PCR fragments to the host plasmids (Figure 4.5).  Sequencing of the new transfer vectors with 
the phF and mR primers, which anneal to DNA sequences flanking the inserts, confirmed the correct 
nucleotide sequences within the polyhedrin loci. 
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Figure 4.5 Image of results obtained from 1% agarose gel electrophoresis of restriction enzyme digested baculovirus 
transfer plasmids extracted from E. coli JM109 cells.  Lane one contains the 1 kb DNA ladder.  To lane two, 
HindIII digested pAB-6xHis/hARLBD was loaded, with HindIII digested pAB-6xHis/ERαLBD and SalI digested 
pAB-6xHis/ERαLBD-f in lanes three and four, respectively.  Lanes five and six contains the parent plasmid, 
pAB-6xHis, digested with HindIII and SalI, respectively. 
4.2.3 Generation of recombinant baculoviruses by homologous 
recombination 
Following mapping of the polyhedrin gene (423) and demonstration that this protein was not essential for 
the production of infectious extracellular virus (424), the first report of the insertion of a foreign gene into 
the polyhedrin locus of the AcMNPV by homologous recombination was presented in 1983 by Smith et 
al. (307).  Wild-type AcMNPV infections are characterised by the formation of a crystalline matrix 
within the cell nucleus which encapsulates viral particles known as occlusion bodies (OB).  Polyhedrin 
deficient phenotypes may be readily distinguished from wild-type infections by altered plaque 
morphology due to the absence of OB in cells infected with the recombinant.  This initial method of 
heterologous gene introduction via homologous recombination was, however, inefficient due to the low 
frequency (< 0.1%) of DNA exchange between circular wild-type virus and transfer vector.  Linearization 
of the viral genome at the polyhedrin locus decreased infectivity, as compared to the circular form, by 15- 
to 150-fold (325), the virus must be in its circular form to be infectious.  Co-transfection of the linear 
virus with appropriate transfer vectors increased the frequency of recombination by up to 30% due to re-
circularisation of the virus.  The relatively high background (~70%) observed after linearisation led to the 
insertion of novel Bsu36I (CC
↓
TNAGG) restriction sites in genes upstream and downstream of the 
polyhedrin locus (326).  Digestion of parental virus with this enzyme therefore removes sections of these 
genes (Figure 4.6).  The upstream gene, ORF603, is non-essential for viral replication, however, 
ORF1629, downstream of the polh gene, encodes for a WASP (Wiscott-Aldrich syndrome protein)-like 
protein, p78/83 (321), which is involved in nuclear actin filament formation and must be present in order 
for the formation of infectious virions. 
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Figure 4.6 A diagram of the AcMNPV genome based on the BakPAK6 virus DNA contain Bsu36I recognition sites within 
the ORF603 and ORF1629 genes, respectively located upstream and downstream of the polyhedrin locus.  
Bsu36I restricted viral particles are linear and non-infective.  Re-ligation of the viral DNA in the absence of a 
functional ORF1629 gene does not restore replicative prowess, since this gene is essential to viral structure.  
Recombination with a transfer vector rescues the virus by restoration of the truncated genes, while 
simultaneously introducing a heterologous gene to the polyhedrin locus of the viral genome.  Image: Clontech. 
The Bsu36I alterations to the baculoviral genome described above have been incorporated into the 
commercially available insect expression vector ProFold™-C1 (Figure 4.7).  The DNA molecule has also 
been engineered to express two human chaperone proteins, Heat-Shock Cognate 70 (Hsc70) and a 
molecular partner, Heat-Shock Protein 40 (Hsp40/ERdj2), which cooperate in protein folding in the 
cytoplasm (425).  Up to 30% of eukaryotic proteins (426) require the availability of molecular 
chaperones to fold into the proper three dimensional configurations necessary for biological activity.  
DnaJ-like proteins, such as Hsp40, stimulate the ATPase activity of Hsc70, allowing stable interaction 
between the chaperone protein and a polypeptide substrate (427).  Upon binding to unfolded substrates, 
Hsp40 can recruit Hsc70 to act upon these nascent polypeptides, thus preventing improper folding by 
stabilisation of the amino acid chain during translation until sufficient protein has been synthesised to 
obtain the correct conformation. 
 
Figure 4.7 Schematic representation of the genetic organisation of AcMNPV derived ProFold™-C1 baculovirus DNA.  The 
vius has been linearised with Bsu36I and is therefore non infectious until rescue by recombination with a 
transfer vector.  The genetic sequences for the human chaperones Hsp40 and Hsc70, along with the reporter 
protein GFP, has been inserted in positions distal to the polyhedrin locus.  Image: AB Vector. 
Insect cells can synthesize these molecular helper proteins, indeed Hsp70, the stress induced connate of 
Hsc70, is up-regulated during baculovirus infection (428, 429).  Moreover, AcMNPV replication is 
assisted by heat shock proteins during infection of Sf9 cells (430, 431).  It has also been reported that 
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Hsc70 and Hsp70 associate with the VP1, VP2 and VP3 capsid proteins of polyomaviruses in the cytosol 
with consequent nuclear translocation, thus assisting in viral assembly (432).  Upon expression of VP1 
and VP2 in Sf9 cells with baculovirus vectors, co-immunoprecipitation with hsp70-like proteins was also 
observed.  Such results suggest that molecular chaperones are involved in the prevention of premature 
cytosolic capsid assembly and, or alternatively, the transport of unassembled capsid proteins to the 
nucleus.  Nobiron et al. (433) demonstrated by a differential display approach that Sf9 host mRNA 
encoded by hsc70 was transiently up-regulated during AcMNPV infection, with expression reaching a 
peak at 6 hpi and complete down-regulation occurring at 24 hpi.  Down-regulation of the expression of 
these proteins from 12 hpi onwards implies that recombinant eukaryotic constructs, expressed during the 
late stages of infection under the control of the polyhedrin or p10 promoters, do not have access to these 
molecular chaperones.  Heterologous proteins which require the assistance of heat shock chaperones are 
thus often misfolded, which may lead to aggregation in structures reminiscent of bacterial inclusion 
bodies. 
DNA inserted into the multiple cloning site of the pAB-6xHis plasmid, in lieu of polyhedrin, is flanked 
on either side by the sequences lef2/ORF603 and ORF1629, respectively.  As explained in the preceding 
discussion, these baculovirus derived gene sequences are the sites of homologous recombination with 
similar, yet truncated, sequences present at the ends of the linearised ProFold™-C1 genome.  Co-
transfection of Sf9 cells with ProFold™-C1 and the recombinant pAB-6xHis plasmids led to successful 
re-circularisation and rescue of the virus, along with the introduction of the heterologous human sex 
steroid LBD’s to the baculoviral genome.  Successful co-transfections were easily identified by 
morphological changes to the treated cultures, as compared to untransfected controls, and by visualisation 
of green fluorescence using simple fluorescence microscopy (434). 
4.2.3.1 Viral titration and amplification 
Baculoviral particles produced during the initial double homologous event are of low titer and therefore 
unsuitable for the large-scale production of recombinant proteins.  Various methods of baculovirus 
titration have been developed since the original inception of traditional plaque assays (435, 436).  Such 
methods include end-point dilutions (437), cytopathic effects based on cell size (438), flow cytometry 
(439), qPCR (440) and methods based on expressed reporter genes such as β-galactosidase (441) or 
colorimetric indicators such as 3-(4,5,-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) or 
AlamarBlue™ (442).  Titration of recombinant baculovirus stock is important for numerous reasons.  
Amplification of virus at excessive MOI is not only wasteful of valuable stocks, but may lead to 
qualitative decreases in subsequently produced infectious particles due to the occurrence of DIPs.  
Furthermore, knowledge of the titer of viral stock allows for quality assurance in terms of the 
reproducibility of protein production runs. 
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Emission and excitation scanning of the recombinant baculovirus infected insect cells gave an emission 
maximum of 509 nm, a major excitation maximum of 395 nm, with a minor peak at 470 nm (Figure 4.8).  
The spectral properties are the result of expression of the 238 amino acid green fluorescent protein (GFP) 
from the jellyfish Aequorea victoria (443, 444).  GFP production by ProFold-C1™ coincides with 
transcription from very late promoters, such as polh.  This highly stable protein is not easily degraded by 
proteases, heat, chemical denaturants or pH fluctuations and therefore serves as a marker molecule for 
viral production. 
 
Figure 4.8 Excitation spectrum of GFP from Aequorea victoria has two maxima, a major peak at 395 nm and a minor peak 
at 470 nm.  The fluorescence emission spectrum has a peak at 509 nm and a shoulder at 540 nm.  GFP is 
expressed by the parent baculovirus, ProFold™-C1, at the very late stages of infection.  The spectra were 
generated by fluorescence scanning of media collected at 60 hpi from Sf9 cells infected with recombinant 
ProFold-C1™ virus. 
Quantitation of the emitted fluorescence of recombinant virus stock against that of the titrated reference 
Green Control (10
8
 pfu/mL) allow for fast approximation of viral titre (445).  The initial virus stock was 
amplified with MOI’s less than one from low starting titres to 7.75 x 107 pfu/mL, 4.00 x 107 pfu/mL and 
4.08 x 10
7
 pfu/mL for ProFold-C1/hARLBD, ProFold-C1/hERαLBD and ProFold-C1/hERαLBD-f, 
respectively, as determined by terminal green dilution (Figure 4.9). 
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Figure 4.9 GFP titration curves of recombinant baculoviruses against a reference stock of known titer (108 pfu/mL).  Viral 
titer is approximated as the mean of the fold decrease observed for 1:1 and 1:2 dilutions of the recombinant 
against Green Control. 
4.2.4 Protein expression 
Conversely to the low MOI commonly used in the amplification of viral stock, synchronicity of infection 
is required for the expression of heterologous protein in the BEVS.  Asynchronous infection leads to 
suboptimal yields of recombinant protein due to premature cell lysis and delayed protein production. 
4.2.4.1 Sf9 v T. ni  
The Sf9 cell line, a clonal isolate of IPLB-Sf21-AE (Sf21) (446), is well suited to the production and 
amplification of recombinant baculovirus due to uniform monolayer formation and consistent cell 
morphology.  However, multiple workers have expressed recombinant proteins in cells derived from 
different insect hosts.  Davis et al. (447) evaluated the expression of secreted alkaline phosphatase 
(SEAP) by a recombinant AcMNPV baculovirus in eight insect cell lines derived from Spodoptera 
frugiperda, Trichoplusia ni, Mamestra brassicae and Estigmene acrea.  McKenna et al. (448) established 
and compared thirty one cell lines from T. ni for viral and protein production.  Hink et al. (449) examined 
expression levels between 23 different insect cell lines.  All these studies found insect cell lines that were 
capable of producing greater amounts of recombinant protein than either Sf9 or Sf21. 
BTI-TN-5B1-4 differs markedly from Sf9 cells in terms of its metabolism and requirements for growth.  
In contrast to Sf9, which, in the presence of ammonium ions, can grow in the absence of glutamine, 
glutamate and aspartate (450), T. ni cells have strict demands for glutamine and asparagine to support 
their growth (451).  Furthermore, the production of ammonium and lactate is low in Sf9 cells (452), yet 
these molecules are produced at high concentrations in T. ni cells and could have possible inhibitory 
effects on cellular growth (453) translating into altered expression profiles of recombinant protein within 
different cell lines. 
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A comparison between the expression levels obtained in Sf-9 cells and the T. ni derived cell line BTI-TN-
5B1-4 is presented in the Western blot image in Figure 4.10.  Densitometric analysis (Figure 4.11) 
indicates that maximal expression of the hERαLBD and hERαLBD-f proteins may be achieved by 
selecting the T. ni cell line as an expression host instead of Sf9 (p < 0.05 and p < 0.001, respectively).  No 
significant difference was observed in the responses obtained from T. ni cells infected with ProFold-
C1/hARLBD, compared to Sf9. 
 
Figure 4.10 Western blots of triplicate Sf9 and T. ni cultures harvested at 60 hpi following infection with recombinant 
baculoviruses expressing the hARLBD, hERαLBD and hERαLBD-f proteins. 
 
 
Figure 4.11 Comparitive production of sex steroid receptors LBD’s in two insect cell lines, Sf9 and T. ni.  No significant 
difference in the relative expression of the hARLBD could be detected between the two cell lines. 
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4.2.4.2 Determination of optimal infection period for LBD production 
Transcription from the strong polh promoter is initiated during the very late stages of infection.  Virally 
expressed very late factor 1, in combination with a virally-induced RNA polymerase leads to a burst of 
high-level transcriptional activity from this promoter (454).  In AcMNPV-infected cells the very late 
genes are activated between 18 and 72 hpi (316).  During wild type baculovirus infection this stage of 
infection is characterised by the appearance of a crystalline matrix of occluded virus (OV), with a 
concomitant start of cell lysis.  Considering the lytic nature of the BEVS, the optimal time to harvest 
infected cells expressing heterologous proteins in the cytosol is an important consideration.  Proteolysis is 
a critical issue and many techniques have been proposed to monitor the state of an infected culture in 
order to predict the correct time to harvest cells, thus maximising recombinant protein yield (455–457).  
Many of these techniques, such as the measurement of oxygen uptake rates or intracellular ATP 
concentrations, are impractical for routine monitoring of peak protein production due to the requirements 
for specialised equipment.  Automated systems are available for the continual assessment of cell viability, 
density and size, yet Sander and Harrysson (458) concluded that the only reliable predictor of the point of 
peak protein production is a peak in the average cell diameter.  The authors, having based their 
observations on the production of enhanced GFP (EGFP), caveats their findings by pointing out that 
proteins other than the very stable EGFP may be more sensitive to proteolysis, thus necessitating 
continual assessment of all parameters over multiple infections.  Alternatives to strict monitoring 
strategies have included the addition of protease inhibitors in infected cultures, or the deletion of genes 
encoding specific proteases from baculovirus vectors.  Other methods, such as the utilisation of pre-lytic 
promoters for heterologous protein expression have also been investigated (459–462).   
In the absence of sophisticated equipment for continual assessment of protein production, the optimal 
duration of infection within the BEVS must be determined empirically.  Western blots of infected T. ni 
cell lysate supernatants (Figure 4.12 and Figure 4.13) indicated maximal responses for recombinant 
hERαLBD after 60 hpi (p < 0.01 and p < 0.05 for the hERαLBD and hERαLBD constructs, respectively).  
The visual increase observed for the hARLBD at 60 hpi and 72 hpi, as compared to 48 hpi were shown to 
be non-significant. 
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Figure 4.12 Determination of optimal expression duration for the production of sex steroid receptor LBDs in T. ni cells.  
Triplicate infections were collected at 48, 60 and 72 hours after infection with recombinant baculoviruses at a 
MOI > 10. 
 
 
Figure 4.13 Relative chemiluminescent responses obtained from Western blots of human sex steroid receptor ligand binding 
domains following expression by T. ni cells infected with recombinant baculoviruses.  
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4.2.5 Purification of recombinant protein 
4.2.5.1 Initial studies 
Heterologous proteins expressed from the ProFold™-C1 polydedrin locus, following rescue of the virus 
by homologous recombination with pAB-6xHis plasmids, are fused to 6xHis metal affinity tags.  The 
inclusion of this molecular marker enables purification of the target proteins by IMAC via the formation 
of coordinated bonds between the imidazole rings of consecutive histidine residues and metal ions bound 
to a stationary matrix.  It is well documented that the ligand binding domains of nuclear receptors are 
highly hydrophobic (391, 463–465); major concerns in the heterologous production of such proteins 
always include at least some reference to issues pertaining to solubility (341, 394).  Primary investigation 
into the purification of BEVS produced hERαLBD protein therefore included the detergent Nonidet P-40 
in the chromatographic buffer as an agent to inhibit protein aggregation and precipitation due to 
hydrophobic interaction.  The inclusion of this non-ionic polyoxyethylene detergent led to substantial 
background interference at the detection wavelength of 280 nm.  Slight repression of peaks was evident 
as background absorption amounted to approximately 545 mAu.  Nevertheless, an elution peak for the 
recombinant hERαLBD was resolved on the chromatogram at 27.59 mL (Figure 4.14). 
 
Figure 4.14 Chromatogram of the first attempt at purification of the hERαLBD construct from T. ni lysate supernatant via 
IMAC.  The slight peak at 27.59 mL (indicated with a red arrow) is the elution volume for the recombinant 
protein of interest. 
Analyses of the eluent fractions immediately surrounding the obtained peak at 27.59 mL (Figure 4.14) by 
SDS-PAGE and Western blot with anti-hERα antibodies (Figure 4.15) revealed that the hERαLBD could 
be purified to a high degree of homogeneity from insect cell lysates as nearly no contaminating proteins 
are observable in lanes four to six.  Moreover, cultures infected at MOI greater than 10 yielded more 
recombinant protein, compared to an MOI > 5, as indicated by the depth of the chemiluminescent 
response obtained during Western blot.  However, a comparison of the purified protein to the original 
lysate supernatants revealed that there is a degree of proteolytic activity prior to IMAC purification, 
resulting in removal of the polyhistidine affinity tag from the recombinant protein, thus decreasing the 
amount of protein that can be purified by this form of affinity chromatography under these conditions. 
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Figure 4.15 SDS-PAGE (panel A) of hERαLBD indicate a high degree of homogeneity following single step purification by 
IMAC.  Lanes four to six were loaded with 25 μL of 2x sample buffer prepared fractions surrounding the 
elution peak of the target protein (Figure 4.14).  Purification of the hERαLBD from insect cell lysates indicate 
some proteolytic activity prior to purification as is evident from the doublet lines occuring in lanes two and three 
of the Western blot insert (panel B).  These lanes contain lysate from cultures infected with MOIs of >5 and >10, 
respectively. 
4.2.5.2 Purification of heterologously expressed nuclear receptor LBDs produced in the 
baculovirus expression vector system 
Exchanging NP-40 for the zwitterionic detergent, CHAPS (3-(3-cholamidopropyl)-dimethylammonio-1-
propanesulfonate), alleviated the high background absorption of the chromatographic system.  CHAPS, a 
mild detergent that does not lead to the denaturation of proteins, has been employed by numerous groups 
(466, 467) for the solubilisation of generally hydrophobic proteins, such as those which are normally 
membrane bound.  According to Stoscheck (468) up to 10% CHAPS is tolerable in protein assays that 
utilize absorption at 280 nm.  Background absorption by NP-40 amounted to 547.5 mA, whilst CHAPS 
contributed less than 7 mAu to the UV absorption spectra. 
 
Figure 4.16 Chromatograms of IMAC purifications of the hERαLBD from insect cell lysate.  The inclusion of Nonidet P-40 
(NP-IMAC buffer) in the chromatographic buffers resulted in substantial background absorbance at 280 nm, 
yet an elution peak for the target protein was still visible.  Exchange of this detergent to CHAPS (C-IMAC 
buffer) markedly removed background absorbance by the buffering system. 
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The hERαLBD could be detected by UV absorption during IMAC in a reproducible and injection volume 
dependant manner (Figure 4.16).  Reproducible elution profiles for the hERαLBD-f (Figure 4.17) protein 
were also observed.  Interestingly, larger absolute absorbance values were obtained for peaks indicating 
elution of the hERαLBD-f protein as compared to the hERαLBD when applying the same amount of 
protein from insect cell lysates to a HisTrap Chelating column.  In addition to the seven phenylalanine 
residues, three tryptophan residues and five tyrosine residues contained within the hERαLBD protein, 
hERαLBD contains an additional phenylalanine residue and two tyrosine residues.  It is doubtful that the 
increase in absorptive capacity is due to the presence of these additional aromatic residues.  Most 
probably, the increased peak area of hERαLBD-f separations, as compared to that of hERαLBD, can be 
explained by the presence of additional contaminating proteins within the dialysate obtained after IMAC 
purification (Figure 4.18, lanes 6 and 7). 
 
Figure 4.17 Chromatograms of IMAC purification of the hERαLBD-f from insect cell lysate.  The 20 mL injection contained 
approximately 110 mg protein resulting in protein recovery of 8.37 mg within the elution fraction of the target 
protein.  Aproximately 82.5 mg protein was applied to the column during the injection of 15 mL lysate, with an 
approximate recovery of 6.93 mg protein during target peak elution. 
Positive development of Western blots using anti-hERα antibodies successfully identified the major 
protein bands in lanes six to nine of Figure 4.18 as being derived from this hormone receptor.  Analyses 
of the lanes six to nine of Figure 4.19 indicates that the hERαLBD-f protein comprises 75.6% of the total 
protein in lanes six and seven (1.92% std.dev.), while the hERαLBD accounts for 92.9% of the protein in 
lanes eight and nine (1.65% std.dev.).  Protein concentrations for the hERαLBD and hERαLBD-f 
containing fractions were respectively determined as 6.42 mg/mL (1.75 mL) and 5.58 mg/mL (1.50 mL).  
Therefore, the quantities of recombinant hERαLBD and hERαLBD-f that could be produced successfully 
in the BEVS equate to approximately 10.44 mg and 6.33 mg, respectively, from cell lysate injections of 
20 mL.  Considering that the initial lysate protein concentration was 5.50 mg/mL, percentage recovery of 
recombinant hERαLBD and hERαLBD-f was approximately 9.49% and 5.75% of the total protein 
complement. 
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Figure 4.18 Image of SDS-PAGE gel (panel A) indicating the purification of the hERαLBD and hERαLBD-f proteins via 
IMAC, with insert of Western blot of these proteins using primary monoclonal antibodies raised against the 
human estrogen receptor.  In lane one, 7.5 μg of the Bio-Rad Kaleidoscope Precision Plus molecular marker was 
loaded.  Lanes two and three contains lysate of T. ni cells infected with ProFold-C1/hERαLBD-f, with ProFold-
C1/hERαLBD infected cell lysate in lanes four and five.  The IMAC purified hERαLBD-f peak fraction was 
loaded in lanes six and seven, with IMAC purified hERαLBD fraction in lanes eight and nine.  The Western blot 
insert (panel B) indicates the presence of the hERαLBD-f and hERαLBD proteins, at the expected sizes, in lanes 
one and two, respectively.  The purified forms of these proteins are visible in lanes three and four, respectively. 
Figure 4.18 also gives evidence that the inclusion of additional protease inhibitors in the lysis buffer 
successfully inhibited cleavage of the recombinant proteins at the thrombin site, located at the carboxy-
end of the polyhistidine affinity tag, as singular bands can be observed in Western blots of the cell lysates 
(lanes one and two). 
UV absorption by proteins during elution of IMAC columns (Figure 4.19), to which T. ni lysates from 
ProFold-C1/hARLBD infections had been applied, is markedly lower for the hARLBD compared to the 
hERαLBD or hERαLBD proteins.  However, a noticeably difference was observed in peak height with 
increasing injection volumes.  Nevertheless, only 54.8% of the purified protein resolved by SDS-PAGE 
(Figure 4.20), according to densitometry, gave a positive result when subjected to Western blot utilising 
anti-hAR antibodies. 
 
Figure 4.19 Chromatograms of the separation of baculovirus/T. ni produced hARLBD.  Injection of 10 mL insect cell lysate 
resulted in a barely detectable elution peak for the target protein.  An increase of the injection volume to 50 mL 
markedly increased the peak height.  Compared to a 50 mL injection of hERαLBD containing lysate at 
approximately half the concentration the elution peak height is relatively low.  
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Figure 4.20 Image of an SDS-PAGE gel (panel A) showing resolved proteins collected during elution of the major peak of 
the 50 mL injection of BEVS expressed hARLBD in Figure 4.19.  Lane one contains the Kaleidoscope molecular 
protein marker, while duplicate samples of the collected IMAC fraction was loaded to lanes two and three.  The 
major bands in the second and third lanes correspond to the target protein, as confirmed by Western blot with 
anti-hAR antibodies (panel B). 
Protein determinations of the initial insect cell lysate and the collected IMAC fraction, following dialysis, 
indicated values of 9.62 mg/mL and 1.03 mg/mL, respectively.  Considering a total amount of 20 mL 
containing 192.4 mg protein was injected onto the column during purification, and the collected peak was 
3 mL, protein recovery within this fraction amounted to 1.60% of the total protein complement.  
Consequently, 1.69 mg, or a mere 0.88% of the total protein content can be ascribed to the hARLBD. 
4.2.6 Protein identification 
4.2.6.1 Mass spectrometry 
Examination of MS results against the IPI human database successfully identified fragmented peptides 
from SDS-PAGE gel excised protein bands as analogous to the major isoforms of the human androgen 
and estrogen receptors.  Proteins with 2 or more peptides were detected with confidence greater than 95% 
(Table 4.3). 
Table 4.3 Mass spectrometric analysis of proteins excised from SDS-PAGE gels.  Proteins were detected with high 
confidence as analogues of the human sex steroid receptors. 
Sample Accession Description Coverage 
Unique 
Peptides 
PSMs 
Sequest 
Score 
Mascot 
Score 
ARLBD IPI00020070.4 Androgen receptor, Isoform 2 27.06% 5 155 91.01 314.83 
ERαLBD IPI00294982.1 Estrogen receptor, α Isoform 18.99% 5 89 99.58 
 ERαLBD-f IPI00294982.1 Estrogen receptor, α Isoform 40.50% 8 398 332.28 701.9 
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4.2.7 Radioligand binding studies 
The biospecific capture of 
3
H-T and 
3
H-E2 to magnetic particle immobilised recombinant steroid receptor 
LBDs is presented in Figure 4.21.  No significant difference (p > 0.05) could be observed between β-
galactosidase and hARLBD immobilised to Ni
2+
-functionalised magnetic nanoparticles when treated with 
tritiated testosterone.  However, compared to the control, significant (p < 0.05) amounts of radioactive 
estradiol could be bound by the recombinant hERαLBD and hERαLBD-f proteins.  For both these 
constructs, three fold more 
3
H-E2 was retained following elution from the magnetic particles, compared to 
β-galactosidase treated in the same manner indicating substantial binding activity of the recombinant 
derivatives of the alpha isoform of the human estrogen receptor LBD. 
 
Figure 4.21 Radioligand binding to proteins immobilised on Ni2+-derivitised magnetic nanoparticles.  Radioactive counts per 
minute obtained were normalised against the maximal response observed.  Panel A indicates the results of 
BEVS produced ARLBD (80 CPM) compared to β-galactosidase (Control) (100 CPM).  Panel B compares the 
hERαLBD (752 CPM) and hERαLBD-f (802 CPM) produced in the baculovirus insect cell system against the 
control (241 CPM). 
According to the manufacturer of SiMAG-IDA/Nickel, approximately 30 μg of histidine tagged protein 
can be immobilised to the surfaces of 1 mg particles.  Assuming that the distribution of protein 
immobilised to the nanoparticles is the same as was determined by densitometric analysis of the SDS-
PAGE separation of the collected recombinant containing fractions, and assuming that a total of 30 μg 
protein was sequestered to the particles, it follows that these radioligand assays were executed with 
27.87 μg hERαLBD and 22.68 μg hERαLBD-f, respectively.  With a tritium counting efficiency of 
61.17%, the observed counts equate to 198.89 fmol 
3
H-E2 and 260.62 fmol 
3
H-E2 that could be bound, 
respectively, by 1 mg of the hERαLBD and hERαLBD-f forms of the human estrogen receptor derived 
proteins. 
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4.3 CONCLUSION 
During this study the genome of a commercially available AcMNPV-derived insect pathogen was 
successfully altered, leading to the generation of three recombinant baculoviruses.  The classical method 
of homologous DNA exchange between the baculovirus genome and a donor plasmid placed the genes 
encoding the histidine tagged LBDs of human nuclear receptors under the control of the very strong viral 
polh promoter.  Good expression of the products from these genes were readily identified following 
initial creation of these viruses, with a majority complement of recombinant protein present within the 
soluble fractions of cell lysates.  Similarly to what has been reported in literature for some constructs, the 
T. ni BTI-TN-5B1-4 cell line performed well in the expression of the hER-derived LBDs (469).  
Considering the yield obtained for the recombinant hERαLBD and hERαLBD-f constructs, 9.49% and 
5.75% of the total protein complement, the purification of active LBD to the androgen receptor with the 
BEVS, as with the E. coli expression system, has to date proven difficult.  Table 4.4 gives an indication 
of the theoretical amounts of recombinant human sex steroid LBDs that can be produced according to the 
protocols and conditions that have been employed during this study. 
Table 4.4 Comparison between the expression of histidine tag containing protein constructs of the human receptor LBDs 
towards androgenic and estrogenic hormones.  Purification of the heterologous proteins was carried out by 
means of IMAC. 
 BEVS Bacterial expression 
 hERαLBD hERαLBD-f hARLBD ARLBD ERαLBD 
Total protein in 400 mL culture (mg) 741.84† 691.2† 636.24† 249.2 384.46 
Protein applied to column (mg) 110.0 110.0 192.4 249.2 384.46 
Concentration after purification (mg/mL) 6.42‽ 5.58‽ 1.03‽ 0.75‡ 0.559‡ 
Elution volume (mL) 1.75 1.50 3.00 4.00 1.50 
Densitometric percentage 92.9 75.6 54.8 57.0 99.2 
Total protein (mg) 10.44 6.33 1.69 1.71 0.832 
Percentage of total protein complement 9.49 5.75 0.88 0.69 0.22 
Theoretical quantity of recombinant protein 
obtainable from 400 mL culture (mg) 
70.4 39.8 5.59 1.71 0.83 
† Protein quantities inferred from 200 mL cultures infected with recombinant baculovirus at MOI > 10 
‽ Concentration of dialysate 
‡ Concentrations calculated as the average concentration of all fractions collected during GPC 
For both the androgen and estrogen receptor constructs the BEVS yield considerably more recombinant 
protein per volume of culture.  The production of human LBDs of the alpha estrogen receptor was 
particularly successful, for both the sole E domain, as well as the E/F construct.  Although the radioligand 
retained by these forms of the receptor was less than anticipated, there was significant capture of 
3
H-E2 
by the ERαLBD-derived proteins over that exhibited by the control.  However, the inability of the 
ARLBD to sequester the tritiated ligand is a concern.  Still further investigation into the binding 
capabilities of the heterologously produced LBDs is required.  Nuclear receptors, especially the domains 
involved in ligand binding, are highly hydrophobic molecules.  As with the bacterially produced receptor 
LBDs, solubility, especially during long term storage involving freezing and thawing cycles, becomes a 
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primary concern.  Precipitation from solution is a frequent and problematic event which hampers analyses 
and biological applications following purification.  Faster turn-around from purification to 
immobilisation onto solid surfaces for activity testing could possibly improve the results obtained thus far 
by inhibition of destabilising aggregation. 
Comparatively, apart from a need for the development of sterile technique, the BEVS, as utilised in this 
project is easily implemented and does not require a level of skill far exceeding that needed for use of the 
bacterial expression system.  Homologous recombination between linearised baculovirus DNA lacking 
the downstream essential ORF1629 gene and a donor plasmid, carrying the missing sequence in addition 
to the transgene, can generate recombinant virions at nearly 100% efficiency.  However, according to 
Kollewe and Vilcinskas (249) the partial deletion of ORF1629 by restriction endonuclease inevitably 
leaves a small amount of undigested parental molecules behind.  Such possible contamination should be 
addressed by plaque assay to assure that no contamination of viral stocks by intact parental viral particles 
has occurred. 
Nevertheless, the purification of two variants of the human ERαLBD that could successfully bind a 
natural ligand to this receptor, while attached to a solid support via an incorporated affinity-tag, was 
achieved.  Therefore, there is a possibility that these heterologously produced human-like proteins may 
be used to sequester molecules exhibiting estrogenic activity within aqueous solutions.  The binding of 
such ligands to receptors may be investigated by a variety of means, including radioactive assays, SPR 
and immunohistochemical techniques.  Consequently, availability of these proteins may be used for 
environmental remediation via the development of technologies capable of the facile detection or removal 
EDCs from aqueous solutions. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE PERSPECTIVES 
The occurrence of synthetic chemicals in the aquatic, marine and terrestrial environments is of major 
concern in terms of global health.  Current projections on population growth indicate that during the first 
decade and a half of the twenty first century more than one billion people will have been added to the 
total population.  Increased access to primary health care, disease eradication programs and improved 
vaccines and pharmaceuticals will result in a global population of 7.1 billion people by 2015 (470).  More 
people are surviving to childbearing age and beyond, thus raising the proportion of adolescent and 
elderly, nonworking people.  Primarily this growth has been, and continues to be, in low- and middle 
income countries.  The rapid addition of more people to a country can make it difficult to provide a 
concomitant rise in health and living standards whilst simultaneously emphasising increased 
environmental protection.  According to the United Nations Population Fund “the eradication of poverty 
and the assurance of environmental sustainability are today’s greatest challenges and are intrinsically 
linked to population dynamics” (471). 
In essence, the more people there are on earth the greater the need for the provision of health care, 
housing, jobs, energy, tillable land, food and access to clean water.  Resultantly, greater pressure is 
exerted on natural resources, ultimately leading to environmental deterioration.  For example, farmable 
land is essential to sustain high rates of human population growth.  Thus, in many parts of the world, 
especially in developing countries, deforestation and subsequent desertification may occur as more land 
is required for intense food producing agricultural practices.  Deforestation leads to diminishment of the 
amount of evapotranspiration of water from soil and plants leading to a reduction in humidity, altering 
rainfall patterns and increasing water runoff to rivers and oceans (472), thereby promoting land 
demineralisation and erosion (473).  Consequently, less soil nutrients and water are available in such 
areas for sustained agriculture.  Water quality and availability is intrinsic to public health and greatly 
impacts on the sustainable development and economic progress of a country.  Between 1990 and 2012, 
more than 2.3 billion people gained access to improved sources of drinking water (474).  Nevertheless, 
within the developing world, where economic progress is limited, a variety of water related issues 
threatens the global gains formulated under the United Nations Millennium Development Goals (475) for 
the improvement of access to safer drinking water (476).  Water quality assurance programs in third 
world countries are often circumscribed by a lack of scientific skill and knowledge, poor monitoring 
capabilities and inadequate regulation, resulting in the contamination of water supplies by industrial 
chemicals, pesticides and biological waste.  Moreover, many persistent chemicals capable of disrupting 
the biochemical processes of the endocrine system are imported to developing countries as agricultural 
aids or agents for pathogen control (11). 
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The occurrence of EDCs and PPCPs within the environment is believed to be detrimental to public health 
and within industrialised countries trace level detection of synthetic biologically active chemicals have 
received much attention.  Conversely, due to poor waste disposal practices and a lack of infrastructure to 
effectively test and treat contaminated water, people in developing countries are increasingly being 
exposed to pesticides and other EDCs.  In light of the deleterious effects that EDCs may elicit, continual 
assessment of the environmental impact of chemical and pharmaceutical discharge at specific locations 
such as water and sewage treatment facilities, industrial zones and rural water access points, which may 
affect the lives of people and animals, is a necessity.  Still, any action plan aimed at the successful 
management of EDCs or the formulation and implementation of strategies for environmental remediation 
(477–479) would ultimately require methods capable of rapid and cost-effective detection of problematic 
compounds.  In contrast to the developing world, industrialised countries have access to the infrastructure 
and knowledge base needed to implement various analytical techniques for the monitoring of specific 
EDCs (41, 115, 116, 480).  However, internationally agreed and validated testing methods capture only a 
limited range of the known spectrum of EDCs (102).  There is therefore a growing need for the 
development of a rapid and economical EDC detection system that may be used in situ with a low 
demand for technical capabilities.  Such a system must negate any necessity for specialised equipment 
and must be able to detect a range of different molecules without the need for complicated end-points or 
additional steps such as chemical derivitisation or the maintenance of test animals.  Ideally, therefore, 
EDCs must be identified by their biological mode of action and not by specific molecular structures. 
The first requirement in the design of such a novel system, capable of the simultaneous detection of a 
variety of chemicals which occur at low concentrations, is the ability to selectively sequester and 
concentrate molecules with analogous biological effects.  Following the inception of IMAC in 1975 by 
Porath et al. (481) the availability of increasingly improved chelating agents, such as nitrilotriacetic acid 
(NTA), iminodiacetic acid (IDA) and carboxymethyl aspartate (CM-Asp) has, in conjunction with 
recombinant DNA technology, led to this technique becoming one of the most widely used forms of 
affinity chromatography available for the purification of proteins in research and industrial environments 
(482).  However, the principles of IMAC also provide an easy yet effective mechanism for the facile 
immobilisation of recombinant proteins to a variety of stationary surfaces.  Examples of surfaces to 
which recombinant oligohistidine-tagged proteins have been stably and functionally immobilised include, 
among others, glass coated with a NTA modified poly(ethylene glycol) polymer (483), paper (484) and 
mesoporous silica (485, 486) functionalised with surface-oxidised nickel nanoparticles, chloro-silane-
functionalised magnetic nanoparticles (487), and nanoporous alumina membranes silanised with 
aminopropylsilane and IDA (488).  The functional immobilisation of 6xHis-tagged nuclear receptor 
LBDs to a stationary contactor membrane surface could therefore present a means to selectively 
concentrate environmental EDCs, with affinity for the specific receptors, to readily detectable levels. 
On the other hand, immunohistochemistry presents a possible means to detect EDCs captured by 
membrane-immobilised receptor LBDs.  Antibodies are highly specific in their interaction with cognate 
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antigens.  Following the development of the hybridoma methodology (489) in 1975 by Cézar Milstein 
and George J. F. Köhler, monoclonal antibodies (mAb’s) have been extensively utilised in a variety of 
applications in the health, academic and commercial sectors.  Vertebrates make billions of different 
antibodies, each with a binding site that recognises a specific region of a macromolecule.  The hybridoma 
technique allows for the isolation and immortalisation of particular, highly specific antibodies.  Via 
coordinated bonds to a defined epitope, mAb’s are capable of detecting small changes in the molecular 
structures of proteins.  For instance, mAb’s have been used for the detection of single amino acid 
substitutions in the tyrosine kinase domain of the epidermal growth factor receptor which promote the 
proliferation of adenocarcinomas of the lung (22, 23 and references included within).  Moreover, post-
translational modifications of proteins have also been probed by means of phosphorylation-state (492) 
and acetylation-state specific (493) mAb’s.  Importantly, mAb’s have been effectively used in the 
detection of conformational changes in the maize auxin-binding protein (494) and the progesterone 
receptor (495). 
The ligand-induced conformational changes that occur within the LBDs of nuclear receptors have been 
well documented in multiple publications and have been discussed in chapter two of this study.  By 
utilising mAb’s that can distinguish between the ligand-bound and apo conformational states of receptor 
LBDs, an EDC detection kit may be assembled to detect a broad range of molecules based on receptor 
interaction (Figure 5.1).  This system would be able to selectively concentrate EDCs with affinity to a 
specific class of membrane-immobilised receptor LBDs, such as the recombinant hARLBD or hERαLBD 
proteins.  Binding of these conformation-indicative mAb’s to liganded receptor LBDs may then be 
detected by secondary, enzyme-coupled antibodies via visualisation with standard colorimetric 
techniques. 
 
Figure 5.1 Schematic representation of an affinity membrane based biosensor for the selective capturing, concentration and 
detection of EDCs using immobilized 6xHis-LBDs of steroid receptors and antibodies specific for the ligand bound 
form of the protein (496).  
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Furthermore, the conformational changes that occur within the nuclear receptor LBD upon ligand binding 
may be exploited to detect specific classes of EDCs.  For example, agonist binding to the estrogen 
receptor leads to the formation of the AF-2 groove on the surface of the LBD.  As with nuclear box 
containing protein cofactors within the cell, monoclonal antibodies that have been raised to detect the 
resulting amino acid arrangement would only be able to coordinate with the LBD if the AF-2 is present.  
Conversely, antagonists would not be able to induce this conformation change, thus this system would 
selectively identify ER agonists.  Weigel et al. (495) prepared a mAb (C-262) to a synthetic peptide 
containing 14 amino acids from the carboxy-terminal of the progesterone receptor (PR).  This mAb was 
able to detect the PR when bound to the antagonist RU486.  However, when bound to the agonists 
progesterone or R5020, C-262 was unable to recognise the PR, suggesting that the epitope present at the 
carboxy-terminus is unavailable to mAb interaction when in the agonist-induced conformation.  
Alternatively, other epitopes may be identified on LBD surfaces that only become accessible upon 
activation of the receptor, regardless of the nature of the ligand.  Using surface plasmon resonance Kong 
et al. (497) describe the interaction of a biotinylated αII peptide (SGSGLTSRDFGSWYA) (498) with an 
ERαLBD construct.  This peptide, while immobilised to a solid support, was able to interact with the 
ERαLBD when bound to both agonists (E2, DES, genistein) and an AF-2 antagonist (OHT).  Importantly, 
this study indicated that AF-2 was not required for αII binding, since a mutant LBD lacking H12 
(ERαΔH12) retained binding capabilities to αII.  Therefore, it may reasonably be argued that mAb’s 
capable of identifying an epitope analogous to that recognised by αII would be able to non-selectively 
identify liganded ERαLBD in the presence of either agonists or antagonists.  Moreover, several other 
such protein-protein interaction surfaces have also been identified (498–501). 
The recombinant baculoviruses produced during this study, along with methods developed for the 
solubilisation of proteins of a hydrophobic nature, allow for high-level expression and purification of 
truncated forms of human nuclear receptors.  Moreover, the incorporation of 6xHis-tags to the 
recombinant proteins not only facilitates directed purification of the receptor LBDs following synthesis in 
heterologous expression systems but will also be used for the facile immobilisation of these proteins to 
synthetic contactor surfaces by means of IMAC principles.  Consequently, the immobilised LBDs will 
form the basis of a novel BBA based on the principles described above that is capable of the 
sequestration, concentration and indiscriminate detection of hormonal mimicking EDCs within 
environmental milieus.  Due to the low skills requirement and economy of the proposed BBA, such EDC 
detection kits may provide beneficial insight into the health and safety aspects of drinking water in urban 
and rural areas alike, especially in parts of the developing world where scientific infrastructure is lacking. 
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